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Glucocorticoids (GC) have a negative effect on age-ssociated cognitive decline and 
the GC metabolising enzyme 11β-hydroxysteroid dehydrogenase Type 1 (11β-
HSD1) plays a key role in these effects. Increased glucocorticoids exert detrimental 
effects on the volume and function of brain regions such as the prefrontal cortex 
(PFC) and hippocampus that are necessary for cognitive functions such as memory 
and working memory. Previous research has identified changes in cell populations, 
metabolite levels and structure within the brain as well as altered levels of 
inflammation with age, and studies have suggested th se biomarkers to be associated 
with cognitive impairments. Aged mice with a deletion in 11ß-HSD1 (11β-HSD1-/- 
mice), resulting in lower levels of glucocorticoids within the brain, exhibit attenuated 
cognitive decline in hippocampal dependent spatial le rning and memory with age. 
However, the mechanisms through which 11β-HSD1 contribute to age-associated 
cognitive decline remain unknown. However, previous genetic models of 11β-HSD1-
/- mice have demonstrated residual 11β-HSD1 activity in the brain which may still 
exert some effects on cognitive processes. Furthermor , the effect of 11ß-HSD1 on 
working memory – a more cognitively demanding process ssential for everyday 
decision making - has yet to be determined. This thesis tests the hypothesis that 
glucocorticoid action mediates age-associated cognitive impairment in spatial 
learning and memory and spatial working memory through alterations in cell 
activity, brain metabolite levels and neuroinflammatory processes. Therefore, we 
aimed to investigate if complete lifelong 11β-HSD1 deficiency would protect against 
age-associated working memory deficits as well as spatial learning and memory 





changes in hippocampal metabolite levels, cell activity and inflammation as a 
function of ageing in a longitudinal manner. At 6, 12, 18 and 22 months, male 11β-
HSD1-/- and C57BL/6J control mice were cognitively assessed in the Morris Water 
Maze (MWM) and Radial Arm Water Maze (RAWM) – tests for spatial reference 
memory and spatial working memory respectively. Magnetic resonance spectroscopy 
(1H-MRS) was performed to examine the hippocampal metabolite profile in the same 
mice at 6, 18 and 22 months. Following their final scan, mice were culled and brains 
dissected for analysis. Results revealed unaltered spatial learning with age in 
C57BL/6J and 11β-HSD1-/- mice and pointed to a development of alternative 
strategies for task completion as a result of repeated testing. Spatial memory was 
more susceptible to age-associated effects with impair ents in wild-type mice but 
not 11β-HSD1-/- mice, though not completely immune from the effects of repeated 
testing. These impairments were correlated with glutamate/glutamine levels and glial 
fibrillary acidic protein (GFAP), whilst GFAP was further correlated with 11β-HSD1 
protein expression. Working memory was impaired with age in both 11β-HSD1-/- and 
wild-type mice, suggesting 11β-HSD1 deletion may be detrimental to cognitive 
processes in the prefrontal cortex. In conclusion, impaired memory with age may be 
attributed to increased glial reactivity and altered glutamate/glutamine cycling in the 
hippocampus, and lifelong removal of 11β-HSD1 may alter these processes. 
However, lifelong removal of 11β-HSD1 may not be as beneficial to working 
memory processes suggesting that 11β-HSD1 and glucocorticoid action play a key 








Stress hormones have a negative effect on impairments in learning and memory with 
age. Changes in processes and structure in the brain have been linked to changes in 
learning and memory, and increased levels of stress hormones have negative effects 
on the brain. Aged mice with a genetic mutation resulting in decreased regeneration 
of stress hormones within the brain do not show the same impairments in learning 
and memory as normal ageing mice. However, the processes resulting in this 
protection remain unknown. Furthermore, the effect of lower levels of stress 
hormones on different types of memory has yet to be determined. This thesis 
investigates the theory that increased levels of stres  hormones with age mediates 
impairments in learning and various types of memory through changes in cell 
activity, substances necessary for brain function, a d inflammation processes. 
Therefore, we investigated if mice with a genetic mutation resulting in the 
termination of stress hormone regeneration would be protected from age-associated 
impairments in spatial memory (information about one's environment and spatial 
orientation) and working memory (the storage and manipulation of information). We 
also examined the effect on cell activity, substances necessary for brain function, and 
inflammatory processes. Spatial memory was more susceptible to age-associated 
impairments in normal mice, and related to changes in cell activity and substances 
playing a key role in cell-to-cell communication. However repeated practice in tasks 
requiring spatial memory was also able to prevent impairments. Working memory 
was impaired with age in both normal mice and mice lacking the regeneration of 
stress hormones, indicating that decreasing stress hormone levels may not be 
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Chapter 1 : Introduction 
 Background 1.1
The frequency of age-related health problems is of gr wing importance as the 
percentage of older individual’s worldwide increases. Projections estimate that by 
2050 the number of individuals older than 60 years will account for 22% of the 
world’s population. With dementia being one of the major disabilities in the elderly 
and a substantial percentage of the elderly population suffering from cognitive 
decline unrelated to an underlying disease, one increasingly vital healthcare concern 
is cognitive ageing. 
It is estimated that the number of people living with mild cognitive impairment and 
dementia will almost double every 20 years with approximately 115.4 million people 
living with mild cognitive impairment or dementia by 2050. Additionally, outside of 
pathological cognitive dysfunction, preliminary estimates suggest that over 55% of 
the aged population experience functional cognitive deterioration with normal 
ageing. Consequently, the health and social burden of cognitive impairment and 
dementia on societies worldwide is increasing rapidly. Thus, tackling the problem of 
age-related cognitive impairment is of great importance in not only ensuring a better 
quality of life for older individuals but also alleviating the growing burden on 
healthcare communities all over the world.  
However, considerable individual differences in cognitive performance are often 







function throughout the lifespan, to pathological aging, with impairment in memory 
and other cognitive abilities present (Daffner, 2010). Understanding what drives 
these individual differences in cognitive aging may provide crucial groundwork for 
developing effective therapeutic interventions to improve the quality of life for the 
rapidly increasing population of elderly. 
It has been proposed that individual differences in both the decline of cognitive 
function and the differences in cognitive abilities during ageing can be attributed to 
variations in glucocorticoid levels and glucocorticoid exposure. This hypothesis has 
resulted in a myriad of studies examining the action of stress and glucocorticoids on 
cognitive function and ways in which these actions can be modulated. In our 
laboratory, we utilise a rodent model of intracellular glucocorticoid modulation 
through the lifelong removal of glucocorticoid metabolising enzyme 11β-HSD1. 
Indeed, the phenotype of this model is similar to those of low glucocorticoid models, 
with an attenuation of cognitive impairment with age. The aim of this thesis was to 
utilise a longitudinal analysis of the 11β-HSD1 knockout model to investigate the 
effect of lifelong removal of 11β-HSD1 on different types of memory at various 
time-points throughout ageing, and to further determine the mechanisms through 
which it may be attenuating age-related cognitive declin . 
 Cognitive Ageing 1.2
1.2.1 Human Studies of Cognitive Ageing 
With the growing ageing population and progressing concerns of age on cognition 







important, increasing knowledge of the problem at hnd and aiding in the 
development of appropriate therapeutic interventions.  
Human studies have identified two major categories of cognitive tests - tests 
assessing processing ability at the time of assessment and those assessing processing 
carried out utilising previously acquired knowledge. Tests assessing processing 
ability at the time of assessment involve the evaluation of memory, efficiency of 
reasoning, processing speed and executive function and typically comprise of novel 
problem solving paradigms. These tests assess what is typically referred to as fluid 
mental abilities, abilities essential for everyday activities and living independently. 
On the other hand, tests assessing processing utilising previously acquired 
knowledge examine previously acquired knowledge of general information, verbal 
ability and numerical ability. These tests assess what is often referred to as 
crystallized ability. 
From examining these aspects of cognitive ability, a vast body of research on 
cognitive ageing in humans has found three major patterns of age-related patterns of 
cognitive function: 1) Cognitive function which remains relatively stable across life; 
2) Declines that occur late in life; and 3) Declines across the lifespan. These three 
patterns suggest that, whilst ageing might have global effects on cognitive ability, it 
affects certain cognitive functions more than others and targeting the mechanisms 
underlying these cognitive processes may be an effective start to tackling the 







 Life-Long Stability 1.2.1.1
Behavioural research examining the effects of age on cognitive function found that 
not all cognitive abilities decline with age.  
Autobiographical memory refers to the memory for an individual’s own life events. 
These memories have been observed to be unaltered in non-pathological cognitive 
ageing with studies observing unchanged patterns of recall in aged individuals 
(Fromholt et al., 2003). 
Similarly, the ability to attribute mental states to other individuals (emotional 
processing) has also been noted to remain unaltered with age (Happe et al., 1998) 
whilst attention to emotions and regulation of emotional states was also found to be 
unaltered in aged individuals (Carstensen et al., 2003). 
Finally, automatic processes – the use of previously learned information for 
subsequent tasks – also demonstrated limited alterations with age. Studies have 
found unaltered performance in aged individuals on c gnitive tasks requiring the use 
of automatic processes such as recognition tasks (La Voie and Light, 1994; Spencer 
and Raz, 1995). 
 Late-life Declines 1.2.1.2
Crystallised abilities involving numerical and verbal recall and tasks requiring 
previously acquired knowledge to be drawn on show little decline until very late in 
life (GrÉGoire and Van Der Linden, 1997). Both longitudinal and cross-sectional 
studies show declines in vocabulary and semantic knowledge only in late in life with 







It has been suggested that a combination of experience a d accumulated knowledge 
in elderly individuals might result in use of preserved knowledge and experience to 
form more efficient or effective strategies when performing tasks in which younger 
adults rely on processing ability explaining the relative stability of these cognitive 
processes throughout ageing (Shimamura et al., 1995; Dixon et al., 2004). 
 Life-Long Declines 1.2.1.3
Basic mechanisms of cognitive function, such as processing speed, working memory 
and encoding of information have been noted to declin  across the adult lifespan, 
however, cross-sectional and longitudinal data sets have produced variable results. 
 In cross-sectional studies by Park et al. (1996, 2002), individuals (matched for 
education, health and demographic variables) from each age decade from 20 to 80, 
processing speed, working memory and episodic memory we e observed to follow a 
linear pattern of decline throughout ageing from the age of 20 with no acceleration of 
decline in later life. These results were also observed in a cross-sectional 
examination of data from the Seattle Longitudinal Study, linear age-related declines 
were observed for processing speed, episodic memory, spatial ability and reasoning 
(Schaie et al., 2004). 
However, in a longitudinal analysis of the Seattle Longitudinal Study and other 
longitudinal studies, cognitive function shows a limited decline from age 20 to 60 
with a linear decline similar to the rates observed in cross-sectional studies becoming 
noticeable only after the age of 60 whilst in other longitudinal studies a sharp decline 
is observed in late life whilst a curvilinear decline observed prior to this decline 







1.2.2 Animal Studies of Cognitive Ageing 
As discussed in the section above, human studies have observed variations in 
cognitive decline with age depending on the type of cognitive function.  
Studies utilising animal models to examine the effect of age on cognitive processes 
stretch far back. In particular, spatial reference and working memory is typically 
assessed in the Morris water maze and in variations f the radial arm maze 
respectively.   
Early studies by Verzár-Mcdougall (1957) already demonstrated impairments in 
learning and memory in aged rats with the rate of learning decreasing with age. More 
studies have further supported non-pathological cognitive deterioration with age 
showing an age-associated impairment in spatial learning and memory in the Morris 
water maze with young and middle-aged rats achieving the learning criteria within 
three trials whilst aged rats required more trials to reach the learning criterion 
(Gallagher and Burwell, 1989; Jiang et al., 1989). Interestingly, individual 
differences in cognitive ageing were also observed in these studies with variable 
learning scores noted within the aged group. Similar studies examining learning and 
memory in mice and rats utilising the Y-maze (Dean t al., 1981), Morris water maze 
(Frick et al., n.d.; Wyss et al., 2000; Bizon et al., 2009), radial arm maze (Shukitt-
Hale et al., 2004) and passive avoidance (McNamara et al., 1977) have also observed 
impairments in aged animals compared to their performance when young or a young 
control group as well as a spread in the performance within the aged groups.  
The neuroanatomies behind these behavioural tests as essing spatial reference and 







key role in spatial memory, with the hippocampus trisynaptic loop (entohinal-
dentate-CA3-CA1) mediating place recall memory (Lee et al., 2005). Furthermore, 
facilitation of plasticity at the entorhinal-dentate synapse in mice is sufficient to 
enhance place recall and hippocampal lesions have been found to impair spatial 
memory (Saab et al., 2016). On the other hand, the prefrontal cortex is a key region 
in spatial working memory with lesions in the prefrontal cortex resulting impaired 
radial arm maze performance (Becker et al., 1980).  As such, the variability in 
performance within aged animals has enabled the search for neural alterations which 
may contribute to age-related cognitive dysfunction. These studies have identified 
key neural alterations within these brain regions associated with cognitive 
impairment with age including, though not limited to, alterations in long-term 
potentiation, blood flow, brain structure and volume, cell morphology, density and 
expression, and metabolite expression. Below, some of the neural correlates 
examined in our study are discussed. 
 
Figure 1.1 Brain regions and circuits mediating spatial memory and 
spatial working memory 







 Patterns, Neural Correlates and Modifiers of 1.3
Cognitive Ageing 
Understanding the patterns and biological underpinnings of the above changes in 
cognitive ability is essential in developing appropriate therapeutic interventions. 
Numerous studies have examined various aspects of changes in the brain with age in 
the hope of identifying common markers and neural patterns which correlate with 
cognitive changes with age. In particular, studies have investigated alterations in 
brain structure, brain metabolite levels and changes in cells expression, morphology 
and distribution in the brain utilising both cross-sectional and longitudinal 
approaches. 
1.3.1 Structural Markers of Cognitive Ageing 
Before the arrival of MRI imaging, investigations into structural changes which may 
occur in the brain during ageing were limited to post-mortem studies. In a study by 
Skullerud (1985) to investigate factors which alter brain weight and ventricle 
volume, age was observed to be a factor resulting in physiological decrease in brain 
weight and increase in ventricular size. Further combined with studies suggesting a 
decrease in brain weight and significant increases in ventricle volume in individuals 
with Alzheimer’s disease, the results suggested that t e structure of the brain in 
ageing is a significant marker of cognitive decline and that the supporting structure 
of the brain is of key importance to cognitive ability. 
The recent development of in-vivo imaging techniques ha  allowed a better insight 
into structural changes in the brain during healthy ageing and the relationship 







increasing global atrophy was observed with age whilst Van Petten (2004) found 
decreased total cerebral volume with age. These results were complemented by 
Tisserand et al. (2000) who observed a decrease in total brain volume with age and a 
relationship between total brain volume and memory and executive function whilst 
MacLullich et al. (2002) who noted that increased general brain size in aged 
individuals was associated with general cognitive factor as assessed by measures of 
premorbid intelligence, fluid intelligence, verbal memory, visuospatial memory, 
verbal fluency, and attention and processing speed, further cementing the 
relationship between age, brain structure and cogniti n. 
Whilst the results observed have been variable from study to study, cross-sectional 
studies have also observed associations between age and volume of a number of 
specific brain structures and have further gone on to establish relationships between 
the volume of these brain structures and cognition.  
In particular, a myriad of studies have examined the hippocampus in ageing – a key 
structure in cognition. An increase in hippocampal atrophy with age has been well 
established in these studies with higher levels of gl bal and verbal memory also 
being associated with increasing hippocampal size. Similarly, Golomb et al. (1993) 
noted a larger group of individuals exhibiting hippocampal atrophy with age 
compared to individuals not exhibiting any hippocamp l atrophy with better levels of 
verbal memory and a trend for higher levels of non-verbal memory (attention, 
working memory and visual memory) in individuals without hippocampal atrophy 
whilst a further study by O’Brien et al. (1997) noted poorer scores in the Cambridge 







Language, Motor Skills, Verbal & Visual Memory) in aged adults with hippocampal 
atrophy compared to those not exhibiting hippocampal atrophy. Additional support 
for alterations in hippocampal structure with age was provided by further studies 
demonstrating a decrease in hippocampal volume withage and an association 
between hippocampal volume and verbal memory, visual memory, working memory 
and executive function (Golomb et al., 1994; Raz et al., 1998, 2000; Tisserand et al., 
2000; Hackert et al., 2002; Convit et al., 2003; Dickerson and Eichenbaum, 2009). 
In addition to the hippocampus, cross-sectional studies revealed the prefrontal cortex 
as a second brain structure altered significantly with age and affecting cognitive 
ability. As was observed with the hippocampus, the pr frontal cortex (PFC) was 
found to decrease in volume with age and PFC volume was noted to be associated 
with visuospatial processing, processing speed, working memory and executive 
function. In particular, Zimmerman et al. (2006) observed that below the age of 40, 
frontal cortex volume was not associated with executive function, however, in 
individuals aged above 40, smaller frontal volumes were observed to be related to 
poorer executive function. Furthermore, Fjell et al. (2006) found that aged adults 
with high fluid ability had thicker cortex in the PFC as compared to aged adults with 
average fluid ability. 
Finally cross-sectional studies also pointed to a significant relationship between 
lateral ventricle size, age and cognition. Studies revealed a significant increase in 
lateral ventricle size with age with ventricle size associated with processing speed 







This illustration of how fragile the relationship between cognitive function and 
supporting structure is further supported by longitudinal studies. In these studies it 
was noted that increased hippocampal atrophy and decreased hippocampal and 
prefrontal volume were associated with increasing age with studies further noting an 
increase in the rate of decrease with increasing age (Cohen et al., 2001; Marquis et 
al., 2002; Rodrigue and Raz, 2004; Walhovd et al., 2004; Raz et al., 2005). 
Conversely, lateral ventricle volume was observed to increase with aging (Cook et 
al., 2004; McArdle et al., 2004). The relationship between these brain structures and 
cognitive function was also assessed and whilst some studies observed minimal 
association between volume of each brain region and cognition, a number of studies 
noted better memory and global cognition levels with larger hippocampal and 
cortical volumes and higher global cognition levels with smaller lateral ventricle size 
(Visser et al., 1999; Marquis et al., 2002; McArdle et al., 2004; Walhovd et al., 
2004). In particular, McArdle et al. (2004) assessed amples of both young and aged 
adults and observed that the relationship between lateral ventricle size and memory 
was strengthened with age. 
1.3.2 Metabolite Markers of Cognitive Ageing 
Along with the ability to assess the structure of the brain, the development of in-vivo 
imaging techniques has also allowed the quantificaton of metabolites within the 
brain through proton magnetic resonance spectroscopy (1H-MRS). As with MRI 
techniques, 1H-MRS has been utilised to examine metabolite markers for cognitive 
ageing although changes in brain metabolite levels throughout ageing is less explored 







Previous 1H-MRS studies have examined age-related changes of brain metabolite 
concentrations with a number of different methods, population size, and variable 
results. In particular, these studies have largely examined the metabolites Choline 
(Cho), Creatine (Cr) and N-acetylaspartate (NAA). These metabolites are associated 
with membrane turnover/breakdown, energy metabolism of neurons and glia, 
neuronal viability, and glial cells respectively. 
No major difference in brain metabolite trends in ageing have been observed, 
however, results remain debated due to the varying structural properties of white and 
gray matter and the lack of a common methodological approach leaving results 
difficult to compare. 
Whilst a side-by-side comparison is limited, due to differences in analysis of results 
and presentation of data, a number of general trends have been observed. 
Perhaps the most established trend observed is a reduction in N-acetylaspartate 
(NAA) with age. Whilst results regarding the rate of decline of NAA in various 
regions and in gray and white matter remain controversial, several studies have 
demonstrated reductions in absolute NAA concentration, NAA as a ratio of creatine 
(NAA/Cr), NAA as a ratio of choline (NAA/Cho) and NAA as a ratio of water 
(NAA/water) over the course of ageing. In particular, these declines have been noted 
in the prefrontal cortex (Chang et al., 1996; Brooks et al., 2001; Driscoll et al., 2003; 
Urrila et al., 2004) and hippocampus (Schuff et al., 1999; Driscoll et al., 2003) of the 








However, the effect of age on other metabolites remains more controversial. In some 
studies, Cho-containing compounds, including phosphrylcholine and 
glycerophosphorylcholine, as precursor and breakdown products of membrane 
phospholipids, respectively, have also been shown to increase with age in several 
brain regions (Chang et al., 1996; Soher et al., 1996; Angelie et al., 2001). However, 
in other contradicting studies, choline has been observed to decrease with age in the 
brain (Charles et al., 1994) whilst further studies have observed no change in choline 
levels during ageing (Schuff et al., 1999; Angelie t al., 2001). 
A few studies have also looked at the effect of age on levels of myoinositol (Ins), a 
marker for glial cells, demonstrating an increase in Ins with age. In particular, Chang 
et al. (1996) noted an increase in Ins in gray matter with ageing. 
1.3.3 Cellular Alterations in Cognitive Ageing 
In addition to structural and metabolite changes with age, cellular alterations have 
also been observed with age and are thought to play a key role in affecting the 
mechanisms of neural plasticity and, in turn, cognitive function.  
Early investigations into the ageing brain suggested that ageing was accompanied by 
a significant loss of neurons in the cortex (Brody, 1955), hippocampus and prefrontal 
cortex. Further studies continued to suggest that neuronal loss and reductions in 
dendritic branching were characteristic of normal ageing and age-associated 
cognitive decline.  
However, the recent development of new stereological techniques has allowed a 







conclusions regarding changing brain structure and cellular alterations with age. 
Whilst previous studies concluded that reductions in brain volume were the result of 
neuronal loss, studies utilising newer techniques have suggested that neuronal loss is 
in fact not a characteristic of normal ageing (West, 1993; Rapp and Gallagher, 1996; 
Rasmussen et al., 1996) functions (Wickelgren, 1996; Morrison and Hof, 1997). 
More recent results support to these conclusions for the cerebral cortex and 
hippocampus of rodents, primates and humans (Burke and Barnes, 2006) whilst 
further rodent and human data suggests that brain volume reduction with age may in 
fact be the result of other cellular alterations (Terry and Katzman, 2001; Hedden and 
Gabrieli, 2004)n dendritic length and complexity (Cruz-Sánchez et al., 1995; Duan et 
al., 2003; Markham et al., 2005; Shimada et al., 2006) were observed along with 
reductions in synaptic density (Itzev et al., 2001, 2003; Adams et al., 2010; Hara et 
al., 2012) and increased spinal loss (Cruz-Sánchez et al., 1995; Dumitriu et al., 
2010). Additionally, some studies have also demonstrated impaired spatial memory 
with age in mice with decreased synaptic density (Geinisman et al., 1986) and 
impaired learning and memory as assessed by a DNMS task in mice with reduced 
synaptic density (Dumitriu et al., 2010; Hara et al., 2012). 
Alterations in other cells in the brain have been examined relatively less than age-
associated changes in neurons due to the assumption that alterations in glia is 
secondary to neuronal degeneration. However, recent studies have observed 
increased glial reaction with age (Kohama et al., 1995). Taken together with the 
importance of neuronal-glia interactions and cognitive function (Bezzi and Volterra, 
2001) this has prompted investigations into the possible role of age-associated glial 







above, studies have suggested that altered synaptic fields with age may play a large 
role in age-associated cognitive impairment and it is noted that glial cells play a large 
role in modulation of synaptic fields (Han et al., 2013) further pointing towards a 
possible role for altered glial cell reactivity in age-associated cognitive impairment.  
Glial cells are classified into three main groups – astrocytes, oligodendrocytes and 
microglia. In aged rats, astrocytic reactivity has been observed in the hippocampus in 
the form of hypertrophy – an increased number of thickened processes and increased 
cell volume (Lindsey et al., 1979). With age, expression of glial fibrillary acidic 
protein (GFAP), a protein found exclusively in astrocytes, and GFAP mRNA was 
observed to be increased indicating increasing glial re ction with age (Goss et al., 
1991; Nichols et al., 1993; Morgan et al., 1997). Additionally, Sugaya et al. (1996) 
observed that increased GFAP with age was associated wi h the extent of cognitive 
impairment with age. 
However, it was also noted that there was an increase in microglia reactivity with age 
with an upregulation of microglial activation markes observed and alterations in 
microglial morphology and expression. Together this data suggests age-related 
neuroinflammation which may also play a role in age-associated cognitive 
impairment and is discussed in further detail below. 
 Neuroinflammation 1.4
1.4.1 The Inflammatory Response 
The immune system is essential in protecting organisms from disease by preventing 







can be divided into two main systems – the innate and the adaptive.  The innate 
immune system is the first line of defence, providing an immediate, non-specific 
response to the detection of pathogens.  The adaptive immune system is subsequently 
activated and responds in a manner more specific to the particular pathogen.  This 
response is stored allowing a faster more efficient r sponse to the pathogen in future. 
The immune response is mediated by phagocyticinnate immune cells, macrophages, 
which detect pathogens via pattern recognition receptors which bind to pathogen-
associated molecule patterns.  The most widely recognised set of receptors are the 
toll-like receptors (TLRs) which are activated by a wide variety of pathogens and 
bacteria.  Activation of these receptors has been fou d to result in the expression of 
cell surface activation molecules [major histocompatibility complex (MHC) class 1, 
II, B7.1, B7.2 and CD40] and the secretion of cytokines [tumour necrosis factor 
(TNF), interleukin (IL)-1, IL-6, IL-12 and IL-18].  The activation of these molecules 
and cytokines then signals the activation of the adaptive immune system to aid in the 
defence of the organism. 
1.4.2 Microglia 
Within the CNS, the immune response is regulated by microglia.  Microglial cells 
comprise 10-15% of the cells in the brain and are concentrated in the hippocampus, 
hypothalamus, basal ganglia and substantia nigra (Lawson et al., 1990).  In the adult 
brain, microglia exist in a resting state characterised by small soma and ramified 
processes which continuously scan the environment in the brain (Nimmerjahn et al., 
2005; Kettenmann et al., 2011).  Minor changes in brain homeostasis activate the 







shorter processes and a bigger soma accompanied by the upregulation of cell surface 
molecules (Davis et al., 1994; Nimmerjahn et al., 2005). 
The extent of microglial activation is influenced by the type and duration of the 
stimulus, however, once activated serve a variety of functions necessary for neuronal 
survival such as cellular maintenance activities and facilitation of repair.  However, 
prolonged activation of microglia can also have detrimental effects and microglial 
activation is controlled through interaction with neuronal signalling molecules.  
Neurons communicate with microglia to maintain their r sting state using membrane 
bound signals such as CD200, CX3CL1 and neurotransmitters (Pocock and 
Kettenmann, 2007; Biber et al., 2008). 
1.4.3 Alternative activation of microglia 
As part of the immune response, research has identified wo main activation states of 
microglia - classical (M1) and alternative (M2) – although it must be noted that it has 
been widely accepted that a number of states inbetween these two states are present.  
Classical activation of microglial cells is mediated by the induction of cell surface 
proteins; in particular receptors involved in the innate immune response are activated 
by a wide variety of ligands including interferon-y, LPS and other TLR activators 
and responses to bacterial and viral infections.  Although the classical activation of 
microglia is effective and essential in responding to pathogens, the response can 
often result in damage to the surrounding tissue and the production of chemokines 
CCL2 and MCP-1 which mediate the recruitment of more microglia.  M1-type 
activation is typically associated with disease state  that are partially driven by low 







However, microglia also exhibit a response which inactivates the initial immune 
response and activates genetic pathways associated with tissue repair.  This activity 
is associated with the production of anti-inflammatory cytokines by glia and neurons.  
In particular, cytokines IL-4, IL-10, IL-13 and TGFβ are responsible for alternative 
activation of microglia to M2 state. M2 microglia are characterised by suppression of 
pro-inflammatory cytokines (For review see Mantovani et al., 2004). 
1.4.4 Neuroinflammation in Ageing 
Recent evidence has suggested that during ageing the inflammatory status of the 
brain is altered.  In particular, studies have found that the healthy aged brain is 
characterised by chronic low level inflammation and ‘primed’ microglia.  ‘Primed’ 
microglia have a phenotype of heightened reactivity and in response to activation of 
the immune system demonstrate a more pronounced and prolonged release of pro-
inflammatory cytokines compared to microglia in young brains (Sparkman and 
Johnson, 2008; Frank et al., 2010).  They are often characterised by morphological 
activation (large soma and short processes) but with minimal basal production of 
pro-inflammatory cytokines.  In particular, ‘primed’ microglia show elevated levels 
of expression cell surface activation molecules MHCII, D68, CD80, CD86 and 
ICAM-1 (Perry et al., 1993; Godbout et al., 2005; Frank et al., 2006, 2010; Bilbo, 
2010).  Along with these changes in microglial reactivity, elevated levels of pro-
inflammatory cytokines IL-1β, IL-6 and TNF-α are observed in the normal aged 
brains (Godbout et al., 2005; Sierra et al., 2007). 
Concurrent with increased microglial reactivity and elevated pro-inflammatory 







in normal aged brains (Frank et al., 2006).  In furthe  support of these findings, 
studies have found that genes involved in oxidative str ss, inflammation and glial 
activation are increased during ageing whilst genes associated with synaptic function 
and growth factors decrease (Lee et al., 2000; Blalock et al., 2003; Bishop et al., 
2010).   
Importantly, age-related microglial priming and theshift of the microenvironment to 
a pro-inflammatory state not only affects cognitive function and behaviour but also 
leaves the brain vulnerable to disruptive effects of intrinsic and extrinsic factors such 
as disease, infection and stress which may in turn exacerbate cognitive dysfunction. 
1.4.5 Neuroinflammation and Cognition 
The idea that neuroinflammation plays a role in cognitive dysfunction is supported 
by studies demonstrating an association between inflammatory markers in the brain 
and a variety of pathological diseases in the brain affecting cognitive function such 
as Alzheimer’s Disease (AD), mild cognitive impairment (MCI) and Parkinson’s 
Disease (PD). Furthermore, studies show that the inflammatory response can affect 
metabolic and molecular pathways influencing neurotransmitter systems that can 







   
    
 
 
Figure 1.2 Effect of inflammation on neural circuits and 
neurotransmitter systems. 
Pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumour necrosis 
factor (TNF) reduce the availability of neurotransmitters such as serotonin (5-
HT), dopamine (DA) and noradrenaline (NE) through the increased expression 
and function of the presynaptic reuptake pumps for 5-HT, DA and NE. Pro-
inflammatory cytokines also alter glutamate (Glu) reuptake and stimulation of 
glutamate release, which can in turn lead to decreased expression of genes 
related to cognition such as brain-derived neurotrophic factor (BDNF) and 
excitotoxicity. This in turn can alter neuronal integrity including neurogenesis, 
long-term potentiation and dendritic sprouting and alter learning and memory
processes. 







In addition to the role of neuroinflammation in neuropathological disease states, 
evidence has also established a link between neuroinflammation and non-
pathological cognitive impairment.  Administration f lipopolysaccharide (LPS) or 
IL-1β to rodents has been found to result in an upregulation of pro-inflammatory 
cytokines and subsequently impaired spatial working memory in rodents and 
impaired hippocampal-dependent memory consolidation (Rosi et al., 2006).  In 
support of this, transgenic mice overexpressing the pro-inflammatory cytokine IL-1 
demonstrate impaired spatial working memory (Moore et al., 2009) whilst mice 
deficient in IL-6 show attenuation of LPS-induced spatial memory impairments.  
Furthermore investigations have established that pro-inflammatory cytokines can act 
directly on neurons in the hippocampus resulting in impaired synaptic plasticity as 
well as alter neuronal function, neurogenesis and impa r long-term potentiation.  
More recently, Bonow et al. (2009) revealed during a microarray analysis of cortical 
tissue from mice injected with LPS that as well as in increase in inflammatory genes, 
neuroinflammation also leads to a decrease in genes r lated to learning and memory. 
In a complimentary study, it has been found that mice deficient in IL-10, an anti-
inflammatory cytokine, show impaired spatial memory following LPS administration 
accompanied by elevated levels of pro-inflammatory cytokines whilst administration 
of anti-inflammatory agents reduces age associated increases is MHCII and 
attenuates impairments in LTP (Griffin et al., 2006). 
Also notable is the effect of peripheral inflammation on cognitive function with 
elevated peripheral cytokine levels associated with lower cognition.  Similarly, 







and acute infection in humans has alluded to a connectio  between inflammation and 
cognitive dysfunction. 
However, it has been observed that in situations such as sepsis and chronic stress 
resulting in the breakdown of the blood brain barrier, peripheral inflammation can 
result in elevated pro-inflammatory cytokine expression in the brain (Munhoz et al., 
2006).   
Therefore, the above evidence demonstrates that infl mmation plays a large role in 
neuronal-glial communication and subsequently neuronal function and cognition, 
whether directly or via peripheral mechanisms, and that both ageing and 
glucocorticoid exposure play a large role in neuroimmune function.  Determining 
how the processes regulate or contribute to neuroinflammation will provide a greater 
understanding of age-related cognitive dysfunction. 
 Glucocorticoids  1.5
Homeostasis is the control of the internal environment and is essential for organisms 
to survive ensuring maintenance of a dynamic equilibrium with their environment. 
The control of this internal environment exists at molecular, cellular, physiological 
and behavioural levels. The condition of stress is a risk to equilibrium and internal 
environment and successful adaptation to the state of stress confers a survival 
advantage. Effective adaptation to stress entails not o ly the ability to react to stress, 
but also the ability to effectively control the stress response according to the stressor. 
The stress system is active even in the absence of stressors, but physical and 







activity of the system. The hypothalamic‐pituitary‐adrenal (HPA) axis and the 
sympathetic and adrenomedullary (sympathetic) system  are primary members of the 
stress system. Increased activity as a result of stress results in central and peripheral 
changes and consequently behavioural adaptation and redistribution of energy to the 
central nervous system, muscle, and stressed body sites.  
Of particular interest to this study, is activation f the HPA axis in response to stress. 
HPA axis activation results in glucocorticoid secretion which is thought to modulate 
the stress response.  
1.5.1 Glucocorticoids 
Glucocorticoids are steroid hormones and are found as cortisol in humans and 
corticosterone in rodents.   Glucocorticoids have a variety of functions including 
playing large roles in developmental processes, regulation of inflammatory responses 
(Sorrells and Sapolsky, 2007), metabolic processes and cognition (Setiawan et al., 
2007).    
Glucocorticoid action is regulated through two different types of glucocorticoid 
receptors: 1) Mineralocorticoid receptors (MR); and 2) Glucocorticoid Receptors 
(GR). Both MR and GR are intracellular ligand-depend t transcription factors 
which, when activated, mediate the termination of the HPA axis stress 
response (via negative feedback at intracellular GRand MR) and modulate the 
responses to stressful experiences (Sapolsky et al., 2000; Oitzl et al., 2001). 
The MR has a high affinity for glucocorticoids (Kd, approximately 0.5 nM) and thus 
facilitates the effect of non‐stress basal fluctuations in glucocorticoids. Conversely, 







glucocorticoid levels are high. Thus, the GR mediates i s effects largely when levels 
of glucocorticoids are elevated due to stress. Glucocorticoid binding to MR and GR 
results in the translocation of activated receptors  the cell nucleus. In the nucleus, 
the ligand-receptor complex binds to the glucocortiid response element (GRE) 
resulting in the transcription of activated genes (Fuller and Young, 2005; Kumar and 
Thompson, 2005). However, the activated GR complex can also repress the 
transcription of other factors present in the cytoplasm of the cell by preventing their 
transcription (Buckingham, 2006) (Fig. 1.3). 
This complementary action of MR and GR allows varying levels of glucocorticoids 








Circulating glucocorticoids diffuse through membranes and bind to GR or MR. 
The activated receptor is then translocated to the nucleus and modulates gene 
transcription through various mechanisms. The ligand-receptor complex can also 
repress transcription by occupying binding sites and competing with co-
activators. 
(Kino, 2010; The Glucocorticoid Receptor; www.http://brainimmune.com/the-
glucocorticoid-receptor/; Accessed Nov 2014) 








1.5.2 HPA axis 
In response to stress, neurons of the paraventricula  nucleus (PVN) of the 
hypothalamus release corticotrophin-releasing hormone (CRH) into the portal blood 
vessel. This surge of CRH acts on CRH type 1 receptors resulting in the release of 
adrenocorticotropic hormone (ACTH) from the anterior pituitary gland into the blood 
where it is transported to the adrenal cortex of the adrenal gland. ACTH 
subsequently binds to receptors in the adrenal cortex which stimulates the secretion 
of glucocorticoids from the adrenal glands (Miller and O'Callaghan, 2005).  This 
results in a surge in circulating glucocorticoid levels, which bind to glucocorticoid 
and mineralocorticoid receptors, activating mechanisms and processes allowing the 
body to adapt to and survive both the physical and emotional disturbances. Once the 
stressor has diminished, negative feedback loops are initiated by binding of 
glucocorticoids to glucocorticoid receptors (GR) in the PVN and anterior pituitary 
gland and mineralocorticoid receptors in the PVN (Fig. 1.2). HPA axis activity to 
stress is in part regulated by the binding of glucocorticoids to the glucocorticoid 
receptor (GR) and the mineralocorticoid receptor (MR) which alter ACTH and CRH 
release. 
However, despite short-term, immediate benefits of elevated glucocorticoids, long-
term exposure to elevated glucocorticoid levels has been found to have deleterious 
effects both peripherally and within the central nervous system.  In particular, 
chronic exposure to elevated levels of glucocorticoids have been associated with 
cardiovascular disease, hypertension, type 2 diabetes, obesity as well as a variety of 
disorders and structural changes within the central nervous system - particularly 









Figure 1.4. HPA-Axis Activation 
The paraventricular nucleus (PVN) in the hypothalamus secretes both CRH and 
AVP from the paraventricular nucleus which stimulates the production of ACTH 
in the anterior pituitary. ACTH travels via the blood to the adrenal gland 
resulting in the secretion of glucocorticoids. A negative feedback mechanism 
mediated by the action of glucocorticoids on MR and GR in the hypothalamus 
and GR in the anterior pituitary results in a reduction in CRH, AVP, and ACTH. 
CRH: corticotrophin releasing hormone; AVP: arginine vasopressin; ACTH: 
adrenocorticotropic hormone; MR: mineralocorticoid receptor; GR: 
glucocorticoid receptor. 







1.5.3 Glucocorticoids and Cognitive Ageing 
The glucocorticoid hypothesis proposes that chronic exposure to elevated circulating 
glucocorticoids promotes the functional and structural degeneration of the brain, 
contributing to age-associated cognitive impairments. There are a number of 
variations to this hypothesis, with different views regarding the mechanisms through 
which chronic glucocorticoid action, stress related glucocorticoid release and age 
interact to result in functional decline and neurodegeneration (Landfield et al., 2007). 
However, they all have the common basis of cooperativ  interaction of 
glucocorticoids, ageing and stress in the impairment of cognitive function and 
hippocampal ageing. Studies consistent with the glucocorticoid hypothesis, have 
shown that glucocorticoids are elevated in ageing ad could adversely affect 
hippocampal structure and vulnerability (Landfield et al., 2007). Additionally, 
correlations have been observed between both cognitive decline in aged rats and 
glucocorticoid levels as well hippocampal degeneration in aged rats and circulating 
glucocorticoid levels (Issa et al., 1990; Meaney et al., 1995). Other studies have 
demonstrated accelerated hippocampal ageing in chronic stress studies (Kerr et al., 
1991) whilst others have found that excess glucocorticoid exposure results in 
increased hippocampal vulnerability and CA3 dendritic retraction (Conrad et al., 
2007).  Most convincingly, studies have shown that m intaining low glucocorticoid 
levels in rodents from mid-life stops the cognitive decline observed with ageing (Yau 







1.5.4 Glucocorticoids and Neural Correlates of Cognitive 
Ageing 
Recent studies of the brain have suggested that brain pl sticity, in particular 
hippocampal plasticity and function, is highly regulated by hormones. 
Glucocorticoids in particular have been noted to have  huge impact on neuronal 
structure and function and consequently brain structu e and volume. 
Of particular interest to our work, is the effect of glucocorticoids on hippocampal 
neurons and structure. Hippocampal neurons express MR and GR and the binding of 
glucocorticoids to these receptors has been observed to play a large role in the 
regulation of neurogenesis, remodelling of neuronal dendrites and the excitability of 
hippocampal neurons, processes correlated with age-related cognitive impairment.  
Whilst basal levels of glucocorticoids are essential for the above processes to occur, 
chronic elevated levels glucocorticoids, as observed in ageing, have been found to 
have adverse effects on brain structure and neuronal expression and morphology. 
Studies shown that glucocorticoids are elevated in ageing and could adversely affect 
hippocampal structure and vulnerability (Landfield et al., 2007). Additionally, 
hippocampal degeneration in aged rats has been observed to be correlated with 
circulating glucocorticoid levels (Issa et al., 1990) whilst studies have demonstrated 
accelerated hippocampal ageing in chronic stress studies (Kerr et al., 1991) and 
increased hippocampal vulnerability and CA3 dendritic retraction in response to 
excess glucocorticoid exposure (Conrad et al., 2007). 
Studies have also shown that chronic elevated glucocorticoid levels have an impact 







in NAA, Creatine and Choline in the brain following a 7 day psychosocial stress 
paradigm to elicit the stress-induced endocrine changes. 
1.5.5 Glucocorticoids and Inflammation 
Interactions between the nervous system, HPA-axis and elements of the immune 
system are essential in regulation of the inflammatory response. The release of 
inflammatory mediators activates peripheral pain receptors and consequently the 
nociceptive pathway. This is turn results in the activ tion of the HPA-axis resulting 
in the release of glucocorticoids. Cytokines act directly on the HPA-axis resulting in 
the release of glucocorticoids. Glucocorticoids then bind to glucocorticoid receptors 
inhibiting the synthesis of cytokines and inflammatory mediators and resulting in a 
negative feedback loop. 
1.5.6 Glucocorticoids and Neuroinflammation 
Glucocorticoids have generally been considered anti-inflammatory and are used 
clinically in this aspect.  However, this view has recently been challenged with 
studies demonstrating both a suppressive (neuroprotective with negative feedback on 
microglial activation) and enhancing (exacerbation of neuroinflammation) role of 
glucocorticoids in neuroinflammation depending on the magnitude and duration of 
the stressor in relation to immune activation (Sorrells and Sapolsky, 2007). 
Studies have shown that stress increases the expression of TNF-α, IL-1β, IL-6 and 
IFN-γ in the CNS and peripheral tissues (Johnson et al., 2002; Munhoz et al., 2006) 
and also induces the release and accumulation of pro-inflammatory mediators such as 
nitric oxide (NO) and cyclooxygenase-2 (cox-2) (Madrigal et al., 2003).  Recent 







to potentiate cytokine response resulting in altered cognitive function and behaviour 
(Munhoz et al., 2010).  Acute and chronic stress has been observed to elevate levels 
of pro-inflammatory cytokines in the hippocampus and frontal cortex of rodents and 
increase microglial activation, reactivity and proliferation (Johnson et al., 2002; 
Munhoz et al., 2006).  Studies have also found that glucocorticoids suppress neuronal 
signalling molecules CD200 and CXC3L1 which play a large role in controlling 
microglia activation (Frank et al., 2007). 
 
(Miller and Raison, 2016; Figure 2) 
Figure 1.5. The role effect of glucocorticoids on inflammatory and 
neuroinflammatory processes 
Glucocorticoids can activate microglia to a M1 pro-inflammatory phenotype







 Intracellular modulation of Glucocorticoid 1.6
Signalling 
As discussed above, excessive and prolonged exposure to glucocorticoids has a 
detrimental effect on cognitive ageing. However, attempts to attenuate these effects 
through adrenalectomy or receptor inhibiting drugs prove difficult as glucocorticoids 
play a large role other processes within the body, such as inflammatory and 
metabolic processes.  Consequently, other components playing a role in the action of 
glucocorticoids on tissues have been identified. 
One such component identified as playing a key role in glucocorticoid action is the 
enzyme 11β-hydroxysteroid dehydrogenase (11β-HSD) – an enzyme which 
modulates intracellular signalling of glucocorticoids. 
Studies have revealed that intracellular concentrations of glucocorticoids, and 
consequently glucocorticoid action, are determined not only by circulating blood 
glucocorticoid levels, but also by glucocorticoid metabolising enzymes which are 
able to convert active glucocorticoids to 11-keto derivatives and vice versa.  The 
enzymes catalysing these reactions are 11β-hydroxysteroid dehydrogenases.   
11β-HSD exists as two isozymes – type 1 (11β-HSD1) and type 2 (11β-HSD2).  
Whilst the type 1 isozyme catalyses the reduction of 11-keto derivatives to active 
glucocorticoids - consequently amplifying glucocorticoid action - the type 2 isozyme 
catalyses the reverse reaction converting glucocorticoids to inactive 11-keto 
derivatives (White et al., 1997).  The benefits of the 11β-HSD2 in their ability to 







tissues, where the presence of 11β-HSD2 reduces intracellular glucocorticoid levels 
allowing mineralocorticoids to bind to the mineralocorticoid receptors which would 
otherwise bind the more abundant glucocorticoids.  Such mechanisms of reducing 
intracellular glucocorticoid action would be ideal in alleviating the deleterious effects 
of glucocorticoids in the brain.  However, 11β-HSD2 expression in the brain is 
restricted to the circumventricular regions and is expr ssed most in mineralocorticoid 
target tissues such as the kidney (Rashid and Lewis, 2005).  
Conversely, 11β-HSD1 has highest expression in glucocorticoid target tissues such 
as the liver, adipose tissue and brain.  In particular and of importance to this study, 
11β-HSD1 is expressed abundantly in the hippocampus and frontal cortex of the 
brain (Moisan et al., 1990) – key structures in cognition and executive function.  As 
stated earlier, 11β-HSD1 catalyses the conversion of 11-keto forms to active 
glucocorticoids and thus amplifies glucocorticoid actions in the brain.  Research has 
established that this amplification of glucocorticoid action has a significant effect on 
age-related cognitive function and structural changes in the brain during ageing 




Inactivation of circulating glucocorticoids by 11β-HSD2, then reactivation in 
peripheral tissues by 11β-HSD1. 
Figure 1.6. Interconversion of inert glucocorticoids and active 
glucocorticoids mediated by 11β-HSD1 and 11β-HSD2 







 11β-HSD1 and Cognitive Ageing 1.7
Investigations have suggested that inhibition of 11β-HSD1 may attenuate the 
deleterious effects of glucocorticoids on cognitive function and brain integrity in 
ageing.  Importantly, Yau et al. (2001) found that in 11β-HSD1 knockout mice, 
despite elevated basal corticosterone levels, aged mice showed significantly lower 
hippocampal corticosterone levels when compared to aged wild-type mice.  In 
addition to this, it was observed that whilst aged wil -type mice experienced learning 
deficits associated with elevated glucocorticoid leve s, no learning deficit was 
observed in aged knockout mice.  Together, these findings suggested that tissue 
glucocorticoid levels are not completely dependent on plasma glucocorticoid levels 
and that it is the intracellular tissue levels which affect hippocampal function.   
Consistent with suggestions that 11β-HSD1 plays a key role in the impact of 
glucocorticoid action in ageing, further studies have revealed  better spatial memory 
and enhanced long-term potentiation in 11β-HSD1 knockout mice compared to age 
matched wild-type controls (Yau et al., 2007).  Additionally, the inhibition of 11β-
HSDs has been associated with improved memory  and cognitive function in healthy 
elderly humans (Sandeep et al., 2004) and more recent studies have suggested a 
predictive link between 11β-HSD1 activity, progressive brain atrophy and cognitive 
decline (MacLullich et al., 2012).  Sooy et al. (2010) have also gone on to show that 
specific inhibition of 11β-HSD1 in C57BL/6J mice results in the prevention of age-
related spatial memory impairments. 
However, both the animal knockout models and inhibition of 11β-HSD studies have 
disrupted or inhibited 11β-HSD1 activity on a global scale, affecting not only the 







also highly expressed.  Along with this, studies have found that peripheral 
replacement of 11β-HSD1 in the liver, in genetic knockouts of 11β-HSD1, can 
effectively reverse the altered HPA axis activity observed in knockout mice 
(Paterson et al., 2007).  Together, the data suggest that changes in peripheral 11β-
HSD1 may also affect localised central nervous system function, perhaps through 
metabolic and neuroendocrine mechanisms, thus making the principal role and 
function of 11β-HSD1 in the brain unclear.  Interestingly, Holmes et al. (2010) have 
found an increase in 11β-HSD1 levels in the hippocampus and parietal cortex with 
age.  Furthermore, they found that this increase in 11β-HSD1 levels correlates with 
cognitive performance with age as well as showing that fore-brain specific 11β-
HSD1 overexpression results in premature age-related cognitive decline.  More 
recently, Yau et al., (2015) demonstrated 11β-HSD1 mediated increased intracellular 
glucocorticoid levels play a key role in that age and stress related spatial memory 
impairments and that lifelong removal or inhibition f 11β-HSD1 abolished age and 
stress related spatial memory impairments. Finally, Wheelen et al. (2014) also noted 
a reversal of spatial memory impairment in aged wild-type mice upon inhibition of 
11β-HSD1 as well as a reduction in fear memory strength and persistence. 
Altogether, this data suggests brain 11β-HSD1 can affect cognitive function 
independent of peripheral 11β-HSD1 effects. However, the 11β-HSD1 knockout 
mouse models used in these studies demonstrated a small amount of 11β-HSD1 
activity in the brain.  As such, it has yet to be established if the effects noted will also 
be seen following complete removal of 11β-HSD1 activity or benefits are only 
observed when 11β-HSD1 levels are reduced.  As such, further work needs to done 







 Summary and Thesis Aims 1.8
To summarise, cognitive impairment in normal ageing has been observed to be 
associated with changes in brain structure, metaboli e levels, cellular alterations and 
neuroinflammation. At the same time, studies have demonstrated a large role for 
glucocorticoids in age-associated cognitive decline and in particular have found 
elevated glucocorticoids to alter brain structure and cellular structure and 
neuroinflammation. Furthermore, animal models of intracellular glucocorticoid 
modulation through the removal of glucocorticoid metabolising enzyme 11β-HSD1 
have observed attenuated age-associated spatial learning nd memory impairments. 
However, these animal models were observed to have a small amount of 11β-HSD1 
activity in the brain and the effect of complete absence of 11β-HSD1 activity on age-
associated spatial memory impairment has yet to be conducted.  Furthermore, 11β-
HSD1-/- mice have only been examined in cross-sectional studies and with tests 
looking at only spatial learning and memory preventing the effect of intracellular 
glucocorticoid modulation on spatial learning and memory and other types of 
memory to be examined longitudinally. Therefore, this t esis tests the hypothesis that 
glucocorticoid action mediates age-associated cognitive impairment in spatial 
learning and memory and spatial working memory through alterations in cell 
activity, brain metabolite levels and neuroinflammatory processes. This will be 
achieved by utilising a longitudinal paradigm to examine the effect of complete 
lifelong 11β-HSD1 removal on spatial memory, working memory and cellular, 
metabolite and neuroinflammatory processes within te brain over a lifespan in an 







brain. This will further understanding on not only the mechanisms of action of 11β-
HSD1 but also provide insight into the effect of 11β-HSD1 on other cognitive 
processes which may be altered with age. 
As such, the aims of this thesis were as follows: 
1) To examine the longitudinal effects of lifelong removal of 11β-HSD1 on 
spatial learning and memory processes and working memory processes 
with age by examining a different 11β-HSD1-/- mouse model, with 
complete removal of 11β-HSD1 activity, and their wild-type counterparts 
in the water maze and radial arm water maze over the span of 24 
months. 
2) To investigate molecular, structural and metabolite mechanisms through 
which 11β-HSD1 may act by investigating changes in these three 
markers with age and their correlation cognitive performance in a subset 
of the longitudinal colony of wild-type and 11β-HSD1-/- mice. 
3) To determine the role of 11β-HSD1 on both acute neuroinflammatory 
responses and neuroinflammation with age by investigating changes in 
inflammatory markers in response to LPS administration and with age 
and their correlation with cognitive performance in a subset of the 
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Chapter 2 : Materials and Methods 
2.1 Materials 
Materials were sourced from the following: 
2.1.1 General Chemicals 
10mM dNTP Promega UK Ltd, Delta House, 
Enterprise Road, Chilworth Research 
Centre, Southampton, SO16 7NS 
Agarose Bio-Rad Laboratories Ltd, Bio-Rad 
House, Maxted Road, Hemel Hempstead, 
Hertfordshire, HP2 7DX, UK 
Borate Buffer Fisher Scientific, Fisher Scientific UK 
Ltd, Bishop Meadow Road, 
Loughborough, LE11 5RG 
Ethanol  Fisher Scientific, Fisher Scientific UK 
Ltd, Bishop Meadow Road, 
Loughborough, LE11 5RG 
Ethylene Glycol Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT  
Fluoromount Aqueous Mounting 
Media 
Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT  
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Road, Gillingham, Dorset, SP8 4XT  
Hydrochloric Acid Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT  
Hydrogen Peroxide VWR International Ltd, Hunter 
Boulevard, Magna Park, Lutterworth, 
Leicestershire, LE17 4XN 
Lightcycler480 Master Mix Roche, Hexagon Place, 6 Falcon Way, 
Shire Park, Welwyn Garden City, AL7 
1TW 
Lipopolysaccharide (LPS) Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT  
Liquid Latex (SBR Polymer) Bonnymans, Willowburn Road, 
Willowyard Industrial Estate, Beith, 
North Ayrshire 
Methanol Fisher Scientific, Fisher Scientific UK 
Ltd, Bishop Meadow Road, 
Loughborough, LE11 5RG 
Paraformaldehyde Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT  
Phosphate Buffered Saline (PBS; 
Tablets) 
Sigma-Aldrich, The Old Brickyard, New 
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Protein assay dye reagent concentrate Bio-Rad Laboratories Ltd, Bio-Rad 
House, Maxted Road, Hemel Hempstead, 
Hertfordshire, HP2 7DX, UK 
Protein Assay Reagent A 
 
Bio-Rad Laboratories Ltd, Bio-Rad 
House, Maxted Road, Hemel Hempstead, 
Hertfordshire, HP2 7DX, UK 
Protein Assay Reagent B Bio-Rad Laboratories Ltd, Bio-Rad 
House, Maxted Road, Hemel Hempstead, 
Hertfordshire, HP2 7DX, UK 
QIAgen RNAeasy Kit Qiagen, Skelton House, Lloyd Street, 
North 
Manchester, M15 6SH 
Sodium Chloride Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT  
Sodium Citrate Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT  
Sodium Hydroxide Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT  
Sodium Phosphate Fisher Scientific, Fisher Scientific UK 
Ltd, Bishop Meadow Road, 
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Sucrose Sigma-Aldrich, The Old Brickyard, New 
Road, Gillingham, Dorset, SP8 4XT 
SuperScript III First Strand Synthesis 
System 
Promega UK Ltd, Delta House, 
Enterprise Road, Chilworth Research 
Centre, Southampton SO16 7NS 
SYBR Safe DNA Gel Stain Life Technologies, 3 Fountain Drive, 
Inchinnan Business Park, Paisley PA4 
9RF, UK 
Tris Fisher Scientific, Fisher Scientific UK 
Ltd, Bishop Meadow Road, 
Loughborough, LE11 5RG 
Triton-X 100 Sigma-Aldrich, The Old Brickyard, New 










Rabbit GFAP Sigma, G9269-2ML 1:500 
Sheep 11β-HSD1 Scott Webster 1:1000 
Rabbit Iba-1 Wako, 019-19741 1:500 
Mouse NeuN Millipore, MAB377 1:500 
Donkey Anti-Sheep 
Alexa Fluor 488 
Invitrogen, A110015 1:500 
Donkey anti-Rabbit 
Alexa Fluor 555 
Invitrogen, A31572 1:500 
Donkey anti-Mouse 
Alexa Fluor 555 
Invitrogen, A31570 1:500 
Donkey anti-Rabbit 
Alexa Fluor 555 














Gene Primer Sequence Probe Number 
11β-HSD1 For: GGAGCCCATGTGGTATTGAC 
Rev: TTCAAGGCAGCGAGACACTA 
69 
Arg1 For:  GAATCTGCATGGGCAAC 
Rev: GAATCCTGGTACATCTGGGAAC 
2 
IL-1β For:  AGTTGACGGACCCCAAAA 
Rev:TTTGAAGCTGGATGCTCTCA 
26 
TNFα For:  CTGTAGCCCACGTCGTAG 
Rev: TTTGAGATCCATGCCGTT 
25 










2.2.1 AnimalsGeneration of 11β-HSD1 knockout mice 
Global 11β-HSD1 knockout mice with complete removal of 11β-HSD1 knockout 
were generated in-house by crossing 11β-HSD1flox/flox mice with Hprt-Cre mice 
(unpublished).  Hprt-Cre mice were bred to 11β-HSD1flox/flox mice. The 11β-
HSD1flox/flox mice have exon 3 of the 11β-HSD gene flanked by loxP sites, allowing 
Cre-driven recombination. The resulting F1 progeny were bred to 11β-HSD1flox/flox to 
generate a global 11β-HSD1 knockout mouse. 
Cre genotyping identified presence (or absence) of the Cre transgene and “Flox” 
genotyping was carried out to check the homozygous state of the “floxed” 11β-HSD1 
gene. 
 Housing 2.2.1.2
Animals were housed in standard cages upon controlled lighting (12h:12h, lights on 
at 7.00), were fed a standard chow and given water ad libitum.  All procedures were 
performed in strict accordance with the United Kingdom Animals (Scientific 
Procedures) Act (1986). 
 Ageing Colony 2.2.1.3
11β-HSD1-/- mice and their wild-type littermates were housed as above. At 6, 12, 18 
and 24 months of age, mice underwent cognitive testing in the water maze and radial 
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A subset of the colony underwent proton magnetic resonance spectroscopy (1H-
MRS) following cognitive testing. 
Following the final testing at 24 months, mice were culled and tissues extracted 
according to the protocol below. 
2.2.2 LPS Experiment 
 Optimisation of LPS Dose and Incubation 2.2.2.1
Mice were administered with either 5mg/kg of LPS (n=4) or saline (n=4) and 
returned to their home cage for 12, 24 hours or 48 hours.  Mice then received an 
overdose of sodium pentobarbital (0.4ml) and were then p rfused with 4% PFA 
through cardiac puncture. Dose was determined based on previous studies showing 
morphological transition of microglia at 5 mg/kg and peak inflammatory response 
between 8-24 hours (Buttini et al., 1996). 
Immunohistochemistry was performed according to the protocol detailed below for 
free floating sections.  Sections were stained for 11Β-HSD1, microglia, neuron and 
glial expression. 
 LPS Experiment 2.2.2.2
C57BL/6J mice were housed in standard cages as above. Mic  were administered 
with either 5mg/kg of LPS (n=4) or saline (n=4) and returned to their home cage for 
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 Tissue Collection 2.2.2.3
Mice then received an overdose of sodium pentobarbital (0.4ml) and were then 
perfused with saline through cardiac puncture. Brains were then dissected out and 
half the brain placed in 4% Paraformaldehyde (4% PFA) before being processed for 
immunofluorescence as described below. The remaining half of the brain was taken 
for real-time PCR analysis and the hippocampus and cortex removed and placed on 
dry ice before being processed as described below. 
2.2.3 Morris Water maze 
 Apparatus 2.2.3.1
A pool 2m in diameter and 60cm in height painted white was used.  The pool was 
filled with water (25oC ± 2) and rendered opaque by the addition of liquid latex (SBR 
polymer).  The pool was arbitrarily divided into 4 quadrants – North West, South 
West, North East and South East (Fig. 2.1).   
Behaviour in the maze was analysed using Water maze image tracking software, 
which tracked the following dependent measures in the 4 quadrants: 1) Time in 












Figure 2.1 Illustration of Spatial Learning Water Maze Set-Up   
Extra-maze cues 
Hidden Platform 
A pool 2m in diameter and 60cm in height painted white was used.  The pool 
was filled with water (25oC ± 2) and rendered opaque by the addition of liquid 
latex (SBR polymer).  The pool was arbitrarily divied into 4 quadrants – North 
West, South West, North East and South East.  Extra-maze cues were placed 
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 Visual Training Procedure 2.2.3.2
Mice were required to locate a hidden submerged platform 10cm in diameter marked 
by a visual cue (a lego wall).  Curtains were drawn round the pool to prevent the use 
of extra maze spatial cues during location of the platform. Four trials each day were 
performed over a period of 3 days.  Starting positin was varied between trials and 
days.  Platform position was varied between days.  Each trial was ended after 120s or 
when the platform was correctly located and mounted.  If mice were not able to 
locate the platform after 120s they were guided to the platform.  Once on the 
platform, mice were left there for 30s.   
 Spatial Learning Test Procedure 2.2.3.3
Following the 3 days of visual training, mice were tested for spatial reference 
memory.  The test consisted of 5 days of training with 4 trials a day, followed by a 
probe test 24hours after the final training trial.  Within each trial, mice were required 
to locate a hidden submerged platform 10cm in diameter.  Curtains around the pool 
were pulled open so that extra maze spatial cues could be seen around the room.  The 
position of the platform was not changed throughout the test.  Starting positions were 
varied between trials and days to ensure the use of patial cues to locate the platform.  
Each trial was ended after 120s or when the platform was correctly located and 
mounted.  If mice were not able to locate the platform after 120s they were guided to 
the platform.  Once on the platform, mice were left there for 30s.   
A probe test was conducted 24 hours after the finalsp tial training trial.  For the test, 
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tracking software recorded the above measures for the 60s in addition to percentage 
zone time, where the zone was a 7.5cm radius around the platform.  
 Animals 2.2.3.4
At each age point, mice were included for testing in the water maze if they were 
physically able, regardless of performance.  Mice with obvious visual impairments 
(such as the development of cataracts) and physical limitations as a result of age or 
sickness were not tested. 
 Morris Water maze Data 2.2.3.5
Following initial water maze testing at 6-9 months of age, a minimum criterion was 
established in order to exclude, from the longitudinal data analyses, mice failing to 
develop a spatial strategy after extended training. Performance incompetent mice 
were excluded by the following criteria: 1) outliers in the last block of visible 
platform training (visible training day 3) with escape latencies ≥ 2 SDs above the 
mean escape latency of wild-type mice; 2) consistently fai ing to follow the escape 
scoop upon failure to find the platform within the 2 minute trial; 3) failing to swim 
over the 5 acquisition training days (i.e. mice floating for the duration of the trial 
with no sign of goal directed swimming); and 4) failure to swim over the previous 
location of the platform (location of the platform over the 5 acquisition training days) 
during the 60 second probe trial. Over the course of the longitudinal study, mice 
exhibiting changes limiting their ability to perform competently in the water maze 
(e.g. development of cataracts) were also excluded from the group. 
Accordingly, 4 wild-type mice and 5 11β-HSD1-/- mice were excluded from group 
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trials) of spatial acquisition training. The remaining 11β-HSD1-/- (n = 14) and wild-
type (n = 14) met the inclusion criteria and were assessed when they were young (6-9 
months), middle-aged (12-15 months) and aged (18-24 months). 
Two principle measures of spatial performance were r corded on a given trial: 1) 
Time taken to find the platform (latency to escape); and 2) Distance travelled before 
escape onto hidden platform. Changes in spatial learning with age were assessed by 
examining the time taken for mice to escape onto a hidden platform and the distance 
travelled before escape over successive acquisition trai ing trials when they were 
young (6-9 months), middle-aged (12-15 months) and aged (18-24 months).  
Long-term spatial memory was then assessed utilising a probe trial 24hours 
following their final acquisition trial. A long interval between the last training trial 
and the probe trial is essential if long-term spatial memory is to be determined 
independent of the memory of the last acquisition training session. Mice were placed 
in the water maze with no platform and their swim paths monitored over 60 seconds 
to examine their retention and retrieval of the platform location over the 5 training 
days and their response to the absence of a platform in the expected location. For 
analysis the water maze was divided into four quadrants: 1) the target quadrant, the 
quadrant where the platform had been located during t aining; 2) quadrant 2, the 
quadrant next to the target quadrant in a clockwise dir ction; 3) quadrant 3, the 
quadrant opposite the target quadrant; and 4) quadrant 4, the quadrant next to the 
target quadrant in an anti-clockwise direction. The primary measures of long-term 
spatial memory are latency to the target zone (the circular region where the platform 
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and a longer percentage of time spent in the target quadrant [greater than predicted 
by chance (25%)] indicating retention of spatial refe nce memory.  
2.2.4 Radial Arm Water Maze 
 Apparatus 2.2.4.1
Following the spatial reference training, mice were tested for spatial reference 
working memory.  The radial arm water maze was chosen ov r the typical radial arm 
maze to assess spatial reference working memory as mice were trained to swim in 
the pool following the Morris water maze.  As such, the need for food deprivation 
and further training, as would have been required in other versions of the radial arm 
maze, were eliminated and the number of confounding factors reduced.  Previous 
studies have established the radial arm water maze as a robust measure of spatial 
reference working memory. 
For this test, white acrylic inserts were placed into the tank, as described above, to 















Figure 2.2 Illustration of Radial Arm Maze Set-Up   
Acrylic inserts were used to divide the tank into 8 arms coming out from a 
central region of the tank.  The arms were labelled as above, with the North arm 
labelled as Arm 1 and other arms labelled consecutively in a clockwise 
direction.  For each day a platform was placed at the end of one of the arms, 
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 Spatial Working Memory Test Procedure 2.2.4.2
The test consisted of 6 days of training with 5 trials a day.  Within each trial, mice 
were required to locate a hidden submerged platform 10cm in diameter placed at the 
end of one of the eight arms and 8cm from the tank wall.  Curtains around the pool 
were pulled open so that extra-maze spatial cues could be seen around the room.  The 
position of the platform was changed between days but remained in the same 
position within the trials of the day.  Starting positions were varied between trials and 
days to ensure the use of spatial cues to locate the platform.   
Between the first and second trial each day there was a retention interval.  The ITI 
between the remaining trials was 20mins.  Each trial was ended after 120s or when 
the platform was correctly located and mounted.  If mice were not able to locate the 
platform after 120s they were guided to the platform.  Once on the platform, mice 
were left there for 30s.   
At 6 months of age, a retention interval of 1 hour was used across all 6 days of 
training. However, at 12 and 18 months of age, a shorter and longer retention interval 
was included. Therefore, over the first 2 days of the ask, a 15 minute retention 
interval was used between the first and second trial. This was followed by two days 
with a 1 hour retention interval and a final two days with a 2 hour retention interval. 
Water maze image tracking software recorded the above measures for the 120s in 
addition to the following measures taken manually: 1)  Number of Errors (where one 
error was taken as a full body entry into an incorrect arm or entry into the correct arm 









At each age point, mice were included for testing in the radial arm water maze if they 
were physically able, regardless of performance.  Mice with obvious visual 
impairments (such as the development of cataracts) and physical limitations as a 
result of age or sickness were not tested. 
 Radial Arm Water maze Data 2.2.4.4
Spatial working memory was assessed by 4 measures: 1) Latency to escape onto 
platform; 2) Distance travelled before escape onto platform ( swim path length); 3) 
Errors (incorrect arm entries before escape onto platform); and 4) Savings Data. Data 
for each trial was averaged over the days with the same retention trial length. Better 
performance is indicated by shorter escape latencies, shorter swim path lengths, 
fewer errors and larger savings. 
Savings data was calculated by calculating the difference between performance 
during the acquisition trial and performance on the trial immediately following the 
retention interval, as assessed by time to platform, number of errors and distance 
travelled before escape.  If performance was worse on the trial following the 
retention interval in comparison to the acquisition trial, the savings was zero. 
2.2.5 Proton Magnetic Resonance Spectroscopy and Imaging 
(1H-MRS) 
 MR Measurements 2.2.5.1
Scanning was performed on a 7T Varian/Agilent Technologies Preclinical System 
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weighted fast spin-echo sequence (TR 2500ms; TE 36ms; Echo-train length 8) with 
contiguous 0.4mm sections (in-plane resolution, 0.15 x 0.15mm). Subsequently, four 
spectroscopic measurements were performed using the point-resolved spectroscopy 
(PRESS) technique at short echo time and long repetition ime (TR 3000ms; TE 23; 
NEX 480). 
The T1-weighted and T2-weighted images (19 axial slice  and 19 coronal slices) 
were used to place the volume-of-interest (VOI) over a unilateral hippocampal area 
(Fig. 2.3). Subsequent repositioning of VOIs at different points in time was done by 
careful three-dimensional visual comparison with the VOI placement for the first 
session.  
The VOI size in the hippocampus was 2.2 x 2.7 x 1.4 mm3. Before the spectroscopic 
acquisitions, shimming of magnetic homogeneity and optimisation of water 
suppression were done. Usually, a linewidth of 14Hz (FWHM) was achieved on the 










 1H-MRS Analysis 2.2.5.2
The spectral raw data were analysed user-independently mploying the linear 
combination method (LCModel, Version 6.01, Provencher) with water referencing. 
 Structural Analysis 2.2.5.3
Hippocampal volume was analysed user-independently using T2-weighted coronal 
images and software Analyze. Hippocampal, ventricle and total brain structures were 
manually traced using the software Analyze and volume calculated by multiplying 
the area of the traced structure by section thickness (0.4mm). Hippocampal volume 
was then calculated as a percentage of total brain volume. 
Figure 2.3 Representative coronal section images of the area and 
size of the voxel taken during MRS scan of the unilateral 
hippocampus of a wild-type mouse  
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2.2.6 11β-HSD1 Antibody  
 Sample Preparation 2.2.6.1
Sheep 11β-HSD1  antibody in serum (obtained from Scott Webster’s Laboratory, 
University of Edinburgh) was prepared for purificaton by adjusting it to buffer 
composition by adding 1ml of sample to 5ml of Binding Buffer [20mM Sodium 
Phosphate, pH7.0:  Na2HPO4.2H
2O, NaH2PO4]. 
 Purification 2.2.6.2
Prior to loading sample into purification column (HiTrap Protein GHP, GE 
Healthcare), column was washed with 10ml of Binding Buffer.  Following this, 
sample was then loaded into the column and subsequently the column was washed 
again with 10ml of Binding Buffer.  Sample was then eluted with Elution Buffer 
[0.1M Glycine-HCl, pH 2.7] in 1ml fractions into tubes containing 200ul of Tris-
HCl, pH 9.0, to preserve the activity of labile IgGs. 
 Characterisation 2.2.6.3
Protein was extracted from the livers of wild type, 11β-HSD1 liver overexpressor 
and 11β-HSD1/ApoE double knockout mice.  Samples were prepar d and run 
through the western blot protocol described below. 
Primary antibodies used were unpurified sheep 11Β-HSD1 antibody [1:1000; 
obtained from Scott Webster], purified sheep 11β-HSD1 antibody [1:1000; purified 
in Holmes Lab as above], mouse β-tubulin [1:10000].  Secondary antibodies used 
were anti-sheep AlexaFluor 680 [1:10000; Molecular Probes, A-21101] and anti-
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11β-HSD1 was observed to be expressed in the liver of both wild type mice and mice 
overexpressing 11β-HSD1 in the liver, with higher expression observed in the livers 
of mice overexpressing 11β-HSD1.  11β-HSD1 was not expressed in the mice with 
an 11Β-HSD1 /ApoE double knockout (Fig. 14). 
Comparison of membrane blotted with unpurifed 11Β-HSD1 antibody (Fig. 14A) 
and membrane blotted with purified 11β-HSD1 antibody (Fig. 14B) revealed 
differences in the specificity of the antibodies.  It was observed that purification of 
the 11β-HSD1 antibody resulted in less bands being observed at sizes other than 
34K.  However, it was also observed that the purified 11β-HSD1 antibody resulted in 



















Figure 2.4. Western blot showing the specificity of both the 
original antibody in serum and purified antibody on liver protein 
extracts from wild type (WT), HSD1 liver overexpressors (OE) and 
11β-HSD1 double knockout (DKO) mice 
The antibodies used to assess levels of 11Β-HSD1 were able to specifically 
recognise a 34K band, co-migrating with β-tubulin.  [A] Representative 
immunoblot to visualise 11Β-HSD1  expression in the livers of  wild type 
mice (WT), mice overexpressing 11Β-HSD1  in the liver (OE) and 11Β-HSD1 
/ApoE double knockout mice (DKO) using unpurified sheep 11Β-HSD1  
antibody [1:1000, Scott Webster]. [B] Representative immunoblot to visualise 
11Β-HSD1 expression in the livers of wild type mice (WT), mice 
overexpressing 11Β-HSD1  in the liver (OE) and 11Β-HSD1 /ApoE double 
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2.2.7 Western Blots 
 Protein Extraction 2.2.7.1
50-100mg of tissue was sliced on dry ice into 2ml eppendorf tubes.  Samples were 
homogenised in 500µl of lysis buffer and placed on a rot tor for 1 hour at 4oC.  
Samples were then spun down at 13,000 rpm for 15mins at 4oC.  The supernatant 
was then pipetted off and placed in a new eppendorf tube and spun down at 
13,000rpm for a further 10mins at 4oC. 
 Bradford Protein Assay 2.2.7.2
Protein concentration of lysates was determined by Bradford Assay (Bio-Rad, USA) 
as per manufacturer instructions.  A standard curve was prepared using BioRad 
Protein Assay Standard (Bio-Rad, USA) 
 Separation of Proteins by Electrophoresis 2.2.7.3
Protein extracts were resolved by SDS-PAGE at 120V on precast NuPage 4-12% 
Bis-Tris polyacrylamide gels (Invitrogen) for 3 hours according to manufacturer 
instructions. 
 Transfer of Proteins 2.2.7.4
Following electrophoresis, a transfer sandwich was m de using 0.2um nitrocellulose 
membranes [2x sponge/ 1x blotting paper/ gel/ 1x nitrocellulose membrane/ 1x 
blotting paper/ 2x sponge].  Transfer sandwich was loaded into transfer tank 
(BioRad) and tank filled with Transfer Buffer [Trizma Base, Glycine, Methanol, 
dH2O].  Transfer was performed at 30V for 1 hour at 4
oC.  Following transfer, 








Membrane was blocked in 5% non-fat dry milk in TBSTw Buffer [27% Tris, 89% 
NaCl pH 7.6, 0.1% Tween-20] for 30mins at room temperature and subsequently 
washed incubated with primary antibody diluted in 5% semi-skimmed milk in 
TBSTw for 1 hour and then washed 3 times in TBSTw for 10 minutes each wash.  
Following this membrane was incubated with secondary antibody diluted in 5% 
semi-skimmed milk in TBSTw for 1hour at room temperature and then washed in 
TBSTw 2 times for 10 minutes each before a final 10 minute was in TBS [27% Tris, 
89% NaCl pH 7.6].  The membrane was scanned and band intensities were quantified 
using the Odyssey infrared imaging system (Licor Biosciences; Lincoln, NE). 
2.2.8 Immunohistochemistry  
 Optimisation of Immunohistochemistry 2.2.8.1
In order to determine the optimal conditions for immunohistochemistry on brain 
sections, a variety of conditions were tested.  Three types of sections were tested: 1) 
Paraffin-Wax embedded; 2) Free-Floating; and 3) Fresh Frozen.  Additionally, two 
types of slides were tested: 1) Silane coated; and 2) Superfrost slides.  Finally, three 
protocols were tested: 1) Streptavidin-DAB; 2) Strep avidin-Fluorescent; and 3) 
Immunofluorescence. 
Trials carried out on Paraffin-Wax embedded sections f und no positive staining for 
11Β-HSD1 or Cd11B in either the Streptavidin-Fluorescent and Immunofluorescent 
protocol.  In the Streptavidin-DAB protocol, brown staining did occur, however, this 
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Trials utilising Fresh Frozen sections were successful, when staining for 11Β-HSD1 
and Cd11B using the immunofluorescence protocol.  Positive staining was observed 
in both the cerebellum and hippocampus of the brain.  However, brain morphology 
was sometimes damaged and brain sections often had ‘holes’ in them following 
cryostating.   
Trials carried out using Free-Floating sections were successful, when staining for 
11Β-HSD1 and Cd11B using the immunofluorescence protocol.  Positive staining 
was observed in both the cerebellum and hippocampus of the brain.  As brains had 
been fixed prior to cryostating, sections were more r bust than fresh frozen sections 
with less damage to the sections observed in the immunohistochemistry process.  As 
such, this method was chosen and is detailed below. 
 Tissue Preparation 2.2.8.2
Brain samples were left in 4% PFA for 2 days before being removed and placed in a 
30% sucrose solution. After 4 days, samples were remov d from the sucrose solution 
and frozen on dry ice before being stored at -80oC. 
Brains were subsequently sectioned at 30um thickness into cryoprotectant [Sucrose, 
0.1M PBS, Ethylene Glycol] and stored at -20oC. 
 Double Immunofluorescence for Free-Floating Sections   2.2.8.3
Sections were washed in PBS and then underwent antigen retrieval in sodium citrate 
buffer (0.01M, pH 8.5) for 30 minutes at 80oC in a water bath.  Sections were 
subsequently left to cool and then washed in PBS before undergoing 
permeabilization in 0.3% PBT (PBS plus 0.3% Triton-X 100) for 15 minutes and 
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incubated with both primary antibodies diluted in the same blocking solution 
overnight at 4oC. To ensure no cross-reactivity occurred, primary antibodies raised in 
different species were chosen. Following this, sections were washed in PBS and then 
incubated with both secondary antibodies diluted in 1% normal serum in 0.3% PBT 
for 1 hour at room temperature. From this point onwards, sections were kept in a foil 
covered container or dark box to block out the light and prevent photo bleaching.  
Samples were then washed in PBS and incubated with TOPRO for 10 minutes at 
room temperature and then washed in PBS again.  Sections were then floated onto a 
slide and left to air dry in a dark box.  Following drying, sections were mounted in 
aqueous mounting media and cover slipped.   
Sections were stained for 11β-HSD1, microglia, neuron and glial expression using 
primary antibodies sheep purified 11β-HSD1 [1:1000; Obtained from Scott Webster 
and purified as above in Holmes Lab], Rabbit Iba-1 [1:500; Wako, 019-19741], 
Mouse NeuN [1:500, Millipore, MAB377] and Rabbit GFAP [1:500, Sigma, G9269-
2ML] and secondary antibodies donkey anti-Sheep Alexa Fluor 488 [1:500; 
Invitrogen, A110015], donkey anti-Rabbit Alexa Fluor 555 [1:500; Invitrogen, 
A31572], donkey anti-Mouse Alexa Fluor 555 [1:500; Invitrogen, A31570] and 
donkey anti-Rabbit Alexa Fluor 555 [1:500; Invitrogen, A31572] respectively. 
Double immunofluorescent stains were conducted on the following combinations: 1) 
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 Immunofluorescent Quantification 2.2.8.4
Samples were analysed under an Axioskop microscope (Carl Zeiss Ltd, Welwyn 
Garden City) at x30 magnification. Three fields per hippocampal and cortex 
subregion were taken and analysed as below. 
Images were then quantified using ImageJ software and area measurements. Images 
from a wild-type/control mouse were used to select a threshold for the fluorescence 
of the target protein being quantified. The area of fluorescence meeting settings was 
then calculated as a percentage of the total area of the image. 
Where specified, images were also quantified through cell counting. 
Data was averaged over the three fields per subregion. 
2.2.9 Quantitative PCR (qPCR) 
 RNA Extraction 2.2.9.1
RNA was extracted from mice brains using the QIAgen RNAeasy Kit according to 
manufacturer instructions with the DNase step included. 
 Reverse Transcription-PCR 2.2.9.2
RNA samples were used for RT-PCR to produce cDNA. Samples underwent reverse 
transcription using SuperScript III First Strand Synthesis System according to 
manufacturer instructions. 
 Quantitative-PCR 2.2.9.3
RT-PCR products were then used for qPCR to quantify 11β-HSD1 and cytokine 
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samples and serially diluting from 1:8 to 1:512. cDNA samples were diluted 1:20 
before adding to reaction mix.  The reaction mix was prepared as follows: 5µl 
Lightcycler480 Master-Mix (Roche; Burgess Hill, UK), 0.1µl For primer, 0.1µl Rev 
primer, 0.1µl primer-probe (Applied Biosystems; Warrington, UK) and 2.7µl of 
RNase-free H2O per sample.  The reaction mix was then added to the plate in 
triplicate, followed by 2µl of cDNA.  Plates were then sealed and centrifuged at 
2000g for 2 minutes.  Negative controls were included in each plate to ensure no 
contamination had taken place.  Internal controls included housekeeping genes 
HPRT and GAPDH. 
 Data Analysis 2.2.9.4
The LightCycler software provided relative quantification using the maximum 
second derivative method, where a fractional cycle (Cp) is determined from the 
amplification curve’s second derivative max indicating the cycle at which 
exponential amplification can no longer be sustained an  starts to decline towards 
linear growth.  The standard curve was used as a reference for extrapolating 
quantitative information for mRNA targets of unknown concentrations. 
2.2.10 Statistical Analysis 
For statistical analysis, GraphPad Prism 5 was used.   
Comparisons between 2 groups (e.g. 11β-HSD1-/- versus WT) were made by 
Student’s t-test (unpaired).   
For the analysis of performance over a period of time, a two-way repeated measures 
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Correlations were determined using Pearson’s correlation. 
Values are shown as means ± SEM. Significance was set as p<0.05. Full details of 
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Chapter 3 : Distinct Roles for 11B-HSD1 on 
Spatial Learning and Memory and Spatial 
Working Memory Impairment 
 Introduction 3.1
Cognitive impairment is often observed in ageing and mild cognitive impairment is 
associated with dementia.  However, within the population there is a large variation 
in the occurrence and rate of progression of cognitive mpairment with age. 
Studies have shown that these variations can be attributed, in part, to glucocorticoids 
where elevated glucocorticoids in ageing with adverse effects on hippocampal 
structure and vulnerability (Landfield et al., 2007). 11β-HSD1 catalyses the reduction 
of 11-keto derivatives to active glucocorticoids, amplifying intracellular 
glucocorticoid levels. In particular and of importance to this project, 11β-HSD1 is 
expressed abundantly in the hippocampus and frontal cortex of the brain (Moisan et 
al., 1990) – key structures in cognition and executive function.   
Investigations have suggested that inhibition of 11β-HSD1 may attenuate the 
deleterious effects of glucocorticoids on cognitive function and brain integrity in 
ageing.  Yau et al. (2001) found that in 11β-HSD1 knockout mice, despite elevated 
basal corticosterone levels, aged mice showed significa tly lower hippocampal 
corticosterone levels when compared to aged wild-type mice.  In addition to this, it 
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associated with elevated glucocorticoid levels, an attenuated learning deficit was 
observed in aged knockout mice.   
Further studies revealed  better spatial memory is correlated with enhanced long-term 
potentiation in hippocampal slices of 11β-HSD1 knockout mice compared to age 
matched wild-type controls (Yau et al., 2007).  Additionally, the inhibition of 11β-
HSDs has been associated with improved memory  and cognitive function in healthy 
elderly humans (Sandeep et al., 2004) and more recent studies have suggested a 
predictive link between 11β-HSD1 activity, progressive brain atrophy and cognitive 
decline (MacLullich et al., 2010).  Sooy et al. (2010) have also demonstrated that 
specific inhibition of 11β-HSD1 in C57BL/6J mice results in the prevention of age-
related spatial memory impairments. 
Nevertheless, normal age-associated memory decline is ot uniform. Studies have 
indicated differences in both the type of memory impaired with age and the age of 
onset of memory decline. Whilst older adults exhibit mpairments in spatial and 
episodic memory - finding one's way around an enviro ment and remembering the 
events that occur within it – a marked decline in working memory has also been 
observed in ageing. 
Working memory is the capacity to temporarily keep in mind information from 
previous experiences in order to monitor and manipulate new information for a 
specific goal. Working memory is therefore essential o integrate different 
information for planning and for goal-directed, puroseful action such as everyday 
decision-making and problem-solving. Results from cross-sectional and longitudinal 
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twenties and continue to decline linearly with age. H nce, performance on tasks of 
episodic and working memory decline in the twenties and continue to decline 
linearly across the life span (Park et al., 1996, 2002).  
Previous studies have established significant effects of glucocorticoids on working 
memory function, namely, working memory is impaired following both acute and 
chronic glucocorticoid administration (Diamond et al., 1996; Barsegyan et al., 2010). 
However, little work has been done on the effects of intracellular glucocorticoid 
levels on age-associated working memory processes. Although elevated intracellular 
glucocorticoid levels have been associated with age-associated hippocampal 
dependent learning and memory impairments, they mayhave distinct effects on 
working memory processes during ageing. Furthermore, th  effect of 11β-HSD1 
removal on cognitive processes has only ever been examined cross-sectionally 
preventing the effects of intracellular glucocorticoid levels on age-associated 
cognitive decline to be examined over the entire lif span of an animal. Therefore, 
this chapter reports the longitudinal effects of lifelong removal of 11β-HSD1 on 
learning and memory processes and working memory processes with age by 
examining 11β-HSD1-/- and their wild-type counterparts in the water maze nd radial 
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Figure 3.1. Number of wild-type and 11β-HSD1-/- mice tested in the 




Male 11β-HSD1-/- mice and their wild-type littermates were maintained in standard 
cages upon controlled lighting (12h:12h, lights on at 7.00), were fed a standard chow 
and given water ad libitum as described in Chapter 2. 
At 6, 12, 18 and 22 months of age, animals underwent b havioural testing and 
subsequently tail nicked for plasma samples. 
Figure 3.1 illustrates the number of animals tested a each age in the water maze and 
radial arm water maze.  At 6 months, no mice were excluded from testing.  At 12 
months, one mouse was excluded from testing following the development of 
cataracts.  At 18 months, one wild-type mouse died. At 24 months, 3 wild-type mice 
and 7 11β-HSD1-/- mice died from age related factors or were terminated following 
the development of tumours.  At 24 months, mice were considered too frail to 
undergo radial arm water maze testing following the initial water maze testing and as 
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Figure 3.2. Number of wild-type and 11β-HSD1-/- mice analysed in the 
water maze and radial arm water maze at each time point. 
 
3.2.2 Morris Water maze 
Spatial learning and memory was assessed at 6, 12, 18 and 22 months of age in the 
Morris Water maze (MWM) as outlined in Chapter 2. 
Following water maze testing at 6 months of age, a minimum criterion was 
established to exclude from analysis those mice failing to develop a spatial strategy 
and demonstrate long-term retention of spatial memory. 
Figure 3.2 below illustrates the number of mice included in analysis at each age in 
the water maze and radial arm water maze. At 6 months, 3 wild-type and 4 11β-
HSD1-/- mice were permanently excluded from analysis after failing to meet the 
inclusion criteria stated in Chapter 2.  The data from these same mice were analysed 
at 12, 18 and 24 months if available (some data was not available at later ages 
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3.2.3 Radial Arm Water Maze 
Spatial working memory was assessed at 6, 12 and 18 months of age in the Morris 
Water maze (MWM) as outlined in Chapter 2. 
3.2.4 Statistical Analysis 
Two-way repeated measures ANOVA with Tukey’s post-hoc test was used to 
analyse performance of wild-type and 11β-HSD1-/- mice over the testing period and 
longitudinally over the lifespan. 
A two-way ANOVA with variables, quadrant and genotype, was used to analyse the 
time spent swimming in each quadrant of the water maze and an unpaired t-test used 
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 Results 3.3
3.3.1 Water Maze Results 
 Young 3.3.1.1
Both wild-type and 11β-HSD1-/- animals learned to find the platform during visual 
training with a decrease in latency to platform [F (2, 70) = 97.36, p < 0.0001].  
When young (6 months), wild-type and 11β-HSD1-/- mice showed a progressive 
reduction in the latency to escape onto a hidden platform over the 5 training days [F 
(4, 104) = 28.07, p < 0.001; Fig. 3.3A]. Swim path data recapitulated escape latency 
results with a progressive reduction in swim path length over the 5 training days in 
both genotypes [F (4, 104) = 30.98, p < 0.001; Fig.3.3B]. No difference in escape 
latency [F (1, 26) = 0.07269, p = 0.7896; Fig. 3.3A] nor swim path length [F (1, 26) 
= 0.16, p = 0.689; Fig. 3.3B] was observed between g otypes. These results were 
observed independent of swim speed and indicate good spatial learning in both wild-
type and 11β-HSD1-/- mice when young. 
Analysis of all mice, including mice not meeting the inclusion criteria, revealed 
similar results showing a progressive reduction in the latency to escape onto a hidden 
platform over the 5 training days [F (4, 140) = 39.21, p < 0.0001] and distance 
travelled in both genotypes [F (4, 140) = 44.13, p < 0.0001]. No difference in escape 
latency [F (1, 35) = 0.01887, p = 0.8915] nor swim path length [F (1, 35) = 0.3074, p 
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There was no difference in latency savings between th  first trial and second trial in 
wild-type and 11β-HSD1-/- mice [11β-HSD1-/- : M = 21.01, SD = 5.158; wild-type: 
M = 23.22, SD = 5.877; t(26) = 0.2824, p = 0.7799].  
 Middle-Age 3.3.1.2
Both wild-type and 11β-HSD1-/- animals learned to find the platform during 
acquisition when middle-aged (12 months), as indicated by a decrease in latency over 
training days [F (3, 75) = 29.25, p < 0.0001; Fig. 3.4A] and a decrease in swim path 
length [F (3, 75) = 31.36, p < 0.0001; Fig. 3.4B] over training days. Escape latencies 
[F (1, 25) = 1.792, p = 0.8582; Fig. 3.4A] and swim path length [F (1, 25) = 0.1179, 
p = 0.7342; Fig. 3.4B] did not differ between the wild-type and 11β-HSD1-/- mice, 
indicating that spatial learning was not affected by genotype at this age. 
Analysis of all mice, including mice not meeting the inclusion criteria, revealed 
similar results showing a progressive reduction in the latency to escape onto a hidden 
platform over the 5 training days [F (3, 102) = 38.40, p < 0.0001] and distance 
travelled in both genotypes [F (3, 102) = 38.84, p < 0.0001]. No difference in escape 
latency [F (1, 34) = 0.002263, p = 0.9623] nor swim path length [F (1, 34) = 0.1262, 
p = 0.7246] was observed between genotypes. 
There was no difference in latency savings between th  first trial and second trial in 
wild-type and 11β-HSD1-/- mice [11β-HSD1-/- : M = 0.6339, SD = 0.2582; wild-type: 
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Figure 3.3. Water Maze performance in Young Wild-
type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.3. Graphs showing unimpaired water maze performance in you g wild-type mice (WT; n 
= 14) and 11β-HSD1
-/- 
mice (KO; n = 14) as measured by [A] the latency to escape onto the 
hidden platform; and [B] the distance travelled before escape (swim path length). A significant 
effect of training day was observed. No effect of genotype was observed. Values represent 
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Figure 3.4. Water Maze performance in Middle-Aged 
Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.4. Graphs showing unimpaired water maze performance in middle-aged wild-type mice 
(WT; n = 14) and 11β-HSD1
-/- 
mice (KO; n = 13) as measured by [A] the latency to escape onto 
the hidden platform; and [B] the distance travelled before escape (swim path length). A significant 
effect of training day was observed. No effect of genotype was observed. Values represent 
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At 18 months, both wild-type and 11β-HSD1-/- animals were able to find the platform 
following a visual cue. No decrease was observed over the visual training days as 
mice were able to locate the platform quickly from the first day [F (1, 33) = 0.8319, 
p=0.3684]. 
When aged (18 months), swim speed of the mice decreased across training days [F 
(4, 92) = 5.02, p = 0.0011; Fig. 3.5] with no effect of genotype on swim speed [F (1, 
23) = 0.00096, p = 0.9755; Fig. 3.5]. As swim speed would have a significant effect 
on the latency to escape, the distance travelled before escape onto the hidden 
platform was analysed to provide a measure of spatial learning independent of swim 
speed at 18 months of age. As seen when young and mid le-aged, an effect of 
training day on swim path length in the water maze [F (4, 92) = 8.73, p < 0.0001; 
Fig. 3.6] and no effect of genotype on swim path length [F (1, 23) = 0.30, p = 0.5885; 
Fig. 3.6] was observed indicating that spatial learning was not affected by genotype 
at this age. 
Analysis of all mice, including mice not meeting the inclusion criteria, revealed 
similar results showing a progressive reduction in the latency to escape onto a hidden 
platform over the 5 training days [F (4, 128) = 19.61, p < 0.0001] and distance 
travelled in both genotypes [F (4, 128) = 15.29, p < 0.0001]. No difference in escape 
latency [F (1, 32) = 0.4619, p = 0.5016] nor swim path length [F (1, 32) = 0.1087, p 
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There was no difference in latency savings between th  first trial and second trial in 
wild-type and 11β-HSD1-/- mice [11β-HSD1-/- : M = 17.64, SD = 5.119; wild-type: 
M = 11.35, SD = 3.596; t(23) = 1.017, p = 0.3197].  
At 24 months, both wild-type and 11β-HSD1-/- animals were able to find the platform 
following a visual cue. No decrease was observed over the visual training days as 
mice were able to locate the platform quickly from the first day [F (1, 25) = 2.038, 
p=0.1658]. 
At the final testing at 24 months of age, a general decrease in latency over the 5 
training days [F (4, 64) = 12.15, p < 0.0001; Fig. 3.7A] and no effect of genotype on 
latency to escape [F (1, 64) = 0.47, p = 0.503; Fig. 3.7A] was observed, post hoc tests 
revealed that latency to escape in wild-type mice was only significantly reduced in 
the latter training days whilst 11β-HSD1-/- mice showed significantly shorter 
latencies on training day 2 onwards. Swim path length supported escape latency 
results with an overall decrease in swim path length over training days [F (4, 64) = 
14.34, p < 0.0001; Fig. 3.7B] and no effect of genotype on swim path length [F (1, 
64) = 2.94, p = 0.1057; Fig. 3.7B] indicating no effect of genotype on spatial learning 
at 24 months of age. 
Analysis of all mice, including mice not meeting the inclusion criteria, revealed 
similar results showing a progressive reduction in the latency to escape onto a hidden 
platform over the 5 training days [F (4, 88) = 10.31, p < 0.0001] and distance 
travelled in both genotypes [F (4, 88) = 14.67, p <0.0001]. No difference in escape 
latency [F (1, 22) = 0.07977, p = 0.7802] nor swim path length [F (1, 22) = 2.516, p 
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There was no difference in latency savings between th  first trial and second trial in 
wild-type and 11β-HSD1-/- mice [11β-HSD1-/- : M = 9.438, SD = 3.636; wild-type: 







Figure 3.5. Swim speed in 18 Month old Wild-type 
(WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.5. Graph showing swim speed in the water maze over the 5 training days in18 month old 
wild-type (WT; n = 13) and 11β-HSD1
-/- 
mice (KO; n = 12). A significant effect of training day 
was observed. No effect of genotype was observed. Values represent the average swim speed over 
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Figure 3.6. Water Maze performance in 18 Month 
Aged Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.6. Graphs showing water maze performance in aged wild-type (WT; n = 12) and 11β-
HSD1
-/- 
mice (KO; n = 6) as measured by [A] the latency to escape onto the hidden platform; and 
[B] the distance travelled before escape (swim path length). A significant effect of training day 
was observed. No effect of genotype was observed. Values represent average latency and swim 
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Figure 3.7. Water Maze performance in 24 Month old 
Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.7. Graphs showing water maze performance in aged wild-type (WT; n = 12) and 11β-
HSD1
-/- 
mice (KO; n = 6) as measured by [A] the latency to escape onto the hidden platform; and 
[B] the distance travelled before escape (swim path length). A significant effect of training day 
was observed. No effect of genotype was observed. Values represent average latency and swim 
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 Ageing Effects 3.3.1.4
Ageing effects in both wild-type and 11β-HSD1-/- mice were analysed using swim 
path data throughout the lifespan of the colony. Spatial learning capacities were 
represented by the total distance covered to locate the hidden platform. A two-way 
repeated measures ANOVA revealed total swim path length decreased with age in 
both wild-type and 11β-HSD1-/- mice [F (3, 48) = 11.82, p < 0.0001; Fig. 3.8] with 
no effect of genotype [F (1, 16) = 3.130, p = 0.0959; Fig. 3.8]. In wild-type mice, 
distance travelled was found to decrease between 6 a d 12 months and then again 
between 18 and 24 months of age [6 vs 12 months, p < 0.01; 6 vs 18 months, NS; 12 
vs 18 months, NS; 6 vs 24 months, p < 0.0001; 12 vs 4 months, NS; 18 vs 24 
months, p < 0.05]. Interestingly, 11β-HSD1-/- mice showed decreased distance 
travelled only at 24 months of age [6 vs 24 months, p < 0.05; 6 vs 12 months, NS; 6 
vs 18 months, NS; 12 vs 18 months, NS; 12 vs 24 months, NS; 18 vs 24 months, 
NS]. 
Thus, wild-type and 11β-HSD1-/- mice did not appear to differ in learning capacity 
throughout life. Moreover, animals appeared to improve their performance with age 
as revealed by a decrease in the distance covered in both wild-type [F (3, 36) = 
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Figure 3.8. Longitudinal Water Maze performance in 
Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice at the ages 
of 6, 12, 18 and 24 months 
 
Fig. 3.8. Graph showing improved water maze performance with age in wild-type mice (n = 14) 
and 11β-HSD1
-/- 
mice (n = 14) as measured by the distance travelled before escape (swim path 
length). A significant effect of age was observed. No effect of genotype was observed. Values 
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3.3.2 Probe Test Results 
 Young 3.3.2.1
When young, mice spent the greatest percentage time in the target quadrant (i.e. the 
quadrant where the platform was previously) regardless of genotype. A two-way 
ANOVA with variables, quadrant and genotype, revealed that young 11β-HSD1-/- 
and wild-type mice spent the greatest percentage tim  swimming in the target 
quadrant compared to the other quadrants [F (3,104) = 5.789, p = 0.0011; Fig. 3.9A] 
whilst no effect of genotype was observed [F (1,104) = 4.6 x 10-10, p > 0.999; Fig. 
3.9A].  
In wild-type mice, the percentage time spent swimming i the target quadrant 
(36.7%) was significantly higher than percentage time spent swimming in quadrant 2 
(20%; p < 0.001), quadrant 3 (23.3%; p < 0.01) and quadrant 4 (20%; p < 0.001) 
[Fig. 3.9A]. However, in young 11β-HSD1-/- mice there was no significant difference 
in percentage time swimming in the target quadrant compared to quadrants 2, 3 and 
4. However, the highest percentage of time swimming was in the target quadrant 
(28.4%) and greater than predicted by chance indicating memorisation of the 
platform quadrant.  
There was no difference in time taken to swim to the pr vious platform location 
between wild-type and 11β-HSD1-/- mice [11β-HSD1-/- : M = 26.6, SD = 5.708; wild-
type: M = 19.4, SD = 2.809; t(26) = 1.132, p = 0.2679; Fig. 3.9B].  
Analysis of all mice, including mice not meeting the inclusion criteria, showed an 
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observed [F (1,140) = 7.367 x 10-10, p > 0.999]. No difference in time taken to swim 
to the previous platform location between wild-type and 11β-HSD1-/- mice [11β-
HSD1-/- : M = 35.39, SD = 5.418; wild-type: M = 28.42, SD = 4.632; t(35) = 0.9727, 
p = 0.3374]. 
 Middle-Age 3.3.2.2
At middle-age, a two-way ANOVA revealed that quadrant had a significant effect on 
the percentage of time spent swimming in each quadrant [F (3,100) = 10.61, p < 
0.0001; Fig. 3.10A] but no effect of genotype on the percentage time spent 
swimming in the four quadrants [F (1,100) = 3e-12, p > 0.999; Fig. 3.10A]. However, 
there was a significant interaction between genotype and quadrant [F (3,100) = 3.19, 
p = 0.0269] suggesting that there are varying effects of genotype on time spent in 
each quadrant. 
Converse to what was observed when young, middle-aged wild-type mice spent less 
time in the target quadrant. Whilst the percentage tim spent swimming in the target 
quadrant (29.8%) differed significantly from percentage time spent swimming in 
quadrant 2 (p < 0.01) it did not differ significantly from quadrant 3 (27%) and 
quadrant 4 (27%) [Fig. 3.10A]. However, middle-aged 11β-HSD1-/- mice swam 
longer in the target quadrant over the 60 second probe trial. Significant differences in 
percentage time swimming in the target quadrant (38%) compared to quadrants 2 
(19.3%; p < 0.001), quadrant 3 (19.7%; p < 0.001) and quadrant 4 (23%; p < 0.01) 
[Fig. 3.10A].  
Despite the above differences 11β-HSD1-/- mice -/- (M = 36.66, SD = 5.813) did not 
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previous platform over the 60 second probe test than wild-type mice (M = 29.84, SD 
= 5.286) [t(25) = 0.8632, p = 0.6540; Fig. 3.10B]. 
Analysis of all mice, including mice not meeting the inclusion criteria, showed an 
effect of quadrant [F (3,136) = 15.06, p < 0.0001] and no effect of genotype was 
observed [F (1,136) = 9.663 x 10-10, p > 0.999]. No difference in time taken to swim 
to the previous platform location between wild-type and 11β-HSD1-/- mice [11β-
HSD1-/- : M = 32.55, SD = 4.186; wild-type: M = 35.88, SD = 4.949; t(34) = 0.5144, 
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Figure 3.9. Probe Test Performance in Young Wild-
type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.9. Graph showing probe test acquisition in young wild-type mice (WT; n = 14) and 11β-
HSD1
-/- 
mice (KO; n = 14) as measured by [A] percentage time spent swimming in the target 
quadrant and the remaining 3 quadrants; and [B] latency taken for mice to swim to the previous 
platform location. A significant effect of quadrant was observed. No effect of genotype was 
observed. Values represent percentage time spent swimming during a 60 second probe test 
conducted 24 hours proceeding the final day of spatial learning +SEM.  
A
B
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Figure 3.10. Probe Test Performance in Middle-Aged 
Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.10. Graph showing probe test acquisition in middle-aged 11β-HSD1
-/- 
mice (KO; n = 13) 
but not wild-type mice (WT; n = 14) as measured by [A] percentage time spent swimming in the 
target quadrant and the remaining 3 quadrants; and [B] latency taken for mice to swim to the 
previous platform location. A significant effect ofquadrant was observed. No effect of genotype 
was observed. Values represent percentage time spent wimming during a 60 second probe test 
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 Aged 3.3.2.3
When aged at 18 months, no preference for the target quadrant was observed, with 
no significant effect of quadrant on the percentage time spent swimming in that 
quadrant was observed [F (3, 92) = 2.46, p < 0.0674; Fig. 3.11A] and no effect of 
genotype on the percentage time spent swimming in the four quadrants [F (1, 92) = 
8.693e-11, p = 1.00; Fig. 3.11A].  
An unpaired t-test of latency to the previous platform data in young 11β-HSD1-/- (M 
= 28.808, SD = 4.303) and wild-type (M = 39.99, SD = 5.945) mice revealed no 
difference in latency between the two groups [t(23) = 1.6, p = 0.1232; Fig. 3.11B].  
Analysis of all mice, including mice not meeting the inclusion criteria, showed an 
effect of quadrant [F (3,128) = 3.590, p = 0.0156] and no effect of genotype was 
observed [F (1,128) = 9.219 x 10-11, p > 0.999]. A significant difference in time taken 
to swim to the previous platform location between wild-type and 11β-HSD1-/- mice 
was observed [11β-HSD1-/- : M = 27.93, SD = 3.860; wild-type: M = 42.37, SD = 
5.074; t(32) = 2.265, p = 0.0304]. 
However, at 24 months, a two-way ANOVA showed that quadrant had a significant 
effect on the percentage of time spent swimming in that quadrant [F (3, 64) = 13.67, 
p < 0.0001; Fig. 3.12A] with no effect of genotype on the percentage time spent 
swimming in the four quadrants [F (1, 64) = 0.00, p = 1.00; Fig. 3.12A]. Converse to 
what was observed at 18 months of age, wild-type mice exhibited a preference for 
the target quadrant, swimming for the greatest percentag  time in the target quadrant 
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showed unimpaired spatial memory, showing a preference for the quadrant where the 
platform was previously located (32.4%) [Fig. 3.12A].  
An unpaired t-test of latency to the previous platform data in aged 11β-HSD1-/- mice 
(M = 30.01, SD = 9.83) and wild-type (M = 27.42, SD = 4.595) mice revealed no 
significant difference in latency between the two gr ups [t(16) = 0.2751, p = 0.7867; 
Fig. 3.12B].  
Analysis of all mice, including mice not meeting the inclusion criteria, showed an 
effect of quadrant [F (3,88) = 12.48, p < 0.0001] and no effect of genotype was 
observed [F (1,88) = 9.255 x 10-10, p > 0.999]. No difference in time taken to swim to 
the previous platform location between wild-type and 11β-HSD1-/- mice [11β-HSD1-
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Figure 3.11. Probe Test Performance in 18 Month 
Aged Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.11. Graph showing probe test acquisition in 11β-HSD1
-/- 
mice (KO; n = 12) but not wild-
type mice (WT; n = 13) as measured by [A] percentage time spent swimming in the target 
quadrant and the remaining 3 quadrants; and [B] latency taken for mice to swim to the previous 
platform location. No effect of quadrant was observed. No effect of genotype was observed. 
Values represent percentage time spent swimming during a 60 second probe test conducted 24 
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Figure 3.12. Probe Test Performance in 24 Month old 
Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.12. Graph showing performance in aged wild-type (WT; n = 12) and 11β-HSD1
-/- 
mice 
(KO; n = 6) as measured by [A] percentage time spent swimming in the target quadrant and the 
remaining 3 quadrants; and [B] latency taken for mice to swim to the previous platform location. 
A significant effect of quadrant was observed. No effect of genotype was observed. Values 
represent percentage time spent swimming during a 60 second probe test conducted 24 hours 
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 Ageing Effects 3.3.2.4
The effect of ageing on probe test performance was an lysed using data representing 
the percentage time spent swimming in the target quadrant and latency to the 
previous platform location.  
The amount of time spent swimming in the target quadrant w s affected by age [F (3, 
48) = 4.669, p = 0.0061; Fig. 3.13] but not genotype [F (1, 16) = 0.9601, p = 0.3417; 
Fig. 3.13]. In both wild-type and 11β-HSD1-/- mice, time spent swimming in the 
target quadrant was noted to increase at 24 months further indicating habituation to 
the task through repeated testing. 
Similarly, the latency to the previous platform location was noted to change with age 
[F (3, 48) = 4.669, p = 0.0061; Fig. 3.14] but not genotype [F (3, 48) = 4.669, p = 
0.0061; Fig. 3.14]. In wild-type mice, latency to the platform location was noted to 
increase at 12 months compared to their performance at 6 months, however, when 
aged at 18 and 24 months, latency was not observed to be higher than when young 
[Fig. 3.14A]. In 11β-HSD1-/- mice, latency to the platform decreased significantly a  
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Figure 3.13. Longitudinal Probe Test performance in 
Wild-Type and 11β-HSD1
-/- 
(KO) mice at the ages of 6, 
12, 18 and 24 months 
Fig. 3.13. Graph showing percentage time spent swimming in the target quadrant in [A] wild-
type mice (n = 14) and [B] 11β-HSD1
-/- 
mice (n = 14) as they age. A significant effect of age was 
observed. No effect of genotype was observed. Values represent percentage time spent swimming 
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Figure 3.14. Longitudinal Probe Test performance in 
Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice at the ages 
of 6, 12, 18 and 24 months 
Fig. 3.14. Graph showing latency taken for mice to swim to the pr vious platform location in 
the probe test in [A] wild-type mice (WT; n = 14) and [B] 11β-HSD1
-/- 
mice (KO; n = 14) as they 
age. A significant effect of age was observed. No effect of genotype was observed. Values 
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3.3.3 Radial Arm Water Maze Results 
 Young 3.3.3.1
Young wild-type and 11β-HSD1-/- mice showed no difference in performance in the 
radial arm water maze and there was a progressive improvement in all measures of 
performance (latency, swim path length and errors) over the 5 trials. A two-way 
repeated measures ANOVA revealed that the latency to escape [F (1,25) = 0.26, p = 
0.6138; Fig. 3.15A], swim path length [F (1,25) = 0.12, p = 0.7283; Fig. 3.15B] and 
number of  errors [F (1,25) = 0.83, p = 0.3717; Fig. 3.15C] was not different between 
genotypes. However, there was a significant effect of trial on latency to escape [F 
(4,100) = 23.80, p < 0.0001; Fig. 3.15A], swim path length [F (4,100) = 19.31, p < 
0.0001; Fig. 3.15B] and errors [F (4,100) = 17.58, p < 0.0001; Fig. 3.15C]. Post-hoc 
tests revealed significantly lower latencies to escape, swim path length and errors in 
the trials 1h following the acquisition trial in wild-type mice but not in 11β-HSD1-/- 
mice [Fig. 3.15]. 
However, no difference was observed in savings made in escape latency across the 1 
hour retention interval between genotypes. An unpaired t-test revealed no significant 
difference in savings following the 1 hour retentio interval [t(25) = 1.268, p = 
0.2164; Fig. 3.16] in both young wild-type (M = 36.05, SD = 5.182) and young 11β-
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Figure 3.15. Radial Arm Water Maze Performance in 
Young Wild-type (WT) and 11β-HSD1
-/- 




Fig. 3.15. Graphs showing radial arm water maze task acquisition n young wild-type mice 
(WT; n = 14) but not young 11β-HSD1
-/- 
mice (KO; n = 14) as measured by [A] the latency to 
escape onto the hidden platform; [B] the distance travelled (swim path length) before escape onto 
the hidden platform; and [C] the number of incorrect arm entries before escape onto the hidden 
platform. A significant effect of trial was observed. No effect of genotype was observed. Values 
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Figure 3.16. Savings across a 1 Hour Retention Interval 
in Young Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.16. Graph showing the savings across a 1 hour retention interval in the radial arm water 
maze in young wild-type (WT; n = 14) and 11β-HSD1
-/- 
mice (KO; n = 14). Savings were not 
significantly different between genotypes. Values rpresent the difference in latency to escape 
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 Middle-Age 3.3.3.2
Spatial working memory was then assessed in middle-aged wild-type and 11β-HSD1-
/- mice in the radial arm water maze. At 6 months of age a 1 hour retention interval 
was used to assess spatial working memory in wild-type and 11β-HSD1-/- mice. 
However, at 12 months of age, two new retention interval lengths were introduced to 
allow a comparison of spatial working memory at shorter and longer retention 
intervals of 15 minutes and 2 hours respectively. 
3.3.3.2.1 15 Minute retention trial interval 
A two-way repeated measures ANOVA revealed no significant effect of genotype on 
latency to escape [F (1, 25) = 0.67, p = 0.4213; Fig. 3.17A], swim path length [F (1, 
25) = 0.45, p = 0.5099; Fig. 3.17B] and number of errors [F (1, 25) = 0.00, p = 
0.9643; Fig. 3.17C]. However there was a significant effect of trial on latency to 
escape [F (4, 100) = 18.53, p < 0.0001; Fig. 3.17A], swim path length [F (4, 100) = 
20.68, p < 0.0001; Fig. 3.17B] and errors [F (4, 100) = 21.95, p < 0.0001; Fig. 
3.17C].  
Post-hoc tests revealed significant reductions in escape latency over the trials 
proceeding the acquisition trial and retention interval in middle-aged 11β-HSD1-/- 
mice but not wild-type mice [Fig. 3.17]. 
An unpaired t-test of savings data, calculated from the savings following the 15 
minute retention interval, showed no significant difference in latency savings after a 
15 minute retention interval [t(25) = 0.8664, p = 0.3945; Fig. 3.18] between middle-
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  Figure 3.17. Radial Arm Water Maze Performance in 
Middle-Aged Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice 




Fig. 3.17. Graphs showing radial arm water maze acquisition in middle-aged 11β-HSD1
-/- 
mice 
(KO; n = 13) but not wild-type mice (WT; n = 14) following a 15 minute retention trial interval as 
measured by [A] the latency to escape onto the hidden platform; [B] the distance travelled (swim 
path length) before escape onto the hidden platform; and [C] the number of incorrect arm entries 
before escape onto the hidden platform. Retention interval was between the acquisition trial and 
Trial 2. A significant effect of trial was observed. No effect of genotype was observed. Values 
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Figure 3.18. Savings across a 15 Minute Retention 
Interval in Middle-Aged Wild-type (WT) and 11β-
HSD1
-/- 
(KO) mice  
Fig. 3.18. Graph showing the savings across a 15 minute retention interval in the radial arm 
water maze in middle-aged wild-type (WT; n = 14) and 11β-HSD1
-/- 
mice (KO; n = 13). Savings 
were not significantly different between genotypes. Values represent the difference in latency to 
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3.3.3.2.2  1 hour retention trial interval 
A two-way repeated measures ANOVA revealed no significant effect of genotype on 
latency to escape [F (1,25) = 0.00, p = 0.9558; Fig. 3.19A], swim path length [F 
(1,25) = 0.04, p = 0.8346; Fig. 3.19B] or incorrect arm entries before escape (errors) 
[F (1,25) = 0.04, p = 0.8516; Fig. 3.19C]. However there was a significant effect of 
trial on latency to escape [F (4,100) = 48.89, p < 0.0001; Fig. 3.19A], swim path 
length [F (4,100) = 53.48, p < 0.0001; Fig. 3.19B] and errors [F (4,100) = 53.45, p < 
0.0001; Fig. 3.19C] following a 1 hour inter-trial nterval between all the trials. 
 Post hoc tests revealed significant reductions in escape latency following the 1 hour 
retention interval in middle-aged 11β-HSD1-/- mice. Despite not showing a 
significant reduction in latency to escape in the trial following the 1 hour retention 
interval, wild-type mice showed reductions in swim path length and errors in trial 2. 
An unpaired t-test revealed no difference in the savings between wild-type mice (M 
= 33.27, SD = 4.009) and 11β-HSD1-/- mice (M = 36.01, SD = 5.273) over the 1 hour 
retention interval [t(25) = 0.4180, p = 0.6795; Fig. 3.20]. 
3.3.3.2.3 2 hour retention trial interval 
A two-way repeated measures ANOVAs revealed no significa t effect of genotype 
on latency to escape [F (1,25) = 0.06, p = 0.8053; Fig. 3.21A], swim path length [F 
(1,25) = 0.02, p = 0.8982; Fig. 3.21B] or errors [F (1,25) = 0.13, p = 0.7231; Fig. 
3.21C]. However there was a significant effect of trial on latency to escape [F (4,100) 
= 32.56, p < 0.0001; Fig. 3.19A], swim path length [F (4,100) = 25.77, p < 0.0001; 
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Post hoc tests revealed reductions in latency, swim path length and errors in the trial 
immediately following the retention interval in wild-type mice. 11β-HSD1-/- mice 
demonstrated lower latencies, swim path length and errors only in the trials 
proceeding the trial immediately after the retention interval. 
Savings did not differ between genotype across the 2 hour retention interval. An 
unpaired t-test revealed no significant difference in savings [t(25) = 0.9684, p = 
0.3421; Fig. 3.22B] following the 2 hour retention interval in wild-type (M = 35.37, 
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Fig. 3.19. Graphs showing radial arm water maze task acquisition n middle-aged wild-type mice 
(WT; n = 14) and 11β-HSD1
-/- 
mice (KO; n = 13) following a 1 hour retention trial nterval as 
measured by [A] the latency to escape onto the hidden platform; [B] the distance travelled (swim 
path length) before escape onto the hidden platform; and [C] the number of incorrect arm entries 
before escape onto the hidden platform. Retention interval was between the acquisition trial and 
Trial 2. A significant effect of trial was observed. No effect of genotype was observed. Values 
represent latency, swim path length and errors for each trial averaged over 5 days of testing +SEM.  
Figure 3.19. Radial Arm Water Maze Performance in 
Middle-Aged Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice 
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Figure 3.20. Savings across a 1 Hour Retention 
Interval in Middle-Aged Wild-type (WT) and 11β-
HSD1
-/- 
(KO) mice  
Fig. 3.20. Graph showing the savings across a 1 hour retention interval in the radial arm water 
maze in middle-aged wild-type (WT; n = 14) and 11β-HSD1
-/- 
mice (KO; n = 13). Savings were 
not significantly different between genotypes. Values represent the difference in latency to escape 
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Fig. 3.21. Graphs showing radial arm water maze performance in middle-aged wild-type mice 
(WT; n = 14) and 11β-HSD1
-/- 
mice (KO; n = 13) following a 2 hour retention interval as 
measured by [A] the latency to escape onto the hidden platform; [B] the distance travelled (swim 
path length) before escape onto the hidden platform; and [C] the number of incorrect arm entries 
before escape onto the hidden platform. Retention interval was between the acquisition trial and 
Trial 2. A significant effect of trial was observed. No effect of genotype was observed. Values 
represent latency, swim path length and errors for each trial averaged over 5 days of testing 
+SEM. 
Figure 3.21. Radial Arm Water Maze Performance in 
Middle-Aged Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice 




Distinct Roles for 11β-HSD1 on Age-Associated Spatial Learning and Memory and
Spatial Working Memory Impairment 
107 
  
Figure 3.22. Savings across a 2 Hour Retention Interval 
in Young Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.22. Graph showing the savings across 2 hour retention interval in the radial arm water 
maze in middle-aged wild-type (WT; n = 14) and 11β-HSD1
-/- 
mice (KO; n = 13). Savings were 
not significantly different between genotypes. Values represent the difference in latency to escape 
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 Aged 3.3.3.3
3.3.3.3.1 15 Minute retention trial interval 
Following a 15 minute retention interval, aged wild-type mice showed good spatial 
working memory whilst data suggested impaired spatial working memory in 11β-
HSD1-/- mice.  A two-way repeated measures ANOVA revealed no significant effect 
of genotype on latency to escape [F (1, 23) = 0.47, p = 0.4990; Fig 3.23A], swim 
path length [F (1, 23) = 0.83, p = 0.3719; Fig 3.23B] or incorrect arm entries before 
escape (errors) [F (1, 23) = 0.85, p = 0.3657; Fig 3.23C]. However there was a 
significant effect of trial on latency to escape [F (4, 92) = 11.60, p < 0.0001; Fig 
3.23A], swim path length [F (4, 92) = 9.78, p < 0.0001; Fig 3.23B] and errors [F (4, 
92) = 10.84, p < 0.0001; Fig 3.23C] following a 15 minute inter-trial interval 
between all the trials.  
Post-hoc tests revealed significant reductions in wild-type mice escape latency, swim 
path length and errors in the trial immediately following the retention interval. On 
the other hand, aged 11β-HSD1-/- mice demonstrated results similar to those 
observed when middle-aged following a 2 hour retention interval with no significant 
difference in latency, swim path length and errors compared to the acquisition trial 
on the trial immediately following the short 15 minute retention interval, trial 2.  
Savings data also revealed a trend for lower savings over the 15 minute retention trial 
in 11β-HSD1-/- mice. An unpaired t-test showed no significant difference in savings 
after a 15 minute retention interval between aged wil -type (M = 40.04, SD = 7.948) 
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This data indicates good spatial working memory across a short 15 minute inter-trial 
interval in aged wild-type mice which is demonstrated by significantly faster and 
shorter escape onto the hidden platform and fewer erro s over the 15 minute retention 
interval. However, aged 11β-HSD1-/- mice do not perform as well with latencies,  
swim path lengths and errors in trial 2 which do not differ from acquisition trial 
suggesting they were unable to retain and retrieve the information across the short 15 
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Fig. 3.23. Graphs showing radial arm water maze task acquisition n aged wild-type mice (WT; 
n = 13) but 11β-HSD1
-/- 
mice (KO; n = 12) following a 15 minute retention interval as measured 
by [A] the latency to escape onto the hidden platform; [B] the distance travelled (swim path 
length) before escape onto the hidden platform; and [C] the number of incorrect arm entries 
before escape onto the hidden platform. Retention interval was between the acquisition trial and 
Trial 2. A significant effect of trial was observed. No effect of genotype was observed. Values 
represent latency, swim path length and errors for each trial averaged over 5 days of testing 
+SEM. 
Figure 3.23. Radial Arm Water Maze Performance in Aged 
Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice following a 15 
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Figure 3.24. Savings across a 15 Minute Retention Interval 
in Aged Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.24. Graph showing the savings across 15 minute retention interval in the radial arm water 
maze in aged wild-type (WT; n = 13) and 11β-HSD1
-/- 
mice (KO; n = 12). Savings were not 
significantly different between genotypes. Values rpresent the difference in latency to escape 
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3.3.3.3.2 1 hour retention trial interval 
When a 1 hour retention trial interval was introduced, aged mice exhibited impaired 
spatial working memory regardless of genotype. A two-way repeated measures 
ANOVA revealed no significant effect of genotype on latency to escape [F (1, 23) = 
0.4637, p = 0.5027; Fig 3.25A], swim path length [F (1, 23) = 0.5298, p = 0.82; Fig 
3.25B] or incorrect arm entries before escape (errors) [F (1, 23) = 0.1709, p = 
0.6832; Fig 3.25C]. However there was a significant effect of trial on latency to 
escape [F (4, 92) = 17.34, p < 0.0001; Fig 3.25A], swim path length [F (4, 92) = 
13.09, p < 0.0001; Fig 3.25B] and errors [F (4, 92) = 11.38, p < 0.0001; Fig 3.25C].  
However, whilst shorter latencies were observed immediately following the retention 
interval, swim path length and number of errors were not significantly reduced 
following the 1 hour retention interval in both wild-type and 11β-HSD1-/- mice. 
Additionally, no difference in savings across the 1 hour retention interval was 
observed between genotypes. An unpaired t-test reveal d no difference in the savings 
between aged wild-type (M = 33.84, SD = 5.793) and 11β-HSD1-/- (M = 28.16, SD 
5.532) mice [t(23) = 7067, p = 0.4868; Fig. 3.26] over the 1 hour retention interval. 
Taken together all of this demonstrates that at 24 months spatial working memory is 
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Fig. 3.25. Graphs showing radial arm water maze performance in aged wild-type mice (WT; n = 
13) and 11β-HSD1
-/- 
mice (KO; n = 12) following a 1 hour retention interval as measured by [A] 
the latency to escape onto the hidden platform; [B] the distance travelled (swim path length) 
before escape onto the hidden platform; and [C] the number of incorrect arm entries before escape 
onto the hidden platform. Retention interval was betwe n the acquisition trial and Trial 2. A 
significant effect of trial was observed. No effect of genotype was observed. Values represent 
latency, swim path length and errors for each trialaveraged over 5 days of testing +SEM.  
Figure 3.25. Radial Arm Water Maze Performance in Aged 
Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice following a 1 




Distinct Roles for 11β-HSD1 on Age-Associated Spatial Learning and Memory and
Spatial Working Memory Impairment 
114 
  
Figure 3.26. Savings across a 1 Hour Retention Interval 
in Aged Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.26. Graph showing the savings across 1 hour retention interval in the radial arm water 
maze in aged wild-type (WT; n = 13) and 11β-HSD1
-/- 
mice (KO; n = 12). Savings were not 
significantly different between genotypes. Values rpresent the difference in latency to escape 




Distinct Roles for 11β-HSD1 on Age-Associated Spatial Learning and Memory and 
Spatial Working Memory Impairment 
115 
3.3.3.3.3 2 hour retention trial interval 
Following a 2 hour retention trial interval, aged wild-type and 11β-HSD1-/- mice 
exhibited impaired spatial working memory. No significant effect of genotype on 
latency to escape [F (1, 23) = 0.01525, p = 0.9028; Fig 3.27A],  swim path length [F 
(1, 23) = 0.3086, p = 0.5839; Fig 3.27B] or incorrect arm entries before escape 
(errors) [F (1, 23) = 0.5449, p = 0.4679; Fig 3.27C]. However there was a significant 
effect of trial on latency to escape [F (4, 92) = 10.77, p < 0.0001; Fig 3.27A], swim 
path length [F (4, 92) = 6.741, p < 0.0001; Fig 3.27B] and errors [F (4, 92) = 5.540, p 
< 0.0005; Fig 3.27C]. 
Further analysis revealed that both wild-type and 11β-HSD1-/- mice did not show 
reductions in escape latency, swim path length and errors in the trial immediately 
following the 2 hour retention interval. This suggests that neither aged wild-type nor 
11β-HSD1-/- mice were able to hold spatial information for the platform in mind 
across the 2 hour interval. Additionally, it was noted that whilst aged wild-type mice 
showed shorter latencies to escape, swim path lengths and fewer errors in trial 3, 
aged 11β-HSD1-/- mice did not show improvement in the task until thefinal 2 trials. 
This suggests that aged 11β-HSD1-/- mice may be exhibit more impaired spatial 
working memory than aged wild-type mice. 
However, no difference in savings across the 2 hour retention interval was observed 
between genotype by an unpaired t-test [Wild-type: M = 32.67, SD = 8.477); 11β-
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  Figure 3.27. Radial Arm Water Maze Performance in 
Aged Wild-type (WT) and 11β-HSD1
-/- 




Fig. 3.27. Graphs showing impaired radial arm water maze performance in aged wild-type mice 
(WT; n = 13) and 11β-HSD1
-/- 
mice (KO; n = 12) following a 2 hour retention trial nterval as 
measured by [A] the latency to escape onto the hidden platform; [B] the distance travelled (swim 
path length) before escape onto the hidden platform; and [C] the number of incorrect arm entries 
before escape onto the hidden platform. Retention interval was between the acquisition trial and 
Trial 2. A significant effect of trial was observed. No effect of genotype was observed. Values 
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Figure 3.28. Savings across a 2 Hour Retention Interval 
in Aged Wild-type (WT) and 11β-HSD1
-/- 
(KO) mice  
Fig. 3.28. Graph showing the savings across 2 hour retention interval in the radial arm water 
maze in aged wild-type (WT; n = 13) and 11β-HSD1
-/- 
mice (KO; n = 12). Savings were not 
significantly different between genotypes. Values rpresent the difference in latency to escape 
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3.3.3.3.4 Ageing Effects 
The effects of ageing on spatial working memory across a 1 hour retention interval 
were analysed using latency and error savings across the 1 hour retention interval 
when mice were young, middle-aged and aged.  
Latency savings data showed no effects of ageing with no change in savings 
observed with age [F (2, 46) = 0.18, p = 0.8362; Fig. 3.29A] and no effect of 
genotype [F (1, 46) = 0.76, p = 0.3917; Fig. 3.29A]. Errors savings data showed no 
effects of ageing with no change in savings observed with age [F (2, 46) = 1.267, p = 
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Figure 3.29. Longitudinal Radial Arm Water maze 
performance in Wild-Type and 11β-HSD1
-/- 
(KO) mice 
at the ages of 6, 12 and 18 months 
Fig. 3.29. Graphs showing radial arm water maze performance wild-type mice (n = 13) and 
11β-HSD1
-/- 
mice (n = 12) as they age, following a 1 hour retention interval as measured by 
savings in [A] the latency to escape and [B] number of errors before escape onto the hidden 
platform. No effect of age was observed. No effect of genotype was observed. Values represent 
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 Discussion 3.4
Our study examined the longitudinal effects of lifelong removal of 11β-HSD1 on 
learning and memory processes and working memory processes with age by 
examining 11β-HSD1-/- mice and their wild-type counterparts in the water maze and 
radial arm water maze over the span of 24 months. Both wild-type and 11β-HSD1-/- 
mice showed no impairment in spatial learning in the raining portion of the water 
maze. Impairment in spatial memory was observed at middle-age and 18 months 
wild-type mice in the probe test portion of the water maze. Interestingly, spatial 
working memory was observed to be impaired with age in both wild-type and 11β-
HSD1-/- mice. 
In both wild-type and 11β-HSD1-/- mice, the latency to escape and distance travelled 
before escape onto the platform were observed to decrease over the 5 training days at 
all age time-points. These data indicate no impairment in spatial learning with age. 
These findings differ from those of previous experiments showing an attenuation of 
age-associated cognitive impairment when 11β-HSD1 is removed or inhibited. Yau 
et al. (2001) documented that aged 11β-HSD1 knockout mice had lower 
hippocampal intracellular corticosterone levels and no learning deficits associated 
with elevated glucocorticoid levels whilst aged wild-type mice had learning 
impairments associated with glucocorticoid levels. Meanwhile, the inhibition of 11β-
HSDs has been associated with improved memory  and cognitive function in healthy 
elderly humans (Sandeep et al., 2004) and a 11β-HSD1 activity,  progressive brain 
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Inhibition of 11β-HSD1 in C57BL/6J mice has also been noted to prevent age-related 
spatial memory impairments (Sooy et al., 2010).   
Repeated testing over the 2 years may have resulted in over training of the mice 
resulting in a learning effect and masking age-associated impairments which may 
otherwise have been observed. Despite efforts to vary the testing arena at each time-
point - by alternating testing arenas, extra-maze cu s, platform location and entry 
position – the number of alterations which could be made were still limited. 
Consequently, with repeated testing mice may have become more familiar with the 
task requirements resulting in consistent learning curves across the ages. Indeed, 
Jansen et al. (2013) observed habituation of mice to the water maze task following 
repeated testing at a later age noting a similar decrease in latency and distance 
travelled when mice were tested again at a later ag. Furthermore, some studies have 
suggested that repeated testing in the water maze may not be robust enough to 
effectively assess long-term deficits (Hodges, 1996). Therefore, age-associated 
impairments in spatial learning are possibly not evid nt in this study as a result of 
repeated testing resulting in over-training. 
However, it is notable that in our study wild-type mice were found to have impaired 
performance in the probe test from middle-age and at 18 months of age whilst 11β-
HSD1-/- mice had no impairment in spatial memory at all ages. As the probe test 
portion of the water maze represents spatial memory which is different from spatial 
learning, it suggests that whilst wild-type mice were able to perform well when 
continuously trained over 5 days, their ability to retain the information over longer 
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was able to attenuate these age-associated spatial memory impairments. Interestingly, 
both wild-type and 11β-HSD1-/- mice did not show any impairment in spatial 
memory at 24 months. It is tenable that the difference in complexity of the cognitive 
processes required for spatial learning and spatial memory is also reflected in the 
extent of a learning or practice effect in a task, with wild-type mice only 
demonstrating habituation to the task following more ‘sessions’. Altogether these 
data highlight the distinct memory processes of spatial learning and spatial memory 
suggesting that whilst age-associated impairments i spatial learning can be 
attenuated through repeated practice, the ability to hold information in mind over a 
long period of time is more susceptible to age-associated cognitive impairments and 
less susceptible, though not completely, to learning effects. Furthermore, it and 
suggests that the process of long-term memory formation is sensitive to changes in 
glucocorticoids and reductions in the levels of glucocorticoids through lifelong 
removal of 11β-HSD1 is beneficial for these processes. 
Despite demonstrating no change in savings in both latency and number of errors 
with age, it was observed that with age the latency to platform and number of errors 
were not significantly decreased in the trial following the retention interval both 
wild-type and 11β-HSD1-/- mice suggesting an impairment in the ability to actively 
maintain spatial information in mind whilst another task is being performed. Most 
notably, impairments were observed in both wild-type and 11β-HSD1-/- mice, 
suggesting that whilst lifelong removal of 11β-HSD1 may attenuate age-associated 
spatial memory impairments, it does not attenuate ag -associated impairments in 
spatial working memory. Previous studies have found that working memory reflects 
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more cognitively demanding. Thus, the higher cognitive demands required for spatial 
working memory may mean that lifelong removal of 11β-HSD1 does not attenuate 
age-associated spatial working memory impairments in the same way it does spatial 
memory. Furthermore, spatial working memory also involves activation of brain 
areas in addition to the hippocampus, such as the prefrontal cortex, and removal of 
11β-HSD1 in these brain areas may be detrimental to the cognitive processes 
occurring within these areas. Furthermore, it was noted that 11β-HSD1-/- mice started 
to exhibit impairments at middle-age following the 2 hour retention interval, 
supporting the suggestion that lifelong removal of 11β-HSD1 may actually be 
detrimental to processes involved in spatial working memory. These data are 
contrary to a previous study documenting no impairment in spatial working memory 
with age in both wild-type and 11β-HSD1-/- mice (Yau et al., 2007). However, it is 
notable that previous 11β-HSD1 mouse knockout models demonstrated some 
residual low level 11β-HSD1 activity whilst 11β-HSD1 activity was completely 
removed in the mouse model used in our study. As it is well established that 
glucocorticoids have an inverted-U shape relationship with cognition, it is possible 
that the residual activity in previous mouse models offered protection from age-
associated spatial working memory impairments whilst the complete absence of 11β-
HSD1 in our study accelerates impairments in spatial working memory. Taken all 
together our data suggest that whilst removal of 11β-HSD1 may be beneficial in age-
associated changes in spatial memory, the presence of 11β-HSD1 may be essential 
for other cognitive processes such as spatial working memory. 
The present study had a number of limitations. Firstly, longitudinal testing appeared 




Distinct Roles for 11β-HSD1 on Age-Associated Spatial Learning and Memory and 
Spatial Working Memory Impairment 
124 
spatial learning processes. Secondly, external factors beyond experimental control 
may alter the performance of mice during the task. Particularly notable in our series 
of experiments was ongoing construction work which may have adversely affect 
cognitive performance in mice and an outbreak of pinworm in the research facility 
requiring the colony of mice to be administered medicine which may affect 
behaviour. Finally, testing constraints arising from the size of the colony and 
availability of equipment may have resulted in more variation, particularly in the 
radial arm maze, as data could not be averaged over as many days. 
In conclusion, our results from this chapter suggest that repeated testing may help 
with performance in tasks requiring information to be held for a short period of time 
whilst being learnt when aged, however, the transfer of this information to long-term 
spatial memory may be impaired with age and attenuat d with lifelong deletion of 
11β-HSD1. Finally, our results show that 11β-HSD1 may have a distinct function in 
spatial memory and spatial working memory, as lifelong removal of 11β-HSD1 
appeared to accelerate age-associated spatial working memory impairments. Further 
work investigating the mechanisms through which 11β-HSD1 levels affect spatial 
memory and spatial working memory performance with age will provide better 
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Chapter 4 : Mechanisms of 11β-HSD1 Action on 
Age-Associated Spatial Learning and Memory 
Performance 
 Introduction 4.1
Data gathered in the previous chapter showed that lifelong removal of 11β-HSD1 
attenuated age-associated spatial memory impairments but not spatial working 
memory impairments. However, the mechanisms through which 11β-HSD1 may 
alter cognitive function with age have yet to be fully established. In particular, the 
relationship between the expression of 11β-HSD1 and biomarkers linked to age-
associated cognitive decline has not yet been investigated. Therefore, this chapter 
will focus on investigating the possible mechanisms through which 11β-HSD1 may 
act on spatial memory and spatial working memory by examining the relationship 
between 11β-HSD1, age-associated cellular, metabolite and structu al changes, and 
spatial memory and spatial working memory. 
Numerous studies have highlighted a variety of cellular, structural and metabolite 
changes in the brain with age, in particular in thehippocampus, a brain structure 
essential for spatial memory. Neurobiological research utilising models of age-
related spatial learning impairment have found associati ns between changes in the 
size, number and structure of hippocampal neurons and spatial learning performance, 
whilst further studies have suggested that synaptic connectivity between neurons 
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Additionally, previous studies into structural markers of cognitive ageing have 
observed marked changes in brain morphology including a decline in total brain 
volume, cortical thinning and gyral atrophy (Uylings and de Brabander, 2002; 
Rodrigue and Raz, 2004). Numerous imaging studies have confirmed age-related 
changes in morphological characteristics of the brain (Pfefferbaum et al., 1994; 
Blatter et al., 1995; Raz et al., 1997; Resnick et al., 2003) and that these are found 
particularly in the prefrontal cortex (PFC) (Raz et al., 1997). White matter 
hyperintensities, reduced white-matter integrity and volume loss have also been 
observed (Ylikoski et al., 1995; Gunning-Dixon and Raz, 2000; Sullivan et al., 2001; 
Bartzokis et al., 2004; Head et al., 2004). Furthermore, the hippocampal formation, a 
structure important to declarative memory, experiences volume loss in advanced 
aging and this volume loss correlates with impaired memory performance with age 
and has been observed to be  significantly accelerat d in early stages of Alzheimer's 
disease (for reviews, see Raz et al. 2005). Finally, proton magnetic resonance 
spectroscopy (MRS) studies have identified metabolite changes linked with cognitive 
impairment with age including, but not limited to, changes in levels of the neuronal 
metabolic marker (N-acetylaspartate, NAA), glial metabolite marker (Inositol, Ins) 
and cellular membrane turnover/breakdown (Choline, Cho). In particular, higher 
levels of NAA were observed in younger adults who swed better spatial memory 
performance than their older counterparts (Driscoll et al., 2003) whilst increased 
levels of Ins have been observed in subjects with mld cognitive impairment. 
Notably, 11β-HSD1 mRNA is highly expressed in the hippocampus of humans 
(Sandeep et al., 2002) and rodents (Moisan et al., 1990). In-situ hybridisation 
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hippocampus suggesting 11β-HSD1 plays a key role in mechanisms and processes 
occurring within the hippocampus. However, the exprssion of 11β-HSD1 in various 
cells within the hippocampus and associated metaboli e levels and structural changes 
have yet to be investigated. Determining the associati n between 11β-HSD1 and 
cellular, metabolite and structural markers of agein , and the association of these 
markers with cognitive decline, is key in underpinning the role 11β-HSD1 plays in 
age-associated cognitive impairment. 
Thus, we hypothesised altered molecular physiology, structural integrity or 
metabolite levels in the hippocampus would be observed with age and these changes 
would be associated with the spatial memory and spatial working memory 
performance observed at 18 months in wild-type and 11β-HSD1-/- mice assessed in 
Chapter 3, respectively. Therefore, this chapter aims to explore the possible 
molecular, structural and metabolite mechanisms through which 11β-HSD1 may 
alter age-associated cognitive function by investigating: 1) The expression of 11β-
HSD1 within the hippocampus; 2) Cellular, metabolite and structural changes with 
age; 3) The relationship between these markers and the cognitive performance of the 
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Figure 4.1. Number of wild-type and 11β-HSD1-/- mice undergoing 
MRS/MRI at each timepoint and timeline of tissue collected. 
 Methods 4.2
4.2.1 Animals 
Male 11β-HSD1-/- mice and their Wild-type littermates were maintained in standard 
cages upon controlled lighting (12h:12h, lights on at 7.00), were fed a standard chow 
and given water ad libitum as described in Chapter 2. 
A subgroup of mice underwent MRS and MRI in a 7Tesla V rian/Agilent 
Technologies MRI Scanner at 6, 18 and 24 months of age, s described in Chapter 2. 
At 24 months of age, brains were removed and half the brain fixed for 
immunofluorescent analysis and the remaining half dissected for real time PCR 
analysis as outlined in Chapter 2. Figure 4.1 illustrates the number of animals 
undergoing MRS and MRI at each time point and the colle tion of brain tissue. 
Tissue was collected following the final testing at 24 months, unless mice were 
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4.2.2  MRS Analysis 
LC Model method was utilised to analyse the spectrum produced.  This 
model analyses and quantitates an in vivo spectrum of brain metabolites as outlined 
in Chapter 2. 
4.2.3 MRI Structural Analysis 
The software ANALYZE was used to analyse hippocampal and whole brain volumes 
from T2 weighted structural scans obtained during the MRS scan as described in 
Chapter 2. 
4.2.4 Immunofluorescence 
Hippocampal brain sections were processed as outlined i  Chapter 2 and stained for 
11Β-HSD1, microglia, neuron and glial expression using primary antibodies purified 
sheep 11β-HSD1, Mouse NeuN and Rabbit GFAP respectively and secondary 
antibodies anti-Sheep Alexa Fluor 488, anti-Mouse Al xa Fluor 555 and anti-Rabbit 
Alexa Fluor 555 respectively.  
4.2.5 Statistics 
Statistical analysis was conducted using PRISM and significant differences 
determined by unpaired t-test where appropriate with a P value < 0.05 signifying a 
significant difference. 
Differences between young and aged mice were calculated using a two-way ANOVA 
or unpaired T-Test with a P value < 0.05 signifying a significant effect or difference 
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The relationship between variables (11β-HSD1, Probe test data, Radial arm water 
maze savings data, NeuN, GFAP, metabolites, structural data) was analysed using 









4.3.1 11β-HSD1 expressed in glial cells 
Previous in-situ hybridisation studies have identified the possible expression of 11β-
HSD1 mRNA in hippocampal neurons. Therefore, to investigate if neuronal 11β-
HSD1 expression and neuronal physiology was altered with age in wild-type mice 
and determine if lifelong deletion of 11β-HSD1 attenuated these changes, a 
qualitative and quantitative analysis  of cellular markers was performed on brain 
sections of the longitudinally aged colony of wild-type and 11β-HSD1-/- mice at 24 
months. 
Interestingly, qualitative results from double immunoflu rescent stains for 11β-
HSD1 expression and a neuronal marker, Neuronal Nuclei (NeuN), in hippocampal 
brain sections of aged wild-type mice revealed limited expression of 11β-HSD1 in 
hippocampal neurons (Fig. 4.2). No expression of 11β-HSD1 was observed in 11β-
HSD1-/- mice, confirming deletion of 11β-HSD1 in the 11β-HSD1-/- mouse colony 
(Fig. 4.3). 
Similarly, in the cortex, no colocalisation of 11β-HSD1 and NeuN was observed in 
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Figure 4.2. 11β-HSD1 and NeuN expression in aged 
wild-type mice 
 
Fig. 4.2. Representative images of patterns of 11β-HSD1(Green) and NeuN (Red) expression in the 
CA1, CA3, Dentate Gyrus (DG) and Cortex of aged wild-type mice.  Images of hippocampal 
subregions CA1, CA3 and DG captured at 30x magnificat on using a Zeiss Axioskop confocal laser 
microscope.  Blue represents DAPI stained nuclei. White arrows indicate example of positive 
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Figure 4.3. 11β-HSD1 and NeuN expression in aged  
11β-HSD1-/- mice 
 
Fig. 4.3.  Representative images of patterns of 11β-HSD1(Green) and NeuN (Red) expression in the 
CA1, CA3, Dentate Gyrus (DG) and Cortex of aged 11β-HSD1-/- mice.  Images of CA1, CA3 and DG 
captured at 30x magnification using a Zeiss Axioskop c nfocal laser microscope.  Blue represents 
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However, 11β-HSD1 appears to be expressed in another group of cells thought to be 
glial cells due to their processes. Double staining for the glial cell marker, glial 
fibrillary acidic protein (GFAP), and 11β-HSD1 confirmed the expression of 11β-
HSD1 in glial cells (Fig. 4.4). In particular, 11β-HSD1 was observed to be expressed 
largely in the cell membrane and dendritic processes of the glial cells. 
These results show that 11β-HSD1 protein is rarely expressed in neurons contrary to 
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Figure 4.4.  11β-HSD1 and GFAP colocalisation in aged 
wild-type mice 
 
Fig. 4.4. Representative images of patterns of 11β-HSD1(Green) and GFAP (Red) expression in the 
CA1, CA3, Dentate Gyrus (DG) and Cortex of aged 11β-HSD1-/- mice.  Images of CA1, CA3 and DG 
captured at 30x magnification using a Zeiss Axioskop c nfocal laser microscope.  Blue represents 
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4.3.2 Hippocampal 11β-HSD1 protein expression and ageing 
Previous studies have established that levels of 11β-HSD1increase with age and are 
associated with spatial impairments observed with age (Holmes et al., 2010). 
A quantitative analysis of the immunofluorescence was performed utilising two 
measures: 1) the area of fluorescence for the specified stain meeting a predefined 
intensity as a percentage of the total area; and 2) the number of cells expressing the 
protein. 
Therefore, we wished to determine if the expression of 11β-HSD1 in the 
hippocampus and cortex is altered with age. As the colony of wild-type and 11β-
HSD1-/- mice were culled at 24 months following longitudinal assessment, a cross 
sectional experimental design was utilised to examine age-related changes. Young (6 
months) wild-type and 11β-HSD1-/- mice were culled and their brain sections 
processed alongside the brain sections of the aged wild-type and 11β-HSD1-/- mice 
colony. 
As expected, both young and aged 11β-HSD1-/- mice showed no expression of 11β-
HSD1 (data not shown for young brains but for aged brains see Fig. 4.1) 
A significantly lower percentage fluorescence of 11β-HSD1 was observed in the 
CA1 of aged wild-type mice [Young: M = 1.436, SD = 0.5126; Aged: M = 0.3720, 
SD = 0.09967; t(16) = 3.369, p = 0.0071; Fig. 4.5A] compared to young mice 
(unpaired T-Test). Significantly lower expression of 11β-HSD1 in aged wild-type 
mice was also observed in the CA3 [Young: M = 4.391, SD = 1.679; Aged: M = 
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hippocampus [Young: M = 4.473, SD = 1.893; Aged: M = 0.9684, SD = 0.2348; 
t(17) = 3.069, p < 0.0001; Fig. 4.5C]. However, there was no significant difference in 
the expression of 11β-HSD1 in the cortex of young and aged wild-type mice [Young: 
M = 2.744, SD = 0.6810; Aged: M = 1.343, SD = 0.4173; t(16) = 1.620, p = 0.9285; 
Fig. 4.5D]. 
The number of cells expressing 11β-HSD1 did not differ between groups in any 
region studied. The number of cells expressing 11β-HSD1 between young and aged 
wild-type mice in the CA1 [Young: M = 6.667, SD = 0.9428; Aged: M = 5.286, SD 
= 0.7718; t(7) = 1.33, p = 0.5251; Fig. 4.6A], CA3[Young: M = 5.567, SD = 0.5364; 
Aged: M = 5.167, SD = 0.5834; t(13) = 0.5047, p = 0.2571; Fig. 4.6B], DG [Young: 
M = 7.4, SD = 1.404; Aged: M = 6.857, SD = 0.6836; t( ) = 0.3476, p = 0.5146; Fig. 
4.6C] and cortex [Young: M = 12.42, SD = 1.96; Aged: M = 9.893, SD = 1.289; t(5) 











Figure 4.5. Percentage Fluorescence of 11β-HSD1 
expression in young and aged wild-type mice 
Fig. 4.5. Graphs showing the percentage area of fluorescence of 11β-HSD1 in [A] CA1 of 
young (n=4) and aged (n=14) wild-type mice; [B] CA3 of young (n=5) and aged (n=14) wild-
type mice; [C] dentate gyrus (DG) of young (n=5) and aged (n=14) wild-type mice; and [D] 
cortex of young (n=4) and aged (n=15) wild-type mice.  Values represent mean percentage area 










Fig. 4.6. Graphs showing the number of cells expressing 11β-HSD1 in A] CA1 of young (n=4) 
and aged (n=14) wild-type mice; [B] CA3 of young (n=5) and aged (n=14) wild-type mice; [C]
dentate gyrus (DG) of young (n=5) and aged (n=14) wild-type mice; and [D] cortex of young 
(n=4) and aged (n=15) wild-type mice.  Values represent mean number of cells (across three 
fields per animal) +SEM. 
Figure 4.6. Number of cells co-expressing 11β-HSD1 






Mechanisms of 11β-HSD1 Action on Age-Associated Spatial Learning and Memory 
Performance 
140 
4.3.3 11β-HSD1 protein expression and spatial memory and 
spatial working memory 
 Probe test performance 4.3.3.1
No correlation was observed between the percentage time spent swimming in the 
target quadrant and percentage area of fluorescence in the CA1 [r = -0.4042, p = 
0.2467], CA3 [ r = -0.3641, p = 0.3010], DG [ r = -0.06404, p = 0.8605] and cortex [ 
r = -0.2246, p = 0.5328] of the brain. 
Similarly, no correlation was observed between the lat ncy to previous platform 
location and percentage area of fluorescence in the CA1 [r = 0.5468, p = 0.1019], 
CA3 [r = 0.3778, p = 0.2817], DG [r = 0.5594, p = 0.0927] and cortex [ r = 0.3781, p 
= 0.2814]. 
 Radial Arm Water Maze 4.3.3.2
In wild-type mice, there was no correlation between 11β-HSD1 expression and 
latency savings over the 1 hour retention interval in the CA1 [r = 0.008253, p = 
0.9821], CA3 [r = 0.01376, p = 0.9676], DG [r = -0.04952, p = 0.8753] and cortex [r 
= 0.2146, p = 0.4780].  There was no correlation betwe n 11β-HSD1 expression and 
error savings over the 1 hour retention interval in the CA1 [r = 0.07652, p = 0.8039], 
CA3 [r = 0.1049, p = 0.7311], DG [r = 0.1049, p = 0.7311] and cortex [r = 0.1899, p 
= 0.5299]. 
In 11β-HSD1-/- mice, there was no correlation between 11β-HSD1 expression and 
latency savings over the 1 hour retention interval in the CA1 [r = 0.01667, p = 
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= -0.6276, p = 0.0773].  There was no correlation between 11β-HSD1 expression and 
error savings over the 1 hour retention interval in the CA1 [r = -0.1167, p = 0.7756], 
CA3 [r = -0.5500, p = 0.1328], DG [r = 0.2008, p = 0.6024] and cortex [r = -0.6360, 
p = 0.0716].   
4.3.4 Number of neurons and hippocampal 11β-HSD1 
expression  
Hippocampal neurons have been found to be a principal s te of glucocorticoid action 
and glucocorticoid sensitive. Subsequently, glucocortic ids have been observed to be 
neurotoxic in some cases with prolonged glucocorticid exposure resulting in 
hippocampal neuron loss. Thus, 11β-HSD1 protein levels were tested to see if they 
affected the number of neurons in the hippocampus and cortex of aged mice to 
determine if the number of neurons was altered by 11β-HSD1 protein levels. 
Indeed, higher levels of 11β-HSD1 were associated with more neurons in the 
hippocampus of wild-type mice. Percentage area fluorescence of NeuN was 
positively correlated with the percentage area of 11β-HSD1 in the CA1 [ r = 0.5549, 
p = 0.049], CA3 [ r = 0.6648, p = 0.0132] and DG [ r = 0.5989, p = 0.0306] of the 
hippocampus, but not in the cortex [ r = 0.5330, p = 0.0607].  
4.3.5 Number of neurons and spatial memory and spatial 
working memory 
Spatial learning and memory is a hippocampal dependent task. As such, the 
association between the number of neurons and latency to escape on the final day of 
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relationship between the number of neurons and spatial learning in aged wild-type 
and 11β-HSD1-/- mice.  
 Probe test performance 4.3.5.1
No correlation was observed between the percentage time spent swimming in the 
target quadrant the number of neurons in the CA1 [r = -0.03178, p = 0.9305], CA3 [ r 
= -0.0003894, p = 0.9991], DG [ r = 0.06712, p = 0.8538].  Similarly, no correlation 
was observed between the latency to previous platform l cation and neuronal number 
CA1 [r = 0.5027, p = 0.1386], CA3 [ r = 0.4880, p = 0.1525] and DG [ r = 0.5112, p 
= 0.1310] in wild-type mice. 
However, in the cortex of wild-type mice, higher neuronal number was associated 
with longer latencies to the previous platform location in the probe test [r = 0.7105, p 
= 0.0213] but not the time spent swimming in the target quadrant [ r = -0.2936, p = 
0.4102].  
In 11β-HSD1-/- mice, probe test performance was not associated with the number of 
neurons in hippocampal subregions CA1 and CA3 and the cortex. No correlation was 
observed between the percentage time swimming in the targ t quadrant and number 
of neurons in the CA1 [r = -0.4476, p = 0.4498], CA3 [ r = -0.5483, p = 0.3387]   and 
cortex [ r = -0.7248, p = 0.1160] of the brain. Similarly, no correlation was observed 
between the latency to previous platform location and number of neurons in the CA1 
[r = 0.2126, p = 0.7314], CA3 [ r = 0.2343, p = 0.7045], DG [ r = 0.4851, p = 0.5149]  
and cortex [ r = 0.3524, p = 0.5608] of the brain. 
However, a significant correlation was observed betwe n percentage time spent 
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0.0086] suggesting that the number of neurons in the dentate gyrus are associated 
with spatial memory. 
 Radial Arm Water Maze 4.3.5.2
In wild-type mice, there was no correlation between NeuN expression and latency 
savings over the 1 hour retention interval in the CA1 [r = -0.005502, p = 0.9889], 
CA3 [r = 0.1403, p = 0.6457], DG [r = 0.1051, p = 0.7443] and cortex [r = 0.2767, p 
= 0.3811].  There was no correlation between NeuN expression and error savings 
over the 1 hour retention interval in the CA1 [r = 0.1417, p = 0.6412], CA3 [r = 
0.2863, p = 0.3389], DG [r = 0.2547, p = 0.4196] and cortex [r = 0.4476, p = 
0.1452].  Similarly, no correlation was observed between the number of neurons and 
latency savings over the 1 hour retention interval in the CA1 [r = 0.1623, p = 
0.5939], CA3 [r = 0.01926, p = 0.9532], DG [r = 0.1576, p = 0.6227] and cortex [r = 
0.2242, p = 0.4801] and no correlation was observed between the number of neurons 
and error savings over the 1 hour retention interval in the CA1 [r = 0.3599, p = 
0.2248], CA3 [r = 0.1757, p = 0.5618], DG [r = 0.3639, p = 0.2426] and cortex [r = 
0.3312, p = 0.2896]. 
In 11β-HSD1-/- mice, there was no correlation between NeuN expression and latency 
savings over the 1 hour retention interval in the CA1 [r = -0.1865, p = 0.6384], CA3 
[r = -0.4746, p = 0.2003], DG [r = -0.06093, p = 0.8792] and cortex [r = -0.4532, p = 
0.3143].  There was no correlation between NeuN expression and error savings over 
the 1 hour retention interval in the CA1 [r = -0.271 , p = 0.4811], CA3 [r = -0.5085, 
p = 0.1688], DG [r = 0.06093, p = 0.8792] and cortex [r = -0.7684, p = 0.0667].  
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savings over the 1 hour retention interval in the CA1 [r = -0.06723, p = 0.8685], CA3 
[r = -0.1017, p = 0.8011], DG [r = -0.1423, p = 0.7174] and cortex [r = 0.04372, p = 
0.9161] and no correlation was observed between the number of neurons and error 
savings over the 1 hour retention interval in the CA1 [r = -0.1167, p = 0.7756], CA3 
[r = -0.2767, p = 0.5809], DG [r = 0.06667, p = 0.8801] and cortex [r = 0.5000, p = 
0.2667]. 
4.3.6 Glial reactivity, density and hippocampal 11β-HSD1 
expression  
As our study noted 11β-HSD1 to be expressed in glial cells, expression of 11β-HSD1 
was tested to see if it would alter glial cell reactivity or the number of glial cells. 
GFAP fluorescence was associated with 11β-HSD1 expression in all hippocampal 
regions. Positive correlations were noted in the CA1 [r = 0.7319, p = 0.0029], CA3 [r 
= 0.7143, p = 0.0041] and DG [r = 0.6, p = 0.0233], however, GFAP fluorescence 
was not correlated with 11β-HSD1 expression in the cortex [r = 0.3407, p = 0.233]. 
The number of glial cell bodies was positively correlated with the number of 11β-
HSD1 expressing cells in the CA1[r = 0.7682, p = 0.0013] and DG [r = 0.6236, p = 
0.0172] but not the CA3[ r = 0.5270, p = 0.0528] and cortex[ r = 0.2228, p = 0.444]. 
This suggests that an increase in glial cell number gives a parallel increase in 11β-
HSD1, as 11β-HSD1 is expressed in glial cells. However, it also suggests that 11β-
HSD1 expression and glial reactivity are related although it cannot be determined 
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4.3.7 Glial reactivity, density and spatial memory and spatial 
working memory 
Traditionally, neurons were considered the basic functional units of the brain with 
glial cells supporting neuronal function. However, more recent evidence has 
suggested that a neuronal-microglia-glia triad is essential for functional organisation 
of the brain (Barres, 2008; Allen and Barres, 2009). Therefore we tested to see if the 
percentage fluorescence of GFAP and the number of glial cells in aged wild-type and 
11β-HSD1-/- mice would alter distance travelled on the final day of spatial learning 
and measures of probe test performance. 
 Probe test performance 4.3.7.1
In wild-type mice, there was no correlation between GFAP expression and the 
percentage time spent in the target quadrant in the CA1 [r = -0.4608, p = 0.2119], 
CA3 [r = -0.3801, p = 0.3129], DG [r = -0.3729, p = 0.3230] and cortex [r = -0.3348, 
p = 0.3784].  Similarly, no correlation was observed between the number of glial 
cells and percentage time spent in the target quadrant in the CA1 [r = -0.4874, p = 
0.1778], CA3 [r = -0.2941, p = 0.4257], DG [r = -0.35, p = 0.3586] and cortex [r = -
0.1461, p = 0.5470]. 
However, increased expression of GFAP was associated wi h longer latencies to the 
previous platform location in the hippocampal regions CA1 [r = 0.7532, p = 0.0191; 
Fig. 4.7A], CA3 [ r = 0.6840, p = 0.0422; Fig. 4.7B] and DG [r = 0.6704, p = 0.0481; 
Fig. 4.7B] but not the cortex [r = 0.5355, p = 0.1373]. But number of glial cells in the 
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0.1475] and cortex [r = 0.6390, p = 0.0747] was not related to latency to previous 
platform 
In 11β-HSD1-/- mice, neither GFAP expression nor number of glial cells number was 
associated with either measure of probe test performance. There was no correlation 
between the two measures and the percentage time spent in the target quadrant in the 
CA1 [GFAP: r = 0.2304, p = 0.7696; Density: r = 0.8, p = 0.333], CA3 [GFAP: r = 
0.2304, p = 0.7696; Density: r = 0.6325, p = 0.5], DG [GFAP: r = 0.2304, p = 
0.7696; Density: r = 0.8, p = 0.333]  and cortex [GFAP: r = 0.2304, p = 0.7696; 
Density: r = -0.6325, p = 0.333]. Similarly, no correlation was observed between 
expression of GFAP and the latency to previous platform location in the CA1 
[GFAP: r = 0.2304, p = 0.7696; Density: r = -0.4, p = 0.75], CA3 [GFAP: r = 0.2304, 
p = 0.7696; Density: r = -0.3162, p = 0.5], DG [GFAP: r = 0.2304, p = 0.7696; 
Density: r = 0.6, p = 0.4167] and cortex [GFAP: r = 0.2304, p = 0.7696; Density: r = 
-0.7379, p = 0.1667]. 
 Radial Arm Water Maze 4.3.7.2
In wild-type mice, there was no correlation between GFAP expression and latency 
savings over the 1 hour retention interval in the CA1 [r = -0.1045, p = 0.7328], CA3 
[r = -0.2806, p = 0.3499], DG [r = -0.05502, p = 0.8592] and cortex [r = -0.2201, p = 
0.4665].  There was no correlation between GFAP expression and error savings over 
the 1 hour retention interval in the CA1 [r = -0.1275, p = 0.6760], CA3 [r = -0.4280, 
p = 0.1447], DG [r = -0.2069, p = 0.4929] and cortex [r = -0.2324, p = 0.4401].  
Similarly, no correlation was observed between the number of glial cells and latency 
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[r = -0.08183, p = 0.7887], DG [r = 0.2837, p = 0.3438] and cortex [r = -0.2525, p = 
0.4004] and no correlation was observed between the umber of glial cells and error 
savings over the 1 hour retention interval in the CA1 [r = -0.2078, p = 0.4896], CA3 
[r = 0.03572, p = 0.9078], DG [r = -0.01987, p = 0.9490] and cortex [r = -0.1034, p = 
0.7350]. 
In 11β-HSD1-/- mice, there was no correlation between GFAP expression and latency 
savings over the 1 hour retention interval in the CA1 [r = -0.0500, p = 0.9116], CA3 
[r = -0.4500, p = 0.2298], DG [r = -0.5167, p = 0.1618] and cortex [r = 0.1167, p = 
0.7756].  There was no correlation between GFAP expression and error savings over 
the 1 hour retention interval in the CA1 [r = -0.2667, p = 0.4933], CA3 [r = -0.5000, 
p = 0.1777], DG [r = -0.6833, p = 0.0503] and cortex [r = -0.0500, p = 0.9116].  
Similarly, no correlation was observed between the number of glial cells and latency 
savings over the 1 hour retention interval in the CA1 [r = -0.06723, p = 0.8685], CA3 
[r = -0.1017, p = 0.8011], DG [r = -0.1423, p = 0.7174] and cortex [r = 0.04372, p = 
0.9161] and no correlation was observed between the umber of glial cells and error 
savings over the 1 hour retention interval in the CA1 [r = -0.2941, p = 0.4392], CA3 
[r = -0.2712, p = 0.4803], DG [r = -0.5439, p = 0.1352] and cortex [r = -0.04372, p = 
0.9161]. 
4.3.8 Hippocampal volume and ageing 
As glucocorticoids are known to alter hippocampal volume, we investigated changes 
in hippocampal and ventricle volume with age. Structural scans were used to 
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HSD1-/- mice at 6, 18 and 24 months of age. Hippocampal volume was measured as a 
percentage of total brain volume. 
Hippocampal volume decreased with age in wild-type mice but not 11β-HSD1-/- 
mice. A two-way ANOVA revealed a significant effect of age on hippocampal 
volume [F (2,39) = 5.821, p = 0.0061; Fig. 4.8], however, there was no significant 
effect of genotype on hippocampal volume [F (1,39) = 2.353, p = 0.603; Fig. 4.8]. 
Post hoc tests revealed smaller hippocampal volumes compared to when they were 
young in aged wild-type mice but not aged 11β-HSD1-/- mice. 
A two-way ANOVA revealed no effect of age on whole brain volume [F (2,42) = 
3.081, p = 0.0564], and no significant effect of genotype on hippocampal volume [F 









Fig. 4.8. Graph showing hippocampal volume (as a percentage of total brain volume) in young 
(n=7) and aged (n=7) wild-type mice (WT) and young ( =8) and aged (n=8) 11β-HSD1
-/-
 mice 
(KO). Values represent mean volume +SEM. *p < 0.05; ** p < 0.01; *** p < 0.001. 
Figure 4.8. Hippocampal Volume (as a % of Total 
Brain Volume) in Young and Aged Wild-Type (WT) 
and 11β-HSD1
-/-
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4.3.9 Hippocampal volume and spatial memory and spatial 
working memory 
 Probe test performance 4.3.9.1
Hippocampal volumes were correlated with spatial memory measures from the probe 
test to examine if hippocampal volume was related to spatial memory. 
Hippocampal volume was not associated with probe test p rformance in either 
genotype.  
There was no correlation between hippocampal volume and percentage time spent in 
the target quadrant [ r = -0.1369, p = 0.8263] and latency to the previous platform 
location [ r = -0.1446, p = 0.8165] during the probe test in wild-type mice.  
No correlation between hippocampal volume and percentag  ime spent in the target 
quadrant [ r = -0.6967, p = 0.1911] and latency to the previous platform location [ r = 
-0.7728, p = 0.1255] during the probe test in 11β-HSD1-/- mice.  
 Radial Arm Water Maze 4.3.9.2
In wild-type mice, there was no correlation between hippocampal volume and 
latency savings over the 1 hour retention interval [r = 0.2319, p = 0.6500].  There 
was no correlation between hippocampal volume and error savings over the 1 hour 
retention interval [r = 0.3043, p = 0.6000]. 
In 11β-HSD1-/- mice, there was no correlation between hippocampal volume and 
latency savings over the 1 hour retention interval [r = -0.09524, p = 0.8401].  There 
was no correlation between hippocampal volume and error savings over the 1 hour 
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4.3.10 Age-associated changes in hippocampal metabolite 
levels 
Changes in neuronal viability, membrane turnover/brakdown, glial cells, excitatory 
neurotransmission and energy metabolism with age and following lifelong removal 
of 11β-HSD1 were investigated. Proton magnetic resonance spectroscopy (1H-MRS) 
was carried out on wild-type and 11β-HSD1-/- mice when they were 6, 18 and 24 
months of age. Specifically, changes in metabolites N-acetylaspartate (NAA), 
Choline (Cho), Inositol (Ins), Glucose (Glc), Glutam te (Glu), Glutamine (Gln) and  
Glutamate/Glutamine complex (Glx) which are  associated with neuronal viability, 
membrane turnover/breakdown, glial cells, energy metabolism and excitatory 
neurotransmission respectively were investigated (Fig. 4.9). 
There was a significant effect of age on hippocampal Cho levels [F (2,28) = 4.645, p 
= 0.00181; Fig. 4.10] but no effect of genotype [F (1,28) = 2.37, p = 0.1349; Fig. 
4.10]. No interaction was found, but post hoc tests revealed significantly higher Cho 
levels in 11β-HSD1-/- mice at 18 months and 24 months of age compared to 6 m nths 
of age. However, no significant differences in Cho levels were observed between 6, 
18 and 24 month aged wild-type mice. This suggests that there is an increase in 
membrane turnover/breakdown with age in mice where 11β-HSD1 is absent. 
A two-way ANOVA of age and genotype on hippocampal NAA levels revealed a 
significant effect of age on hippocampal NAA levels [F (2,35) = 3.542, p = 0.0397; 
Fig. 4.11] but no significant effect of genotype on hippocampal NAA levels [F (1,35) 
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differences between young and aged wild-type mice hppocampal NAA levels and 
young and aged 11β-HSD1-/- mice hippocampal NAA levels. 
Similarly, a two-way ANOVA of age and genotype on hippocampal Ins levels 
revealed a significant effect of age on hippocampal Ins levels [F (2,35) = 4.069, p = 
0.0258; Fig. 4.12]  but no significant effect of genotype on hippocampal Ins levels [F 
(1,35) = 0.3855, p = 0.5387; Fig. 4.12]. No interaction was observed, however, post 
hoc tests revealed no significant differences betwen young and aged wild-type mice 
hippocampal Ins levels and young and aged 11β-HSD1-/- mice hippocampal Ins 
levels. This suggests that there is an effect of age on gliosis within the hippocampus.  
No effect of age or genotype was observed for hippocampal levels of glucose, 











Figure 4.10. Choline (Cho) Levels in Young and Aged  




Fig. 4.10. Graph showing Choline (Cho) levels (as a ratio of Creatine, Cr) in young (n=7) and 
aged (n=7) wild-type mice (WT) and young (n=8) and aged (n=8) 11β-HSD1
-/-
 mice (KO). 





Fig. 4.9. Representative unilateral hippocampus 1H-MRS spectra of a wild-type mouse. The 
chemical shift for each peak is shown in parts per million (ppm), and the area under the curve of 
the peak indicates the relative amount of a particular metabolite.  The major peaks represent 
choline (Cho) [3.2 ppm], creatine (Cr) [3.05 ppm], N-acetyl aspartate (NAA) [2.0 ppm] the 
glutamate –glutamine complex (Glx) [3.75ppm], glutamate [3.34ppm] and glutamine [2.42ppm].  
These metabolites can be identified by their chemical shift on the spectrum. 












Figure 4.11. NAA Levels in Young and Aged   




Fig. 4.11. Graph showing N-acetylaspartate (NAA) levels (as a ratio of Creatine, Cr) in young 
(n=7) and aged (n=7) wild-type mice (WT) and young ( =8) and aged (n=8) 11β-HSD1
-/-
 mice 
(KO). Values represent mean metabolite level (/Cr) +SEM. 
Figure 4.12. Ins Levels in Young and Aged   




Fig. 4.12. Graph showing Inositol (Ins) levels (as a ratio of Creatine, Cr) in young (n=7) and 
aged (n=7) wild-type mice (WT) and young (n=8) and aged (n=8) 11β-HSD1
-/-
 mice (KO). 
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4.3.11  Hippocampal metabolite levels and spatial memory 
and spatial working memory 
 Probe test performance 4.3.11.1
Metabolite levels at 18 months were correlated with their performance in the probe 
test at 18 months of age to investigate if age-associated spatial learning impairment 
was related to metabolite levels. 
 In the probe test, no relationship was observed between any of the metabolites and 
the measures of probe test performance in wild-type mice. 
However, in the probe test, N-acetylaspartate (NAA) [r = 0.9662, p = 0.0074; Fig. 
4.13] and Glutamate (Glu) [r = 0.9752, p = 0.0047; Fig. 4.14] were observed to be 
correlated with percentage time spent in the target quadrant in 11β-HSD1-/- mice. 
No correlation was observed between probe test performance and any other  
 Radial Arm Water Maze 4.3.11.2
No relationship was observed between any of the metaboli es and the measures of 









Figure 4.13. 18 Months: Correlations between 
hippocampal NAA levels and probe test 
performance in aged 11β-HSD1
-/-
 mice 
r = 0.9662** 
Fig. 4.13. Correlation coefficient (r) of the correlation calculated between N-acetylaspartate 
(NAA) and percentage time swimming in the target quadrant in the probe test in  18 month aged 
11β-HSD1
-/-
 mice (n=5). ** p < 0.01. 
Figure 4.14. 18 Months: Correlations between 




r = 0.9752** 
Fig. 4.14. Correlation coefficient (r) of the correlation calculated between Glutamate (Glu) 
and percentage time swimming in the target quadrant in the probe test in  18 month aged 11β-
HSD1
-/-








This chapter aimed to explore the possible molecular, structural and metabolite 
mechanisms through which 11β-HSD1 expression may alter cognitive function. Age-
associated changes in 11β-HSD1, hippocampal volume and metabolites choline, 
inositol and NAA were observed. However, these markers were not associated with 
spatial memory performance at 18 months. 11β-HSD1 was observed to be expressed 
in glial cells in the brain and associated with glial reactivity and neuronal expression, 
and both glial reactivity and neuronal expression were associated with spatial 
memory ability in wild-type mice. Levels of glutamine and the glutamate-glutamine 
complex were correlated with spatial memory performance i  the water maze in aged 
wild-type mice but not aged 11β-HSD1-/- mice, suggesting that age-associated 
impairments in spatial memory in wild-type mice are associated with altered glial 
cell activity and altered levels of glutamate and the glutamate-glutamine complex. 
Spatial working memory measures in aged mice were not associated with any 
cellular, metabolite or structural markers. 
Previous research has demonstrated a large role for glucocorticoids and glial cell 
regulation (Jauregui-Huerta et al., 2010), with immunohistochemical studies also 
noting increased GFAP reactivity in response to chronic glucocorticoid exposure 
(Bridges et al., 2008). Furthermore, in more recent years, animal models of stress 
have observed elevated GFAP-immunoreactive astrocytes in the hippocampus 
(Lambert et al., 2000). Thus, our results add to previous data, suggesting that 
intracellular glucocorticoid levels regulated through 11β-HSD1 may alter glial cell 
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performance in aged mice pointing to a possible mechanism through which the 
increase of intracellular glucocorticoids through 11β-HSD1 may impact cognitive 
function with age. 
Notably, in our study higher levels of glutamine and the glutamate-glutamine 
complex were correlated with poorer performance in the water maze in wild-type 
mice. Previous studies have shown that glial cells play a large role in the glutamate-
glutamine cycle playing an essential role in producing glutamate for neurons (Hertz 
and Zielke, 2004). Furthermore, glutamate dysfunctio  has been implicated in 
cognitive impairment in a variety of diseases (Merritt et al., 2013). In particular, 
elevated levels of glutamate-glutamine have been associated with age-related 
diseases such as mild cognitive impairment (Olson et al., 2008) and further studies 
have implicated chronically elevated levels of glucocorticoids with poor glutamate 
uptake subsequently impairing damaging glutamate from being removed from 
synapses resulting in neuronal damage (Virgin et al., 1991).  
Taken all together our data suggest that altered glutamatergic neurotransmission may 
play a key role in age-related cognitive impairment a d that this role may be 
mediated by 11β-HSD1 activity on glial cell reactivity. 
The previous chapter showed age-associated impairments in spatial working memory 
were observed to be accelerated in both wild-type and 11β-HSD1-/- mice, with 11β-
HSD1-/- mice showing impairments earlier than wild-type mice. However, 
performance in the radial arm water maze, as assessed by savings across the 1 hour 
retention interval, was not associated with any changes in neurons, glial cells, 
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impairments in spatial working memory may be mediated by other mechanisms. 
Notably, measures of these metabolite and structural ch nges were taken in the 
hippocampus and previous studies have established key structures in addition to the 
hippocampus to also be involved in working memory. Spatial working memory 
requires both short-term storage and online manipulation of information which are 
processes sub-served by distinct cortical structures (Cohen et al., 1997). In particular 
numerous studies have shown the prefrontal cortex to be vital for the manipulation 
and retrieval of information with more posterior regions of the brain responsible for 
active maintenance of information (Cohen et al., 1997; van Asselen et al., 2006). 
Furthermore, some studies have suggested that the hippocampus plays a limited role 
in spatial working memory (Cave and Squire, 1992). Therefore, our data suggest that 
age-associated spatial working memory impairments are not mediated by age-
associated cellular, metabolite or structural changes within the hippocampus. As 
such, further work examining changes in metabolites and structure in 11β-HSD1-/- 
mice in other key brain regions involved in working memory will help identify the 
mechanisms through which 11β-HSD1 mediates working memory processes. 
This study had a number of limitations. Firstly, asmentioned previously, the 
longitudinal aspect of this study resulted in overtraining of mice on the water maze 
task, which may itself impact cellular, structural and metabolite changes with age. 
Additionally, as tissue could not be obtained on the longitudinal colony of mice till 
they were aged, it was not possible to include cell and protein data from when they 
were young and middle-aged. Consequently, the range of data available to test 
whether protein levels were related to cognitive performance was small, limiting 
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that data sets were used for multiple comparisons increasing the chance of false 
positive errors. Sample size for longitudinal H-MRS analysis was small which may 
have resulted in changes in metabolites being missed. Furthermore, metabolite levels 
in this study may have been at the level of detectability which may mask differences 
between genotypes and throughout ageing. Finally, analysis of protein expression 
through percentage fluorescence required a background fl orescence level to be set 
for determination of changes in fluorescence. Although background fluorescence was 
determined using negative control sections, analysis of changes in fluorescence may 
have been limited by comparing fluorescent changes to a predetermined background 
level as opposed to background for each individual sample. 
However, it is notable that repeated testing in such a longitudinal manner may itself 
be advantageous in replicating the ongoing use of cognitive faculties required 
throughout an individual’s lifespan and as such may provide clues as to the 
mechanisms through which age and glucocorticoids may affect performance in tasks 
and situations encountered throughout a lifespan as opposed to novel cognitively 
demanding situations.  
In conclusion, it was noted that elevated levels of intracellular glucocorticoids may 
alter cognitive function through altered glial reactivity profiles and altered 
glutamatergic neurotransmission. Indeed, in recent y ars, glial cells have been found 
to play key roles in modulation of neurotransmission (Auld and Robitaille, 2003) and 
have been noted to increase reactivity in inflammatory and neurodegenerative states. 
Examining how glucocorticoids might regulate neuroinflammation will provide a 
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Chapter 5   : Mechanisms of 11β-HSD1 Action 
on Acute and Age-Related Neuroinflammation 
 Introduction 5.1
In the previous chapter, an altered glial reactivity profile was observed in wild-type 
(but not 11β-HSD1-/- mice) and associated with cognitive function when aged, 
suggesting neuroinflammation may play a role in age-ssociated cognitive deficits. 
Therefore, in this chapter we will be focusing on the role of 11β-HSD1 on acute and 
age-related inflammatory changes and the effect of this on cognitive ageing. 
The immune system is essential in protecting organisms from disease by preventing 
and responding to the entry of pathogens into an organism. Within the CNS, the 
immune response is regulated by microglia (brain macrophages) comprising 10-15% 
of the cells in the brain and are concentrated in the hippocampus, hypothalamus, 
basal ganglia and substantia nigra (Lawson et al., 1990). 
Recent evidence has suggested that the aged brain is characterised by a chronic low 
level inflammation and ‘primed’ microglia – microglia demonstrating heightened 
reactivity in response to activation of the immune system (Sparkman and Johnson, 
2009; Frank et al., 2010). Additionally, it has been observed that genes involved in 
oxidative stress, inflammation and glial activation are increased during ageing whilst 
genes associated with synaptic function and growth factors decrease (Lee et al., 
2000; Blalock et al., 2003; Bishop et al., 2010).  Despite a large number of studies 
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have suggested there is also a pro-inflammatory role f r glucocorticoids with 
potentiation of the inflammatory response with elevat d acute and chronic 
glucocorticoid levels. In particular, this potentiation was observed to result in altered 
cognitive function and behaviour (Munhoz et al., 2010) and increased microglial 
activation, reactivity and proliferation (Johnson et al., 2002; Munhoz et al., 2006). 
Furthermore, studies have shown that prolonged activation of microglia can result in 
autoregulatory negative feedback with microglia consequently shifting phenotype 
from a classically activated state (M1) to and alternatively activated state (M2) which 
inactivates the initial immune response and activates genetic pathways associated 
with tissue repair (For review see Mantovani et al., 2004). However, whether 
intracellular regulation of glucocorticoids by 11β-HSD1 contributes to 
neuroinflammation and cognitive impairment with age has not yet been investigated.  
Thus, we hypothesised that 11β-HSD1 may contribute to cognitive decline by 
altering neuroinflammatory processes in the hippocampus. Therefore, this chapter 
aims to explore the role of 11β-HSD1 on both acute neuroinflammatory responses 
and neuroinflammation with age by investigating changes in inflammatory markers 
in response to LPS administration and with age and their correlation with cognitive 
performance in a subset of the longitudinal colony f wild-type and 11β-HSD1-/- 









Male 11β-HSD1-/- mice and their wild-type littermates were maintained in standard 
cages upon controlled lighting (12h:12h, lights on at 7.00), were fed a standard chow 
and given water ad libitum as described in Chapter 2. 
 LPS Experiment 5.2.1.1
A pilot study was conducted to determine the optimal time and dose. Mice were 
administered with either 5mg/kg or 10mg/kg of LPS or saline and returned to their 
home cage for 12, 24 or 48 hours.  Mice then receivd an overdose of sodium 
pentobarbital (0.4ml) and were then perfused with saline through cardiac puncture. 
Brains were then removed and half the brain fixed for immunofluorescent analysis 
and the remaining half dissected out for real time PCR analysis as outlined in 
Chapter 2. Levels of pro-inflammatory and anti-inflammatory cytokines were 
assessed and the dose and time-point producing the hig st inflammatory response 
were chosen. 
Mice were administered with either 5mg/kg of LPS or saline and returned to their 
home cage for 24 hours.  Mice then received an overd s  of sodium pentobarbital 
(0.4ml) and were then perfused with saline through cardiac puncture. Brains were 
then removed and half the brain fixed for immunoflurescent analysis and the 
remaining half dissected out for real time PCR analysis a  outlined in Chapter 2. 
Figure 5.1 illustrates the number of wild-type and 11β-HSD1-/- mice administered 
LPS or saline and the number from which tissue was obtained 24 hours post-
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Figure 5.1. Number of wild-type and 11β-HSD1-/- mice administered 
LPS or saline and the number from which tissue was obtained 24 
hours post-treatment administration. 
died and four 11β-HSD1-/- mice died following poor recovery from LPS 




 Ageing Experiment 5.2.1.2
Mice utilised were the same colony of mice examined Chapters 1 and 2.  
Following the final scan at 24 months of age, mice were perfused with saline through 
cardiac puncture and brains were removed. Half the brain was fixed for 
immunofluorescent analysis and the remaining half dissected out for real time PCR 
analysis as outline in Chapter 2. 
5.2.2 Immunofluorescence 
Sections were processed as outlined in Chapter 2 and stained for 11Β-HSD1, 
microglia, neuron and glial expression using primary ntibodies sheep purified, Rat 
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Fluor 488, anti-Rat Alexa Fluor 555 , anti-Mouse Alexa Fluor 555 and anti-Rabbit 
Alexa Fluor 555 respectively.  
A quantitative analysis of the immunofluorescence was performed utilising ImageJ 
to calculate the area of fluorescence for the specified stain meeting a predefined 
intensity as a percentage of the total area with hig er fluorescent percentages indicate 
a greater expression of 11β-HSD1 protein. The average area of fluorescence was 
taken over three fields from each brain region per mouse. 
5.2.3 Quantitative PCR 
Tissue was processed as outlined in Chapter 2 and RT-PCR products were then used 
for qPCR to quantify mRNA levels of: a) 11Β-HSD1; b) Pro-inflammatory cytokines 
– TNFα and IL-1β; and c) Alternative activated microglia markers – YM1 and Arg 1. 
Negative controls were included in each plate to ensure no contamination had taken 
place.  Internal controls included housekeeping genes HPRT and GAPDH. The 
LightCycler software provided relative quantification using the maximum second 
derivative method. 
5.2.4 Statistical Analysis 
Statistical analysis was conducted using PRISM with a P value < 0.05 signifying 
significance. 
Differences in neuroinflammatory markers in LPS and saline treated 11β-HSD1-/- 
and wild-type mice were calculated using a two-way ANOVA. Differences in 
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The relationship between variables (Probe test data, Radial arm water maze savings 
data, pro-inflammatory cytokine levels, anti-inflammatory cytokine levels) was 









5.3.1 11β-HSD1 in acute inflammation 
To determine if 11β-HSD1 mediates increased neuroinflammation in ageing and 
subsequently age-associated cognitive decline we inv stigated if 11β-HSD1 was 
expressed in microglia in-vivo and if the expression of 11β-HSD1 was altered in 
activated microglia following acute LPS administration. 
In wild-type mice, 11β-HSD1 was not expressed in the microglia in either saline 
treated or LPS treated mice (Figure 5.2). As expected, no 11β-HSD1 staining was 
observed in both saline and LPS treated 11β-HSD1-/- mice. 
A quantitative analysis of the immunofluorescence wasperformed utilising ImageJ 
as described in the methods section. 
There was no difference in levels of 11β-HSD1 protein in wild-type mice in any 
hippocampal subregion in response to LPS as measured by fluorescent 
immunohistochemistry. This was observed 24 hours following LPS administration 
suggesting that, contradictory to previous studies, 11β-HSD1 is not highly expressed 
in microglia in a basal state nor when activated by LPS. An unpaired t-test of 11β-
HSD1 fluorescence in saline and LPS treated wild-type mice revealed no significant 
difference in 11β-HSD1 fluorescence between saline and LPS treated wild-type mice 
in the CA1 [Saline: M = 1.436, SD = 0.5126, n = 4; LPS treated: M = 1.301, SD = 
0.2566, n = 6; t(4) = 0.2353, p = 0.3187; Fig. 5.3A], CA3 [Saline: M = 4.391, SD = 
1.679, n = 5; LPS treated: M = 3.916, SD = 1.493, n = 6; t(8) = 0.2112, p = 0.92951; 




Mechanisms of 11β-HSD1 Action on Acute and Age-Related Neuroinflammation 
 
168 
0.8022, n = 5; t(5) = 0.167, p = 0.1250; Fig. 5.3C] and cortex [Saline: M = 2.744, SD 
= 0.6810, n = 5; LPS treated: M = 5.181, SD = 1.345, n = 5; t(5) = 1.616, p = 0.2238; 
Fig. 5.3D] 
The expression of 11β-HSD1 mRNA in wild-type and 11β-HSD1-/- mice was also 
analysed by qPCR to investigate if 11β-HSD1 mRNA expression was altered 
following LPS administration. 
Hippocampal 11β-HSD1 mRNA was not altered by LPS compared to saline 
administration in wild-type mice [Saline: M = 1.019, SD = 0.2397, n = 4; LPS 
treated: M = 0.9435, SD = 0.3533, n = 5; t(5) = 0.1772, p = 0.5943; Fig. 5.4]. As 
expected, and in support of previous immunofluorescent data, 11β-HSD1 mRNA 
was not present in both saline and LPS treated 11β-HSD1-/- mice. 
These results suggest that 11β-HSD1 expression is not altered following activation of 
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Figure 5.2. 11β-HSD1 and Iba-1 expression in wild-type mice 
 
Fig. 5.2. Representative images of patterns of 11β-HSD1(Green) and Iba-1 (Red) expression in the 
CA1, CA3, Dentate Gyrus (DG) and Cortex of aged wild-type mice.  Images of CA1, CA3 and DG 
captured at 30x magnification using a Zeiss Axioskop c nfocal laser microscope.  Blue represents 



























Figure 5.3. Percentage Fluorescence of 11β-HSD1 
expression in saline and LPS treated wild-type mice 
A B
DC
Fig. 5.3. Graphs showing the percentage area of fluorescence of 11β-HSD1 in the [A] CA1 in 
young saline treated (n=4) and young wild-type mice treated with lipopolysaccharide over 24 
hours (LPS; n=5); [B] CA3 in young saline treated (n=5) and young LPS treated (n=6) wild-type 
mice; [C] dentate gyrus (DG) in young saline treated (n=5) and young LPS treated (n=5) wild-
type mice; and [D] cortex in young saline treated (n=4) and young LPS treated (n=5) wild-type 
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  Figure 5.4. 11β-HSD1 mRNA expression in saline 
and LPS treated wild-type mice 
Fig. 5.4. Graphs showing 11β-HSD1 mRNA expression in the whole hippocampus of saline 
treated wild-type mice (n=5) and wild-type mice treated with lipopolysaccharide over 24 hours 
(LPS; n=4).  Values represent mean relative mRNA expr ssion as a ratio of housekeeping genes 
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5.3.2 Microglia activation in acute LPS administration  
Microglial activation during an inflammatory response has been noted to result in the 
up-regulation of Iba-1, allowing activated and resting microglia to be differentiated 
(Ito et al., 1998). To investigate if microglia activation, following an acute 
inflammatory response, was altered by the lifelong deletion of 11β-HSD1, brain 
sections from young mice treated with LPS and saline were stained for microglia 
marker Iba-1 and immunofluorescence quantified. 
Interestingly, LPS treatment did not appear to stimulate microglia activation in either 
control or 11β-HSD1-/- mice. A two-way ANOVA analysis of percentage 
fluorescence of Iba-1 revealed no significant effect of treatment on the percentage 
fluorescence of Iba-1 in the CA1[F (1,13) = 4.143, p = 0.0627; Fig. 5.5A], CA3[F 
(1,13) = 1.258, p = 0.2838; Fig. 5.5B], DG [F (1,13) = 1.703, p = 0.2145; Fig. 5.5C] 
and cortex  [F (1,13) = 2.698, p = 0.1244; Fig. 5.5D] and no effect of genotype on the 
percentage fluorescence of Iba-1 in the CA1 [F (1,13) = 0.05132, p = 0.8243; Fig. 
5.5A], CA3 [F (1,13) = 0.3955, p = 0.5403; Fig. 5.5B], DG [F (1,13) = 0.3560, p = 
0.5610; Fig. 5.5C] and cortex [F (1,13) = 2.609, p = 0.1303; Fig. 5.5D]. 
This suggests that 24 hours following LPS treatment, there is no change in microglial 












Figure 5.5. Percentage Fluorescence of Iba-1 







Fig. 5.5. Graphs showing the percentage area of fluorescence of 11β-HSD1 in [A] CA1 in 
young saline treated wild-type mice (Saline; WT; n=5), young wild-type mice treated with 
lipopolysaccharide over 24 hours (LPS; WT; n=3), young saline treated 11β-HSD1
-/- 
mice (Saline; 
KO; n=4) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; 
n=5); [B] CA3 in young saline treated wild-type mice (Saline; WT; n=5), young wild-type mice 
treated with lipopolysaccharide over 24 hours (LPS; WT; n=3), young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=4) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 
hours (LPS; KO; n=5); [C] dentate gyrus (DG) in young saline treated wild-type mice (Saline; 
WT; n=5), young wild-type mice treated with lipopolysaccharide over 24 hours (LPS; WT; n=3), 
young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=4) and young 11β-HSD1
-/- 
mice treated 
with lipopolysaccharide over 24 hours (LPS; KO; n=5); and [D] cortex in young saline treated 
wild-type mice (Saline; WT; n=5), young wild-type mice treated with lipopolysaccharide over 24 
hours (LPS; WT; n=3), young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=4) and young 11β-
HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; n=5). Values represent 
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5.3.3 Expression of pro-inflammatory cytokine mRNAs 
following acute LPS administration  
An attack on the immune system results in an inflammatory response which is 
typically accompanied by an increase in pro-inflammatory cytokines, in particular 
tumour necrosis factor (TNF), interleukin (IL)-1, IL-6, IL-12 and IL-18. These 
cytokines then signal the activation of the adaptive immune system to aid in the 
defence of the organism. 
Therefore, to investigate if there was an increase in pro-inflammatory cytokines 
following acute LPS administration, brains were dissected out according to the 
protocol listed above and the expression of pro-inflammatory cytokine mRNA in the 
hippocampus and cortex was assessed using quantitative PCR. 
LPS significantly increased expression of TNFα mRNA in the hippocampus of 11β-
HSD1-/- mice independent of genotype.  A two-way ANOVA revealed a significant 
effect of treatment on mRNA expression of pro-inflammatory cytokine TNFα in the 
hippocampus following LPS administration [F (1,15) = 10.5, p = 0.055; Fig. 5.6A]  
but no effect of genotype on mRNA expression of pro-inflammatory cytokine TNFα 
in the hippocampus [F (1,15) = 0.1088, p = 0.7460; Fig. 5.6A]. Post hoc tests 
revealed significantly increased levels of TNFα mRNA in LPS treated 11β-HSD1-/- 
mice (p < 0.05) compared to their saline controls, however, wild-type TNFα mRNA 
levels were not significantly altered by LPS treatment. 
However, there was no significant effect of LPS trea ment on mRNA expression of 
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5.6B] and no effect of genotype on mRNA expression of pro-inflammatory cytokine 
TNFα in the cortex [F (1,13) = 0.00007313, p = 0.9933; Fig. 5.6B]. 
LPS had no effect on IL-1β in the hippocampus or cortex irrespective of genotype. A 
two-way ANOVA revealed no significant effect of treatment on mRNA expression 
of pro-inflammatory cytokine IL-1β in the hippocampus [F (1,15) = 1.420, p = 
0.2519; Fig. 5.7A] and cortex [F (1,13) = 0.6413, p = 0.4376; Fig. 5.7B] following 
LPS administration and no effect of genotype on mRNA expression of pro-
inflammatory cytokine IL-1β in the hippocampus [F (1,15) = 0.1049, p = 0.7505; 
Fig. 5.7A]  and cortex [F (1,13) = 0.01075, p = 0.919; Fig. 5.7B] following LPS 
administration. 
These results indicate that an inflammatory response was induced by acute LPS 
administration in 11β-HSD1-/- mice but not wild-type mice. The lack of increase in 
pro-inflammatory cytokine IL-1β suggests that each cytokine has its own time-course 
of expression in response to LPS and IL-1β may not be induced at this time point. 
Indeed, in our pilot study, we observed not only a much larger expression of TNFα 
following an acute inflammatory response but also a differing time-course of 
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Figure 5.6. TNFα mRNA expression in saline and LPS 




Fig. 5.6. Graphs showing TNFα mRNA expression in [A] the hippocampus of young saline 
treated wild-type mice (Saline; WT; n=5), young wild-type mice treated with lipopolysaccharide 
over 24 hours (LPS; WT; n=6), young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=4) and 
young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; n=4); and [B] 
cortex of saline treated wild-type mice (Saline; WT; n=4), young wild-type mice treated with 
lipopolysaccharide over 24 hours (LPS; WT; n=5), young saline treated 11β-HSD1
-/- 
mice (Saline; 
KO; n=3) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; 
n=5). Values represent mean relative mRNA expression as a ratio of housekeeping genes HPRT 










Figure 5.7. IL-1β mRNA expression in saline and LPS 




Fig. 5.7. Graphs showing IL-1β mRNA expression in [A] the hippocampus of young saline 
treated wild-type mice (Saline; WT; n=5), young wild-type mice treated with lipopolysaccharide 
over 24 hours (LPS; WT; n=6), young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=4) and 
young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; n=4); and [B] 
cortex of saline treated wild-type mice (Saline; WT; n=4), young wild-type mice treated with 
lipopolysaccharide over 24 hours (LPS; WT; n=5), young saline treated 11β-HSD1
-/- 
mice (Saline; 
KO; n=3) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; 
n=5). Values represent mean relative mRNA expression as a ratio of housekeeping genes HPRT 










Figure 5.8. Time-course of pro-inflammatory mRNA 
expression in LPS treated wild-type mice 
Fig. 5.8. Graph showing TNFα and IL-1β mRNA expression in the hippocampus of young wild-
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5.3.4 Expression of alternative activated microglia (M2) 
markers following acute LPS administration  
Previous research has indicated that in addition to the classical response of microglia 
(M1) and the release of pro-inflammatory cytokines to defend the body, microglia 
are also alternatively activated (M2). Although theclassical activation of microglia is 
effective and essential in responding to pathogens, the response can often result in 
damage to the surrounding tissue and is typically associated with disease states that 
are partially driven by low grade inflammation and i  particular is associated with 
Alzheimer’s disease. However, microglia also exhibit a response which inactivates 
the initial immune response and activates genetic pathways associated with tissue 
repair, M2-type activation.  This activity is associated with the production of anti-
inflammatory cytokines by glia and neurons, such as IL-4 and IL-10, and is 
characterised by suppression of pro-inflammatory cytokines, TNFα and IL-1β.  
Therefore, to investigate if the lack of increase in pro-inflammatory cytokine IL-1β 
was the result of M2-type microglia activation and subsequently the suppression of 
pro-inflammatory factors, the expression of markers M2-type activated microglia 
were examined following acute LPS administration in wild-type and 11β-HSD1-/- 
mice. The expression of mRNA for YM1 and Arg1, markers for activated microglia, 
in the hippocampus and cortex were assessed using quantitative PCR. 
LPS increased YM1 above saline controls irrespectiv of genotype. A two-way 
ANOVA revealed a significant effect of treatment on mRNA expression of activated 
microglia marker YM1 in the hippocampus [F (1,15) = 8.715, p = 0.0099; Fig. 5.9A] 
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administration and no effect of genotype on mRNA expr ssion of YM1 in the 
hippocampus [F (1,15) = 0.9522, p = 0.3446; Fig. 5.9A] and cortex [F (1,13) = 
0.5207, p = 0.4833; Fig. 5.9B] following LPS administration. 
However, there was no effect of treatment [F (1,15) = 0.007006, p = 0.9344; Fig. 
5.10] or genotype [F (1,15) = 1.036, p = 0.3249; Fig. 5.10] on mRNA expression of 
activated microglia marker Arg1 in the hippocampus whilst Arg1 mRNA levels in 
the cortex were undetectable. 
This suggests that removal of 11β-HSD1 had no effect on the alternative activation 
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Figure 5.9. YM1 mRNA expression in saline and LPS 




Fig. 5.9. Graphs showing YM1 mRNA expression in [A] the hippocampus of young saline 
treated wild-type mice (Saline; WT; n=5), young wild-type mice treated with lipopolysaccharide 
over 24 hours (LPS; WT; n=6), young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=4) and 
young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; n=4); and [B] 
cortex of saline treated wild-type mice (Saline; WT; n=4), young wild-type mice treated with 
lipopolysaccharide over 24 hours (LPS; WT; n=5), young saline treated 11β-HSD1
-/- 
mice (Saline; 
KO; n=3) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; 
n=5). Values represent mean relative mRNA expression as a ratio of housekeeping genes HPRT 










Figure 5.10. Arg1 mRNA expression in saline and LPS 





Fig. 5.9. Graph showing Arg1 mRNA expression in the hippocampus of young saline treated 
wild-type mice (Saline; WT; n=5), young wild-type mice treated with lipopolysaccharide over 24 
hours (LPS; WT; n=6), young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=4) and young 11β-
HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; n=4). Values represent 
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5.3.5 GFAP expression following acute LPS administration  
In the previous chapter, 11β-HSD1 was found to be expressed in glial cells. Previous 
research has suggested that glia and neurons may play an interactive role in the 
production of anti-inflammatory cytokines and suppression of the inflammatory 
response. In particular, glia cells have been noted to exhibit altered morphology and 
an upregulated expression of cell specific markers such as glial fibrillary acidic 
protein (GFAP) in response to inflammation. This enha ced GFAP expression has 
been associated with astrogliosis which can be botheneficial for neuronal growth 
and survival but also detrimental to the brain (Eng a d Ghirnikar, 1994). Therefore, 
we aimed to investigate if GFAP expression would be altered during an 
inflammatory response and if lifelong removal of 11β-HSD1 would alter this 
expression. 
Therefore, hippocampal sections of wild-type and 11β-HSD1-/- mice treated with 
saline or LPS were stained with the GFAP marker and immunofluorescent staining 
quantified to assess glial reactivity. 
LPS did not alter percentage fluorescence of GFAP in control or 11β-HSD1 
knockout hippocampus (any subregion) or cortex. A two-way ANOVA revealed no 
significant effect of genotype on percentage fluorescence of GFAP in the CA1 [F 
(1,14) = 0.09013, p = 0.7684; Fig. 5.11A], CA3 [F (1,14) = 0.9947, p = 0.3355; Fig. 
5.11B]  and DG [F (1,13) = 0.5992, p = 0.1818; Fig. 5.11C] of the hippocampus and 
no effect of treatment on percentage fluorescence of GFAP in the CA1 [F (1,14) = 
0.4311, p = 0.5221; Fig. 5.11A], CA3 [F (1,14) = 0.7333, p = 0.4062; Fig. 5.11B]  
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A two-way ANOVA revealed a significant effect of treatment on percentage 
fluorescence of GFAP in the cortex [F (1,11) = 6.69, p = 0.0252; Fig. 5.11D] but no 
significant effect of genotype on percentage fluorescence of GFAP in the cortex [F 
(1,11) = 0.2157, p = 0.6514; Fig. 5.11D]. However, post hoc tests revealed a 
significant increase in percentage fluorescence of GFAP in LPS treated 11β-HSD1-/- 
mice compared to saline treated 11β-HSD1-/- mice (p < 0.05) while no effect was 









Figure 5.11. Percentage Fluorescence of GFAP 







Fig. 5.11. Graphs showing percentage fluorescence of GFAP expression in [A] the CA1 of 
young saline treated wild-type mice (Saline; WT; n=5), young wild-type mice treated with 
lipopolysaccharide over 24 hours (LPS; WT; n=6), young saline treated 11β-HSD1
-/- 
mice (Saline; 
KO; n=4) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; 
n=4); and [B] CA3 of saline treated wild-type mice (Saline; WT; n=4), young wild-type mice 
treated with lipopolysaccharide over 24 hours (LPS; WT; n=5), young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=3) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 
hours (LPS; KO; n=5); [C] CA3 of saline treated wild-type mice (Saline; WT; n=4), young wild-
type mice treated with lipopolysaccharide over 24 hours (LPS; WT; n=5), young saline treated 
11β-HSD1
-/- 
mice (Saline; KO; n=3) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide 
over 24 hours (LPS; KO; n=5); and [D] CA3 of saline treated wild-type mice (Saline; WT; n=4), 
young wild-type mice treated with lipopolysaccharide over 24 hours (LPS; WT; n=5), young 
saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=3) and young 11β-HSD1
-/- 
mice treated with 
lipopolysaccharide over 24 hours (LPS; KO; n=5). Values represent mean percentage area of 
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5.3.6 NeuN expression following acute LPS administration  
Whilst neurons have been thought to play a role in the production of anti-
inflammatory cytokines, neurodegenerative diseases ar  typically characterised by 
neuronal loss and evidence has also pointed to neuro al death as a consequence of 
neuroinflammation and elevated levels of pro-inflammatory cytokines (Qin et al., 
2007). Therefore, we aimed to investigate if neuronal death would be observed 
during an inflammatory response and if lifelong removal of 11β-HSD1 would alter 
this expression. 
Therefore, hippocampal sections of wild-type and 11β-HSD1-/- mice treated with 
saline or LPS were stained for neuronal expression with the NeuN marker and 
immunofluorescent staining quantified. NeuN is a widely used marker which binds 
to an antigen expressed solely in neuronal nuclei, th refore, giving an indication of 
neuronal loss. 
Both wild-type and  11β-HSD1-/- mice exhibited significant neuronal loss in all 
hippocampal subregions and the cortex in response to LPS treatment, with a 
significant effect of treatment on percentage fluorescence of NeuN in the CA1 [F 
(1,13) = 84.45, p < 0.0001; Fig. 5.12A], CA3 [F (1,13) = 97.86, p < 0.0001; Fig. 
5.12B], DG [F (1,13) = 25.63, p = 0.0003; Fig. 5.12C] and cortex [F (1,13) = 95.28, 
p < 0.0001; Fig. 5.12D]. Post hoc tests indicated a decrease in percentage 
fluorescence of NeuN in LPS treated wild-type and 11β-HSD1-/- mice compared to 
saline treated wild-type and 11β-HSD1-/- mice (p < 0.05). 
No effect of genotype in any hippocampal subregions CA1 [F (1,13) = 0.8261, p = 
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0.4195, p = 0.5294; Fig. 5.12C] and the cortex [F (1,13) = 0.009432, p = 0.9244; Fig. 
5.12D] was observed.  
  
Figure 5.12. Percentage Fluorescence of NeuN 







Fig. 5.12. Graphs showing percentage fluorescence of NeuN expression in [A] the CA1 of 
young saline treated wild-type mice (Saline; WT; n=5), young wild-type mice treated with 
lipopolysaccharide over 24 hours (LPS; WT; n=6), young saline treated 11β-HSD1
-/- 
mice (Saline; 
KO; n=4) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 hours (LPS; KO; 
n=4); and [B] CA3 of saline treated wild-type mice (Saline; WT; n=4), young wild-type mice 
treated with lipopolysaccharide over 24 hours (LPS; WT; n=5), young saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=3) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide over 24 
hours (LPS; KO; n=5); [C] CA3 of saline treated wild-type mice (Saline; WT; n=4), young wild-
type mice treated with lipopolysaccharide over 24 hours (LPS; WT; n=5), young saline treated 
11β-HSD1
-/- 
mice (Saline; KO; n=3) and young 11β-HSD1
-/- 
mice treated with lipopolysaccharide 
over 24 hours (LPS; KO; n=5); and [D] CA3 of saline treated wild-type mice (Saline; WT; n=4), 
young wild-type mice treated with lipopolysaccharide over 24 hours (LPS; WT; n=5), young 
saline treated 11β-HSD1
-/- 
mice (Saline; KO; n=3) and young 11β-HSD1
-/- 
mice treated with 
lipopolysaccharide over 24 hours (LPS; KO; n=5). Values represent mean percentage area of 
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5.3.7 Microglia expression in aged mice 
Our study revealed no alteration in expression of microglia marker Iba-1 following 
LPS administration in both wild-type and 11β-HSD1-/- mice. However, previous 
research has suggested that ageing is associated with chronic low level inflammation 
and primed microglia. 
Therefore, to investigate if microglia expression was altered by age and lifelong 
removal of 11β-HSD1, sections were stained for the microglia marker Iba-1 and 
immunofluorescence quantified. 
There was no change in Iba-1 expression with age in the hippocampus or cortex 
suggesting there is a not significant activation of microglia in either genotype with 
age. A two-way ANOVA analysis of percentage fluorescence of Iba-1 revealed no 
significant effect of age on the percentage fluorescence of Iba-1 in the CA1 [F (1,24) 
= 4.883, p = 0.4914; Fig. 5.13A], CA3 [F (1,23) = 1.554, p = 0.2251; Fig. 5.13B] and 
DG [F (1,24) = 0.07533, p = 0.7858; Fig. 5.13C] of the hippocampus and no effect of 
genotype on the percentage fluorescence of Iba-1 in the CA1 [F (1,24) = 0.001155, p 
= 0.9732; Fig. 5.13A], CA3 [F (1,23) = 0.3426, p = 0.5640; Fig. 5.13B] and DG [F 
(1,24) = 0.1620, p = 0.6909; Fig. 5.13C] of the hippocampus. 
A two-way ANOVA revealed a significant effect of treatment on the percentage 
fluorescence of Iba-1 in the cortex [F (1,24) = 6.413, p = 0.0183; Fig. 5.13D] and  an 
effect of genotype on percentage fluorescence of Iba-1 in the cortex [F (1,24) = 









Figure 5.13. Percentage Fluorescence of Iba-1 
expression in young and aged wild-type mice 
A B
DC
Fig. 5.13. Graphs showing the percentage area of fluorescence of Iba-1 in young (n=4) and aged 
(n=13) wild-type mice (WT) and young (n=3) and aged (n=5) 11β-HSD1
-/-
 mice (KO) in the [A] 
CA1; [B] CA3; [C] dentate gyrus (DG); and [D] cortex.  Values represent mean percentage area 
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5.3.8 Pro-inflammatory mRNA expression in aged mice  
Altered levels of pro-inflammatory cytokine TNFα were observed following acute 
LPS administration in 11β-HSD1-/- mice. These results suggest that whilst wild-type 
mice did not have a large immune response to acute LPS administration, 11β-HSD1-/- 
mice have a large response to LPS induced inflammation suggesting that lifelong 
deletion of 11β-HSD1 alters the immune response to acute inflammation. 
Previous research has also suggested that chronic lw level inflammation is 
associated with ageing. Therefore, to investigate if inflammation was present during 
ageing and the effect of lifelong deletion of 11β-HSD1 on age-related inflammatory 
changes, levels of pro-inflammatory cytokine mRNA was examined in our aged mice 
colony. 
As was observed following acute LPS administration, a  unpaired t-test revealed 
significantly higher levels of TNFα mRNA in aged 11β-HSD1-/- mice compared to 
aged wild-type mice [11β-HSD1-/-: M = 0.9026, SD = 0.1083; Wild-type: M = 
0.3667, SD = 0.07763; t(18) = 4.021, p = 0.0008; Fig. 5.14A]. 
However, an unpaired t-test revealed no difference i  levels of pro-inflammatory 
cytokine IL-1β between aged 11β-HSD1-/- mice and aged wild-type mice [11β-
HSD1-/-: M = 1.844, SD = 0.5369; Wild-type: M = 1.372, SD = 0.3783; t(18) = 
0.7193, p = 0.4812; Fig. 5.14B]. 
These results show elevated levels of pro-inflammatory cytokine TNFα in 11β-
HSD1-/- mice compared to wild-type mice and that this is ob erved with ageing as 
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However, it is worthy to note that only elevated levels of TNFα were observed in 
11β-HSD1-/- mice whilst mRNA levels of pro-inflammatory cytokine IL-1β were 
found to remain unaltered both with age and following an acute inflammatory 
response. 
These results suggest that lifelong deletion of 11β-HSD1 has an impact on the levels 
of pro-inflammatory cytokine TNFα both following an acute inflammatory response 










Figure 5.14. TNFα and IL-1β mRNA expression in 
aged Wild-Type (WT) and 11β-HSD1-/- (KO) mice 
Fig. 5.14. Graphs showing hippocampal mRNA expression of [A] TNFα and [B] IL-1β in aged 
wild-type (WT; n=12) and 11β-HSD1
-/-  
mice (KO; n=11). Values represent mean relative mRNA 
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5.3.9 Expression of alternative activated microglia (M2) 
markers with age  
Previous research has suggested that during inflammation microglia also exhibit a 
response which suppresses the expression of pro-inflammatory cytokines and 
inactivates the initial immune response and activates signalling pathways associated 
with tissue repair. 
We investigated if the elevated levels of TNFα in 11β-HSD1-/- mice with age would 
alter the expression of alternative activated microglia and in turn aid in the 
attenuation of age-related spatial learning and memory impairments. 
YM1 mRNA expression was not altered in aged 11β-HSD1-/- mice  compared to 
aged wild-type mice. An unpaired t-test no differenc  in levels of YM1 mRNA in 
aged 11β-HSD1-/- mice compared to aged wild-type mice [11β-HSD1-/-: M = 1.643, 
SD = 0.3431; Wild-type: M = 1.155, SD = 0.3613; t(20) = 0.9792, p = 0.3392; Fig. 
5.15A]. 
Similarly, another alternative activated microglia marker Arg1 between aged 11β-
HSD1-/- mice and aged wild-type mice was unchanged [11β-HSD1-/-: M = 0.7059, 
SD = 0.2135; Wild-type: M = 0.7457, SD = 0.2517; t(20) = 1.207, p = 0.9051; Fig. 
5.15B]. 
These results suggest that the expression of alterntive activated microglial markers 










Figure 5.15. YM1 and Arg1 mRNA expression in 




Fig. 5.15. Graphs showing hippocampal mRNA expression of [A] YM1 and [B] Arg1 in aged 
wild-type (WT; n=12) and 11β-HSD1
-/-  
mice (KO; n=11). Values represent mean relative mRNA 
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5.3.10 Pro-inflammatory cytokine mRNA expression and 
spatial memory and spatial working memory 
 Probe Test 5.3.10.1
We tested if expression of pro-inflammatory cytokines would alter spatial memory in 
aged wild-type and 11β-HSD1-/- mice. 
mRNA levels of pro-inflammatory cytokines TNFα and IL-1β were tested to see if 
they would alter probe test performance at 24 months of age. Specifically, the latency 
to previous platform location and percentage time spnt swimming in the target 
quadrant were used to assess probe test performance. 
In the probe test, TNFα and IL-1β mRNA expression was not observed to be 
correlated with probe test performance in aged wild-type mice [TNFα x Latency to 
previous platform location: r = 0.1769, p = 0.6250; TNFα x Percentage time spent 
swimming in target quadrant:  r = -0.5731, p = 0.0833; IL-1β x Latency to previous 
platform location: r = -0.1241, p = 0.7326; IL-1β x Percentage time spent swimming 
in target quadrant:  r = -0.1557, p = 0.6675; Fig. 5.16]. 
However, aged 11β-HSD1-/- mice with higher expression of TNFα mRNA exhibited 
lower latencies to previous platform location in the probe test [ r = -0.8137, p = 
0.0489; Fig 5.16C]. However, no correlation was observed between the time spent 
swimming in the target quadrant and TNFα mRNA expression in aged 11β-HSD1-/- 
mice [ r = 0.1888, p = 0.7202; Fig. 5.16D]. 
No correlation was observed between the latency to previous platform location and 
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time spent swimming in the target quadrant and IL-1β mRNA expression in aged 





Figure 5.16. Correlation of TNFα mRNA 
expression and probe test performance in aged 






Fig. 5.16. Correlation coefficients (r) of the correlations calculated between hippocampal 
TNFα mRNA expression and [A] latency to previous platform location in the probe test in wild-
type mice (WT; n=10); [B] percentage time spent swimming in the target quadrant in the probe 
test in wild-type mice (WT; n=10); [C] latency to previous platform location in the probe test in 
11β-HSD1
-/-  
mice (KO; n=6); and [D] percentage time spent swimming in the target quadrant in 
the probe test in 11β-HSD1
-/-  
mice (KO; n=6). *p < 0.05; ** p < 0.01; *** p < 0.001. 
r = 0.1796 r = -0.0833 
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 Radial Arm Water Maze 5.3.10.2
No correlation was observed between the latency savings over the 1 hour retention 
interval and TNFα mRNA expression in aged wild-type [ r = 0.3190, p = 0.2460] and 
11β-HSD1-/- mice [ r = -0.3168, p = 0.2678] and error savings over the 1 hour 
retention interval and TNFα mRNA expression in aged wild-type  [ r = 0.1681, p =
0.5454] and 11β-HSD1-/- mice [ r = -0.2055, p = 0.4794]. 
No correlation was observed between the latency savings over the 1 hour retention 
interval and IL-1β mRNA expression in aged wild-type [ r = 0.2135, p =0.4416] and 
11β-HSD1-/- mice [ r = 0.1520, p = 0.6006] and error savings over the 1 hour 
retention interval and IL-1β mRNA expression in aged wild-type  [ r = 0.2219, p =
0.4215] and 11β-HSD1-/- mice [ r = 0.2396, p = 0.4053]. 
5.3.11 Expression of alternative activated microglia markers 
and spatial memory and spatial working memory 
 Probe Test 5.3.11.1
mRNA levels of alternative activated microglia markers YM1 and Arg1 were tested 
to see if they would alter spatial learning performance and probe test performance at 
24 months of age.  
Performance in the probe test section of the water maze was not associated with 
mRNA expression of alternative microglia activation markers YM1 and Arg1 in aged 
wild-type mice and aged 11β-HSD1-/- mice. No significant correlation between YM1 
mRNA expression and latency to previous platform location [ r = -0.4852, p = 
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was observed in wild-type mice and no correlation was observed between YM1 
mRNA expression and latency to previous platform location [ r = 0.6118, p = 
0.1968] and time spent swimming in the target quadrant and YM1 mRNA expression 
[ r = -0.2169, p = 0.6797] in aged 11β-HSD1-/- mice. 
No correlation was observed between the latency to previous platform location and 
Arg1 mRNA expression in aged wild-type mice [ r = -0.3419, p = 0.3755; Fig 5.17A] 
and time spent swimming in the target quadrant and Arg1 mRNA expression in aged 
wild-type mice [ r = 0.1770, p = 0.6248; Fig. 5.17B]. 
However, 11β-HSD1-/- mice with higher levels of Arg1 mRNA were noted to swim 
to the previous platform location faster with a significant correlation between the 
latency to previous platform location and Arg1 mRNA expression in aged 11β-
HSD1-/- mice [ r = -0.9740, p = 0.001; Fig. 5.17C]. No correlation was observed 
between the time spent swimming in the target quadrant and Arg1 mRNA expression 









Figure 5.17. Correlation of Arg1 mRNA expression 







Fig. 5.17. Correlation coefficients (r) of the correlations calculated between hippocampal Arg1 
mRNA expression and [A] latency to previous platform location in the probe test in wild-type 
mice (WT; n=10); [B] percentage time spent swimming in the target quadrant in the probe test in 
wild-type mice (WT; n=10); [C] latency to previous platform location in the probe test in 11β-
HSD1
-/-  
mice (KO; n=6); and [D] percentage time spent swimming in the target quadrant in the 
probe test in 11β-HSD1
-/-  
mice (KO; n=6). *p < 0.05; ** p < 0.01; *** p < 0.001. 
r = -0.3419 r = 0.1770 
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 Radial Arm Water Maze 5.3.11.2
No correlation was observed between the latency savings over the 1 hour retention 
interval and YM1 mRNA expression in aged wild-type [ r = 0.05475, p = 0.8487] 
and 11β-HSD1-/- mice [ r = 0.1414, p = 0.6269] and error savings over the 1 hour 
retention interval and YM1 mRNA expression in aged wild-type  [ r = 0.1518, p = 
0.5691] and 11β-HSD1-/- mice [ r = 0.3062, p = 0.2855]. 
No correlation was observed between the latency savings over the 1 hour retention 
interval and Arg1 mRNA expression in aged wild-type [ r = 0.2170, p = 0.4338] and 
11β-HSD1-/- mice [ r = 0.1967, p = 0.4968] and error savings over the 1 hour 
retention interval and Arg1 mRNA expression in aged wil -type  [ r = 0.827, p = 










The first part of this chapter aimed to examine the eff ct of acute inflammation on 
11β-HSD1 expression and the effect of lifelong removal of 11β-HSD1 on an acute 
inflammatory response. 11β-HSD1 was not expressed in microglia and levels did not 
change following LPS induced inflammation. However, lifelong removal of 11β-
HSD1 was found to potentiate the inflammatory response. 
Previous studies have found 11β-HSD1 to be expressed in cultured in-vitro microglia 
and upregulated following LPS administration (Gottfried-Blackmore et al., 2010). 
However, Initial investigations into the expression f 11β-HSD1 in microglia 
showed that 11β-HSD1 is not expressed in microglia. One possible reason for the 
difference in expression is the difference in experim ntal methodology with 
Gottfried-Blackmore et al. (2010), where cultured microglia were used possibly 
altering cell conditions and expression.  
LPS did not induce changes in either 11β-HSD1 protein or mRNA levels as observed 
by Gottfried-Blackmore et al. (2010) and studies demonstrating increased 11β-HSD1 
expression by pro-inflammatory cytokines IL-1 and TNFα (Chapman et al., 2006a, 
2006b; Cooper and Stewart, 2009), suggesting that in the brain 11β-HSD1 
expression may be driven by other additional factors. Notably, pro-inflammatory 
cytokine expression also showed limited change in this study, both wild-type and 
11β-HSD1-/- mice exhibited unaltered expression of the microglia marker, Iba-1, and 
pro-inflammatory cytokine IL-1β mRNA levels. These data indicate that the 
inflammatory response may not have been strong which may account for the absence 
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Interestingly, elevated levels of TNFα were observed following LPS administration 
in 11β-HSD1-/- mice. Previous research has suggested that whilst glucocorticoids 
inhibit both TNFα and IL-1β, there is a grading of sensitivity, with TNF having the 
greatest sensitivity and suppression occurring at physiological levels (O’Connor et 
al., 2000). Thus, our data suggest that 11β-HSD1-/- mice may be more sensitive to 
LPS administration. This is consistent with the classical view of glucocorticoids 
demonstrating anti-inflammatory effects through the inhibition of synthesis of 
cytokines and inflammatory mediators and resulting in a negative feedback loop. of 
glucocorticoids. Taken together our results suggest that 11β-HSD1-/- mice 
demonstrate a heightened inflammatory response following LPS administration, and 
that this response is likely mediated by the absence of anti-inflammatory actions of 
glucocorticoids.  
The second part of this study aimed to examine if age nd lifelong removal of 11β-
HSD1 altered the inflammatory status of the brain and if this inflammatory status 
was associated with cognitive performance with age. Secondly, it aimed to examine 
if the improved cognitive performance associated with 11β-HSD1 deletion is 
associated with decreased inflammation in the aged brain. 
Significantly higher mRNA levels of pro-inflammatory cytokine TNFα in aged 11β-
HSD1-/- mice compared to aged wild-type mice although no difference in pro-
inflammatory cytokine IL-1β was observed. Similarly, no difference in anti-
inflammatory cytokines YM1 and Arg 1 were observed. These results are consistent 
with previous studies indicating higher levels of inflammation in 11β-HSD1-/- mice 
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higher levels of age-related neuroinflammation. However, one key point to be taken 
into consideration when analysing these results is he unusual occurrence of tumours 
in a number of the aged 11β-HSD1-/- mice which may alter the inflammatory status 
observed. 
Markers of neuroinflammation were not associated with measures of spatial memory 
and spatial working memory in wild-type mice. Previous investigations have 
established that pro-inflammatory cytokines can act directly on neurons in the 
hippocampus resulting in impaired synaptic plasticity as well as alter neuronal 
function, neurogenesis and impair long-term potentiation.  Whilst more recently, 
Bonow et al. (2009) revealed during a microarray analysis of cortical tissue from 
mice injected with LPS that as well as in increase in inflammatory genes, 
neuroinflammation also leads to a decrease in genes related to learning and memory. 
However, TNFα mRNA levels were not related to spatial memory and spatial 
working memory in aged wild-type mice, suggesting that markers of 
neuroinflammation may not be directly related to cognitive performance.  
Interestingly, in 11β-HSD1-/- mice, higher levels of TNFα were associated with better 
spatial memory performance in the probe test. Notably, in 11β-HSD1-/- mice, higher 
expression of alternative activated microglia markers was associated with better 
spatial memory performance in the probe test. Previous studies have observed two 
main activation states of microglia - classical (M1) and alternative (M2) – with 
alternative activation characterised by the inactivation of the initial immune response 
and activation of genetic pathways associated with tissue repair.  This activity is 
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(For review see Mantovani et al., 2004). As such, our data suggest that the increased 
neuroinflammatory status of 11β-HSD1-/- mice may result in a shift of microglia 
states from classically activated microglial to alternatively activated microglia. This 
shift in activation may result in an attenuation of age-associated changes in the brain 
which may subsequently aid in the attenuation of processes contributing to age-
associated cognitive decline. 
However, some considerations to be made when examining the results of this chapter 
are the small group sizes. Although our study aimed to have group sizes as large as 
possible, experimental restraints and unforeseen tissue damage may have limited the 
group sizes.  
In conclusion, our data show that lifelong removal of 11β-HSD1 results in higher 
levels of neuroinflammatory markers. However, this increase in pro-inflammatory 
markers may lead to alternative activation of microglia which may subsequently have 
beneficial effects on age-associated spatial memory impairments.  Therefore, future 
work examining the relationship between alternative activated microglia and age-
associated brain changes will help in determining mechanisms underlying age-










Chapter 6 : General Discussion 
The primary goal of the research described in this the is was to determine the effect 
of reduced intracellular glucocorticoids through lifelong 11β-HSD1 removal on 
spatial memory and working memory over a lifespan and to investigate the possible 
mechanisms through which 11β-HSD1 removal may exert its effects. To this end, I 
used a longitudinal paradigm to examine how spatial memory and working memory 
were altered across the lifespan in wild-type mice and 11β-HSD1-/- mice. I tested 
spatial memory and working memory using a Morris water maze and the radial arm 
water maze respectively. I attempted to also examine lo gitudinally, structural and 
metabolite changes across the lifespan of the same wild-type and 11β-HSD1-/- mice 
by proton magnetic resonance spectroscopy (1H-MRS). A subset of the wild-type and 
11β-HSD1-/- mice undergoing longitudinal cognitive testing underwent 1H-MRS 
scanning following cognitive testing and their struc ural and metabolite data tested 
for associations with their cognitive performance prior to scanning. Tissue samples 
were collected proceeding final cognitive testing when aged and used to examine 
neuronal and glial profiles in wild-type and 11β-HSD1-/- mice and to assess if they 
altered cognitive function when aged. Finally, I examined the possible role of 
neuroinflammation as a mechanism through which glucocorticoids may alter 
cognitive function with age. I investigated the effect of an acute LPS-induced 
inflammatory response on the neuroinflammatory profile of wild-type and 11β-
HSD1-/- mice and examined the neuroinflammatory profile of the same wild-type and 
11β-HSD1-/- mice undergoing longitudinal cognitive testing. I then investigated the 







profile. In the following discussion I will summarise my main findings, discuss their 
wider implications and highlight some suggestions for future work. 
 Spatial learning and memory with age 6.1
Wild-type mice showed no impairment in spatial learning with age and 11β-HSD1-/- 
mice were not found to perform better than wild-type mice when aged as observed in 
previous studies (Yau et al., 2007, 2015; Wheelan et al., 2014). Spatial memory was 
observed to be impaired in wild-type but not 11β-HSD1-/- mice at 18 months. 
However, at 24 months both wild-type and 11β-HSD1-/- mice performed equally as 
well. These results are most likely attributed to repeat testing over the lifespan of 
wild-type and 11β-HSD1-/- mice and highlight the difference in processes behind 
spatial learning and spatial memory. Practice effects are characteristic of serial 
neurocognitive assessments. They refer to changes in t t performance as a result of 
increasing familiarity and exposure to test paradigms. Practice effects can be divided 
into two components - task familiarity and practice-related effects. These can result 
in the development of strategies over time that aid in the completion of the cognitive 
task, resulting in improvements that are unrelated to genotype. As spatial learning 
was assessed not only repeatedly with age, but also continuously over 5 days at each 
assessment, it is likely that mice became familiar with not only the task requirements 
but also with the testing arena. This may have result d in the development of 
different strategies to find the hidden platform with age which could explain why no 
impairment was observed in their spatial learning with age. One possibility is that 
over time, mice were more able to identify the platform location through other cues 







The effect of repeated testing on cognitive function could also explain the 
impairment and then improvement in spatial memory with age in wild-type mice. In 
particular, it is notable that spatial memory is a different process from spatial 
learning, requiring the transfer of information from short to long term memory. This 
may account for the different effect of longitudinal testing on the mice with spatial 
memory being more susceptible to age-associated impair ents as a result of the 
additional cognitive processes required for spatial information to be moved to long-
term memory. As such, repeated testing may not attenuat  spatial memory 
impairments as easily as for spatial learning impairments which may account for the 
u-shaped performance of wild-type mice in the probe test. Additionally, as the probe 
test was only conducted once at each time point, the practice effect may not have 
been as strong as seen in the spatial learning portion of the water maze.  
Taken altogether, these data suggest that longitudinal testing may result in a practice 
effect in cognitive tests which may prevent changes with age being observed. 
Secondly, these results highlight the difference in cognitive processes, demonstrating 
that spatial memory is more susceptible to age-associated impairments than spatial 
learning processes. These results parallel what is seen in age-associated cognitive 
decline in human, with long-term memories of events showing the largest 
impairment with age and short-term memory and procedural memories showing little 
decline with age. Notably, cognitive function throughout an individual’s lifespan, 
rarely consists of completely novel situations and task requirements. As such, whilst 
longitudinal testing may result in a practice effect and prevent changes in cognition 
from being observed, the effects occurring from longitudinal and repeated testing 







Therefore these results highlight the role of practice and repeated use of cognitive 
faculties in cognitive ageing. Assessing age-associated cognitive decline with a more 
robust cognitive test which is less susceptible to the practice effect would help to 
determine not only the role of 11β-HSD1 in age-associated cognitive decline but also 
the extent to which practice and task repetition may be beneficial in maintaining 
cognitive function with age.  
 Spatial working memory with age 6.2
It was hypothesised that spatial working memory would be impaired with age (Park 
et al., 1996, 2002) and, as working memory is more cognitively demanding, it was 
expected that impairments would be observed earlier in life and that these 
impairments would be attenuated by 11β-HSD1 removal in similar manner to the 
attenuation of spatial learning and memory deficits.  Spatial working memory did not 
appear to be affected by repeated testing in the same manner, with wild-type mice 
showing impaired spatial working memory with age. Most surprisingly, this 
impairment was not attenuated by 11β-HSD1 removal, rather, lifelong removal of 
11β-HSD1 was found to result in spatial working memory impairments earlier in life. 
This finding is novel and previously unreported, and suggests that 11β-HSD1 may be 
essential for maintaining spatial working memory throughout ageing. In particular, 
these results imply a distinct role for 11β-HSD1 in spatial learning and memory and 
in spatial working memory. Whilst both spatial memory and spatial working memory 
share some neural components, studies have concluded that these memory processes 
are independently regulated by different neuroanatomical circuits. As such, these 







involved in spatial working memory. Previous studies have found that spatial 
working memory involves activation of brain areas in addition to the hippocampus, 
such as the prefrontal cortex, and removal of 11β-HSD1 in these brain areas may be 
detrimental to the cognitive processes occurring within these areas (Cohen et al., 
1997; van Asselen et al., 2006). In particular, studies have found that glucocorticoids 
are essential for the maintenance of prefrontal cortex cognitive function, with 
reduced glucocorticoid action resulting in impaired working memory through altered 
dopaminergic function (Mizoguchi et al., 2004). Furthermore Barsegyan et al. (2010) 
glucocorticoid action could both enhance and impair different cognitive process at 
the same time. Therefore, the removal of 11β-HSD1, whilst beneficial in the 
hippocampal dependent cognition, 11β-HSD1 may be essential for cognitive 
processes in other brain regions. In particular, ou data show that removal of 11β-
HSD1 does not attenuate age-associated working memory i pairments and suggest 
that the absence of 11β-HSD1 may be detrimental to some aspects of cognition. 
Examining whether this is also the case when 11β-HSD1 is inhibited and whether 
inhibition completely removes 11β-HSD1 activity may be key in determining the 
extent to which 11β-HSD1 affects spatial working memory. 
 Glial cell activity and cognitive function 6.3
Interestingly, immunohistochemical data revealed 11β-HSD1 to be expressed in glial 
cells as opposed to neurons. This too was a novel finding and unreported by previous 
studies. Previous data had suggested that 11β-HSD1 may be expressed in neurons 
(Rajan et al., 1996; Wan et al., 2002), however, this study suggests that this is not the 







show that higher levels of 11β-HSD1 were found to be correlated with greater glial 
reactivity in wild-type mice and, in turn, increased glial reactivity was associated 
with poorer spatial memory in the water maze. These r ults suggest that increased 
glial reactivity may be a mechanism through which elevated intracellular 
glucocorticoids exert negative effects on memory with age. Indeed, glial reactivity 
has been observed to increase with age in the hippocampus and reductions in glial 
reactivity have been associated with better neuronal survival and long-term 
potentiation (McCall et al., 1996; Menet et al., 2000, 2001).  Therefore, elevated 
11β-HSD1 and glucocorticoids with age may contribute to increased glial reactivity 
and subsequently alter cognitive function.  
Furthermore, higher levels of the glutamate/glutamine complex were found to alter 
spatial memory in aged wild-type mice but not 11β-HSD1-/- mice. These results 
suggest that glutamate/glutamine levels may also be a mechanism through which 
glucocorticoids may act to alter cognitive function. Taken together with glial cell 
data discussed in the paragraph above, the data perh ps points to a process where 
intracellular glucocorticoids alter glial reactivity which in turn alters 
glutamate/glutamine expression and subsequently neuro al and cognitive function.  
As such, the implications of this data are that age- ssociated memory impairments 
may be mediated by glial cells in the hippocampus and that these glial cells may alter 
neuronal function and cognitive performance through altered glutamate/glutamine 
cycling. Thus, it may be beneficial to further explore the role of 11β-HSD1 in 








 Neuroinflammation and cognitive function 6.4
In our aged colony of mice, elevated levels of pro-inflammatory cytokines were 
observed in 11β-HSD1-/- mice compared to their wild-type counterparts. However, at 
the same time, increased expression of alternative activated microglia markers was 
found to be associated with better spatial memory.  
These results suggest that elevated pro-inflammatory cytokine levels throughout the 
lifespan of 11β-HSD1-/- mice results in a shift in microglial activation from 
classically activated microglia to alternative activa ed microglia with a 
neuroprotective and neuron supporting phenotype (Mantov ni et al., 2004). Thus, 
this study suggests that lifelong removal of 11β-HSD1 may alter the 
neuroinflammatory profile of the brain and this chronic or heightened 
neuroinflammatory profile may induce a microglial shift to a more protective state. 
This shift in microglial activation may then be beneficial during ageing when the 
neuroinflammatory profile of the brain is heightened and aid in attenuating any 
negative effects of neuroinflammation on cognition. Furthermore, taken together 
with  
 Proposed future work 6.5
This study was limited in a number of key ways, particularly for robustness of the 
water maze task to repeated testing and sample size. These limitations were due to a 
number of factors, including costs and limited resources and space to sufficiently 
vary the water maze arena when testing. Protein data w s also unavailable at early 
ages due to the longitudinal nature of the experiment. This data will have proven 







Ideally, the first step in creating follow up studies would be to combine groups of 
animals to be tested cognitively then culled and tissue collected for analysis at each 
age-point throughout the lifespan, this would provide a complete picture of 
alterations with age and their relationship to cognitive function and 11β-HSD1. 
Additionally, further work investigating the extent to which 11β-HSD1 activity 
regulates prefrontal cortex cognitive function will be key in determining the overall 
functional benefits of 11β-HSD1 inhibition on age-associated cognitive impairments. 
Finally, examining the role of 11β-HSD1 in glial cell signalling and function and 
glutamate/glutamine cycling, and 11β-HSD1 in the activation of alternative activated 
microglia would enable a deeper understanding into how regeneration of intracellular 
glucocorticoids might alter cognitive function with age. This may help in identifying 
more specific therapeutic targets for age-associated cognitive impairments. 
 Final Conclusions 6.6
In conclusion, longitudinal testing resulted in a pr ctice effect resulting in minimal 
impairments in spatial learning. Spatial memory showed some impairment with age, 
which were attenuated by 11β-HSD1 removal, highlighting the increased 
susceptibility of memory to age-associated long-term memory impairments and 
benefit of 11β-HSD1 removal on hippocampal dependent memory. These 
impairments in spatial memory were found to be associated with increased glial 
reactivity and increased glial reactivity. Notably, increased levels of the 
glutamate/glutamine complex, which is highly regulated by glial cells and plays an 







suggesting an overall effect of glucocorticoids on cognitive function through 
increased glial cell reactivity and consequently altered glutamate/glutamine cycling. 
Importantly, this study also highlighted the role of enzyme 11β-HSD1 in reducing, 
although not completely suppressing, neuroinflammation with age. However, it also 
indicated a role for 11β-HSD1 in altering the polarisation of classically activated 
microglia to alternative activated microglia, suggesting overall that memory 
impairments with age may also be mediated by the eff ct of glucocorticoids on 
microglial activation. 
Finally, our study found that complete removal of 11β-HSD1 may not be beneficial 
for all cognitive processes, in particular working memory processes. This suggests 
that 11β-HSD1 may alter cognition through different mechanisms in different brain 
regions and highlights the need to further examine the impact of 11β-HSD1 on 
different cognitive processes to determine the overall benefit of 11β-HSD1 inhibition 
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